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ABSTRACT
The genus B rucella is composed o f Gram-negative, facultative intracellular
pathogens that impact man and animals. B rucella species express a 25 kDa major
outer membrane protein termed Omp25. To determine the role o f Omp25 in
virulence, mutants were created in B rucella abortus (B A25), B rucella m elitensis
(BM25), and B rucella ovis (B025) that contain disruptions in the om p25 gene
(Aomp25 mutants).
In the murine brucellosis model, each Aomp25 mutant was attenuated when
compared to the virulent parental strain. To assess the ability o f the B . abortus and B.
m elitensis mutants to colonize and induce abortions in the ruminant host, cattle and
goats in late-gestation were inoculated with BA25 or BM2S, respectively. Significant
decreases in the abortion and colonization profiles of BA25-infected cattle and BM25infected goats were observed when compared to animals inoculated with the parental
strains (P<0.05, n = 10). While virulent B . abortus colonized 10/10 calves and
induced abortions in 5/10 dams, BA25 colonized only 3/10 calves and caused one
abortion. BM25 did not cause abortions and failed to colonize 5/9 caprine dams
compared to 6/6 colonized dams and abortions in goats inoculated with the parental
strain. The capacity o f brucellae to replicate inside macrophages and chorionic
trophoblasts plays an important role in fetal pathogenesis. The in vitro replication rate
o f the B . abortus Aomp25 mutant in these cells is significantly less than the replication
rate of the parental strain (P<0.05, n = 5). Such differences may explain the
attenuation o f both BA25 and BM25 in vivo.
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Because they appeared attenuated, the effectiveness o f the mutants as vaccine
candidates was subsequently determined. Vaccination o f mice with either BM25 or
B 02S provided significant protection against challenge with the homologous virulent
parental strain (/*<0.01, n = 5). Vaccination o f goats with BM25 provided protection
against abortion and colonization at levels equal to the current caprine vaccine, B.
m elitensis strain Rev. 1. Unlike strain Rev. 1 which causes abortions when given to
pregnant goats, BM25 is safe for pregnant goats and may be a possible vaccine
alternative to strain Rev. 1. In summary, the described B rucella bom p25 mutants are
attenuated and efficacious against virulent challenge.
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CHAPTER I
RESEARCH OBJECTIVES
Introduction
B rucella species (spp.) are facultative, intracellular Gram-negative bacteria
that infect a wide variety o f hosts (Corbel, 1998). B rucella m elitensis and Brucella
abortus are recognized causes o f abortion during the third trimester o f pregnancy in
goats and cattle, respectively (Enright, 1990). Infection o f humans with either strain
causes the disease undulant fever, which is characterized by severe fever, arthritis,
depression, and spondylitis (Young, 1995). Although non-pathogenic to humans,
B rucella ovis causes epididymitis, orchitis, and infertility in rams (Blasco, 1990).
The cell envelope o f B rucella spp. is composed o f an inner cell membrane, a
periplasmic space, a peptidoglycan layer, and an outer cell membrane containing
lipopolysaccharide (LPS) (Corbel, 1998). Located on the distal end o f the LPS is the
hydrophilic O-polysaccharide (O-side chain) (Corbel, 1998). The outer membrane
contains outer membrane proteins (Omps), including a 94 kDa structural protein
(group 1), a 41-43 kDa porin protein (group 2), and two proteins o f 25 and 31 kDa
(group 3) (Verstreate et al., 1982; Cloeckaert et al., 1996a). The function o f the 25
kDa Omp (Omp25) is unknown while the 31 lcDa Omp (Omp31) may be a second
porin (Cloeckaert et al., 1992; Vizcaino et al., 1996). Omp25 is a transmembrane
protein that is expressed on the surface o f the outer cell membrane and is covalently
bound to the peptidoglycan layer o f the cell (Dubray and Charriaut, 1983; Cloeckaert
et al., 1990; Cloeckaert et al., 1992). Omp25 may be a structural outer membrane

1
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protein that stabilizes the outer membrane by binding the underlying peptidoglycan
layer and outer cell membrane.
Omp25 may also be an important component o f the protective immune
response against B rucella spp. Immunization of mice with whole-cell sonicates o f
Escherichia coli expressing recombinant Omp2S provides protection against challenge
with rough strains o f B. m elitensis which lack the LPS O-side chain (Bowden et al.,
1998). Murine vaccination with the sodium dodecyl sulfate insoluble cell wall
fraction o f B. abortus, which contains approximately 50% outer membrane protein,
provides protection equal to that o f killed-whole cells (Dubray and Bezard, 1980;
Cloeckaert et al., 1996c). Cattle and mice vaccinated with native cell envelope which
was enriched for Omp25 in an oil base adjuvant developed lymphocyte blastogenesis
responses and delayed hypersensitivity reactions to Omp25 one to three months
following vaccination (Winter and Rowe, 1988). A hot saline extract (HS) o f the B.
ovis outer membrane, which is rich in Omp25, protected mice against challenge with
virulent B. ovis, and passive transfer o f both T lymphocytes and antibodies from
similarly vaccinated mice provided protection (Jimenez de Bagues, 1994a). Based on
these findings, Omp25 might be a good candidate for inclusion in a subcellular
vaccine for brucellosis.
Alterations in the cell envelope o f Gram-negative bacteria can produce mutants
with diminished pathogenicity for the host. In E. coli K -l the lack o f the structural
outer membrane protein A (OmpA) results in mutants that are attenuated in both
neonatal rats and embryonated chick eggs (Weiser and Gotschlich, 1991). A
Campylobacterje ju n i mutant lacking the CadF outer membrane protein was unable to

2
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colonize the cecum o f newly hatched chicks (Ziprin et al., 1999). Both OmpA and
CadF are outer membrane proteins with structures similar to that o f Omp25
(Baldermann et al., 1998).
Hypotheses
The lack o f Omp25 in Brucella spp. may affect the ability o f these organisms
to cause disease in the ruminant host. As a transmembrane protein spanning the outer
cell membrane and peptidoglycan, the lack o f Omp2S may affect the integrity o f the
outer membrane. One hypothesis for this research is that the lack o f Omp25 will
renAex Brucella spp. attenuated in ruminants.
Alternatively, the absence ofOm p25 in Brucella spp. may alter the host’s
immune response to this pathogen. Brucellae lacking Omp25 may fail to generate a
typical cell-mediated or humoral immune response in infected animals, resulting in an
exacerbation o f disease. The alternative hypothesis for this research is that the lack o f
Omp2S may render B rucella spp. more virulent in ruminants due to an altered immune
response.
Statem ent o f Research Objectives
The goal o f this work is to investigate the importance o f Omp25 in B rucella
spp. by analyzing the pathogenicity o f Aomp25 mutants o f B . m elitensis, B. abortus,
and B. ovis in the murine and ruminant models. The research objectives for these
studies are:
1.

To create and verify Aom p25 mutants o f B . m elitensis, B.
abortus, and B . ovis.

3
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2.

To initially characterize Omp25 mutants o f B. m elitensis, B . abortus,
and B. ovis in the murine brucellosis model.

3.

To evaluate the pathogenic potential o f the B. abortus Omp25 mutant
in the ruminant host utilizing in vitro assays with bovine phagocytes
and trophoblasts and an in vivo trial with pregnant cattle.

4.

To analyze the colonization and pathogenic potential o f the B.
m elitensis Omp25 mutant in the ruminant host with non-pregnant and
pregnant goats.

5.

To determine if the B . m elitensis and B . ovis Omp25 mutants are
efficacious vaccine candidates in the murine brucellosis model.

6.

To evaluate the vaccine efficacy o f the B . m elitensis Omp25 mutant
in pregnant goats.

In this dissertation, the research results are presented as four separate chapters.
A review o f the biology and pathology o f B rucella infections, focusing on key aspects
for virulence, precedes these sections. The chapters are as follows:
Chapter 2. Literature Review.
Chapter 3. Generation and Initial Description of B rucella m elitensis,
Brucella abortus, and Brucella ovis Mutants Lacking a 25 kDa Outer
Membrane Protein (Omp2S).
Chapter 4. A B rucella abortus Aomp25 Mutant in Cattle.
Chapter 5. A B rucella m elitensis Aomp25 Mutant in Goats.

4
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Chapter 6. Vaccine Trials with B rucella m elitensis and B rucella ovis
Mutants Lacking a 25 kDa Outer Membrane Protein (Omp2S).
Chapter 7. Assessments and Perspectives.

5
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CHAPTER2
LITERATURE REVIEW
In this review o f B rucella species (spp.), emphasis will be placed on
pathogenesis and those aspects o f bmcellae important for virulence. The general cell
envelope structure o f brucellae and specific disease caused by each species will be
described. The ability o f these organisms to survive inside the professional phagocyte
and to cause abortions will be discussed. Aspects of the immune system important for
protective immunity will be explained along with available vaccines. Based on this
information, the pathogenic importance o f a Brucella structural outer membrane
protein will be hypothesized.
Genus Brucella
Brucella spp. are Gram-negative, non-motile, non-encapsulated, non-spore
forming, aerobic, facultative intracellular pathogens (Corbel, 1998). The bacteria are
small coccobacilli which are 0.6-1.5 pm in length and 0.5-0.8 pm in width (Corbel,
1998). There are currently six recognized species in the genus B rucella; Brucella
abortus, Brucella m elitensis, B rucella suis, Brucella neotom ae, B rucella ovis, and
B rucella canis. Brucellae are important zoonotic and agricultural pathogens, infecting
a variety of hosts with varying degrees o f pathology. B rucella spp. contain two
chromosomes and a G + C DNA content o f 58-59 mol% (Corbel, 1998). Due to a
sequence homogeneity o f >90%, the genus may contain only a single species, which is
separated into different biovars. It has been proposed that all B rucella spp. be
considered biovars o f B. m elitensis (Meyer, 1990). However, this nomenclature has
not been accepted, and the traditional terminology is currently used.

6
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The genus is a member o f the 012 subdivision o f the Proteobacteria (Corbel,
1998). Other members o f this group include the animal pathogens o f the B artonella
genus, the plant symbionts o f the Rhizobium genus, and the plant pathogens o f the
Agrobacterium genus (Zinder, 1998). The phylogenetic relationship o f this group has
been further supported by the finding o f common antigenic determinants between
B rucella spp. and other members o f the 012 Proteobacteria (Cloeckaert et al., 1999).
Cell Envelope
The cell envelope o f B rucella spp. is comprised o f an inner cell membrane, the
periplasmic space, a peptidoglycan layer, and the outer cell membrane containing
lipopolysaccharide (LPS). The outer cell membrane and associated LPS is
approximately 9 nm thick and the muramic acid-containing peptidoglycan layer is 3-5
nm thick (Corbel, 1998). The LPS o f Gram-negative bacteria is composed o f three
parts: the proximal, hydrophobic lipid A region; the distal, hydrophilic Opolysaccharide region (O-side chain) that protrudes from the outer cell membrane; and
the core polysaccharide region (Nikaido and Vaara, 1987). The core polysaccharide is
attached to the lipid A by 2-keto-3-deoxyoctulosonic acid (KDO) (Nikaido and Vaara,
1987). In Brucella spp. the glycose backbone o f lipid A is made o f 2,3-diamino-2,3dideoxyglucose and 2-amino-2-dioxyglucose (Corbel, 1998). The core polysaccharide
is comprised o f glucose, mannose, and 6-amino-6-deoxyglucose (quinovosamine).
Both B . abortus and B. m elitensis O-side chain consist o f 4,6 dideoxy-4-formamidoD-mannose (V-formyl-D-perosamine). However, while the O-side chain o f 2?. abortus
biovar 1 comprises approximately 100 glycose residues linked a-1,2, the O-side chain
o f B . m elitensis biovar 1 consist o f a repeating pattern o f 4 residues linked a-1,2

7
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followed by one residue linked a - 1,3 (Meikle et al., 1989; Corbel, 1998). The
difference in O-side chain structure between B. abortus biovar 1 and B . m elitensis
biovar 1 causes antigenic differences that can be identified by serological analysis.
The O-side chain structure o f B . m elitensis biovar 1 is termed the M antigen while that
of B. abortus biovar 1 is termed the A antigen (Meikle et al., 1989). Brucella suis
biovar 1 generates both M and A antigen-specific antibodies in the infected host due to
the presence o f both a-1,2 and a-1,3 linkages in the O-side chain (Meikle et al.,
1989).
The ceil envelopes o f B rucella spp. are more resistant to lysozyme digestion
than are the cell envelopes o f enterobacterial organisms, such as Escherichia coli,
which suggest that brucellae have unusual properties to the peptidoglycan structure
(Corbel, 1998). The B rucella peptidoglycan consist o f a glycan skeleton o f Dglucosamine and muramic acid linked by short chains o f alanine, glutamic acid, and
a,e-diaminopimelic acid. The phospholipid composition o f B rucella spp. is unusual
when compared to other Gram-negative organisms. The primary phospholipid o f
Brucella spp. is phosphatidylcholine, which is uncommon in both E. coli and
Salmonella typhim urium (Coman and Rock, 1987; Corbel, 1998). The phospholipids
phosphatidylethanolamine and cardiolipin, while being major lipid components o f E .
coli and S. typhim urium , are only a small percentage o f the total phospholipids in
brucellae (Coman and Rock, 1987; Corbel, 1998).
Contained within the cell envelope are three groups o f outer membrane
proteins (Omps) that are classified as group 1 (94 kDa), group 2 (41-43 kDa), and
group 3 (2S-31 kDa) (Dubray and Bezard, 1980; Verstreate et al., 1982). The 94 kDa

8
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group 1 Omps are considered minor components o f the cell envelop (Verstreate et al.,
1982). The group 2 Omps are porins that form a trimer in the native state (Douglas et
al., 1984). Ficht et al. (1988, 1989) have shown that the Brucella group 2 porin is
encoded and potentially expressed by two closely related genes, om p2a and omp2b.
The two genes share 85% DNA homology at the nucleotide level, are separated by 900
bp, and are oriented in opposite directions on the chromosome. The predicted amino
acid sequence o f both genes shares 30-40% identity with the RopA protein o f
Rhizobium leguminosarum, an ct2 Proteobacteria (Cloeckaert et al., 1996a).
The group 3 Omps comprise two separate proteins of 25 kDa (Omp25) and 31
kDa (Omp31) (Cloeckaert et al., 1996a). Based on the predicted amino acid sequence,
Omp31 shares 34% identity with Omp25 and 35% identity with the structural outer
membrane protein RopB o f R. legum inosarum (Vizcaino et al., 1996). Omp31 is
present on the outer cell membrane, associates with the peptidoglycan, and appears to
form oligomers resistant to sodium dodecyl sulfate (SDS) denaturation at low
temperatures, which is typical o f bacterial porins (Cloeckaert et al., 1990; Cloeckaert
et al., 1992; Vizcaino et al., 1996). Based on these findings, Omp31 is proposed to be
a porin (Vizcaino et al., 1996). The protein is expressed by all brucellae except fori?.
abortus due to a 17,119 bp genomic deletion (Vizcaino et al., 1996; Vizcaino et al.,
1999). This leaves Omp25 as the only group 3 Omp in B. abortus.
The Omp25 protein is expressed on the outer cell membrane o f each Brucella
spp. (Cloeckaert et al., 1996c). The protein is tightly associated with the
peptidoglycan layer by a possible covalent bond, and association o f Omp25 with LPS
is important for the reconstitution o f conformational epitopes on purified Omp25

9
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(Dubray and Charriaut, 1983; Cloeckaert et al., 1992; Cloeckaert et al., 1996c).
Analysis o f the Omp25 gene (omp25) with PCR-RFLP and nucleotide sequencing
indicates that the gene is highly conserved among the B rucella spp. (Cloeckaert et al.,
199S; Cloeckaert et al., 1996b). Only 12 variations in nucleotide sequence were
observed in the 639 bp length omp25. The greatest variation was a short 36 bp
deletion detected at the 3’ end of omp25 from B . ovis (Cloeckaert et al., 1996b).
The Omp25 protein is a highly conserved structural outer membrane protein o f
Brucella spp. that is associated with both the LPS and peptidoglycan. The protein was
originally considered a homologue o f the E . coli structural outer membrane protein,
OmpA, based on amino acid composition (Verstreate et al., 1982). However,
sequencing o f om p25 found the predicted amino acid sequence to have no homology
with the OmpA proteins o f E. coli, S. typhim urium , Serratia m arcescens, E nterobacter
aerogenes, or Shigella tfysenteriae (de Wergifosse et al., 1995). Baldermann et al.
(1998) have shown that while Omp25 and OmpA do not share amino acid sequence
homology, they do contain similar secondary structural properties.
The B rucella Omp25 does have 43% identity with the structural outer
membrane protein RopB o f R. leguminosarum (Cloeckaert et al., 1996a). Analogous
to Omp25, RopB is covalently associated with the peptidoglycan and shares structural
similarities with Omps from a variety o f Gram-negative bacteria (Roest et al., 1995;
Baldermann et al., 1998). Research indicates that RopB may play a role in the
formation o f the bacteroid (Roest et al., 1995). Under low nitrogen conditions,
Rhizobium spp. are able to interact with the roots o f leguminous plants to form
nitrogen-fixing nodules. During the establishment o f a root nodule, Rhizobium
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differentiates into a bacteroid form that undergoes distinct morphological and
biochemical changes, including a dramatic reduction in the expression o f RopB (Roest
et al., 1995). A more complete understanding o f the role o f RopB in the formation o f
the bacteroid may lend additional information on the function o f Omp25 in B rucella
spp.
B rucella m elitensis
In 1883 a small micrococci was isolated by Bruce from the spleen o f a British
soldier that had died o f a febrile illness common in soldiers stationed on the island o f
Malta (cited in Madkour, 1989; cited in Hall, 1989). The bacterium was termed
M icrococcus m elitensis, with m elitensis being derived from the Roman name for
Malta, “Melita”. The first accurate description o f the human disease was published in
1897 by Hughes, and the illness named “undulant fever” due to the recurring severe
pyrexia (cited in Madkour, 1989). Zammit identified goat’s milk as the source o f
M icrococcus m elitensis infection of humans on the island o f Malta in 1905 (cited in
Madkour, 1989; cited in Hall, 1989). Based on cell morphology and agglutination
profile, M icrococcus m elitensis was renamed Brucella m elitensis by Meyer and Shaw
in 1920 (cited in Madkour, 1989).
Besides being a human pathogen, B . m elitensis is also an agricultural problem
o f economic impact. Pregnant goats and sheep infected with B . m elitensis will often
abort during the last trimester of pregnancy. In crowded facilities the pathogen can
spread quickly following an abortion, posing a serious health threat to the flock and
animal handlers. Many scientists consider the coastal areas o f the Mediterranean to be
the origin o f B . m elitensis (Alton, 1990a; Garin-Bastuji et al., 1998). However, the
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organism is found in goats and sheep throughout the Middle East, Mongolia, Russia,
Mexico, and Latin America (Alton, 1990a; Garin-Bastuji et al., 1998; Kahler, 2000).
A recent serological survey indicates that B. m elitensis may also be common in goats
in Uganda (Kabagambe et al., 2000). Except for a few sporadic cases o f B. m elitensis,
o f which the last report was in 1970, the U.S. was thought to be free o f this pathogen.
However, in October 1999, four cows and a large flock o f goats and sheep from
Southern Texas were found to be infected with B. m elitensis (Kahler, 2000). This is
the first report o f a large population o f animals infected with B . m elitensis in U.S.
history. The probable source o f the infection is goats from Northern Mexico, which
may have been introduced into this naive population.
Brucella suis
In 1914, Traum isolated what appeared to be B . abortus from an aborted pig
obtained from an Indiana farm (cited in Madkour, 1989; cited in Hall, 1989).
However, subsequent work by Huddleson found the organism to be a new species o f
Brucella that was termed B. suis (cited in Madkour, 1989; cited in Hall, 1989). Like
B. m elitensis, B . suis is also a cause o f abortion, in this case, in pregnant sows. Feral
and domestic pigs in the U. S., South America, China, Polynesia, Australia, Germany,
and Poland are infected with B. suis biovar 1 (Alton, 1990b; Robson et al., 1993; Lord
et al., 1997; Heinritzi et al., 1999).
Infection o f sows with B . suis is characterized by abortions in late-gestation.
Often an infected sow will deliver some piglets live and healthy, while others will be
bom dead or die soon after birth (Alton, 1990b). Unlike B . abortus and B. m elitensis
where the male rarely develops clinical disease, boars colonized by B. suis present
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with epididymitis, orchitis, and subsequent infertility. B rucella suis is essentially a
venereal disease that is passed from the infected boar to the naive sow (Alton, 1990b).
Besides the reproductive complications of B . suis, swine can also develop partial
paralysis due to bursitis and spondylitis. Like B . m elitensis, B . suis is a major
zoonotic pathogen that will become increasingly important in developing countries
with the introduction o f large-scale swine operations (Alton, 1990b; Gibbs, 1997)
B rucella abortus
The organism B acillus abortus was isolated as a cause o f infectious bovine
abortion by Bang in 1897 and later renamed B rucella abortus in 1920 (cited in
Madkour, 1989). Infection o f naive cows with B . abortus often causes abortions
during the last trimester o f pregnancy (Enright, 1990). Like both B . m elitensis and B.
suis, the organism is also a zoonotic agent which causes undulant fever in man
(Young, 199S). Due to the agricultural and human health risk associated with bovine
brucellosis, the U.S. government led a sixty-year campaign to eradicate this pathogen
from domestic cattle in the U.S. The success o f this program is attested to by the fact
that only six states were classified “infected” as o f February 1, 2000 (Stevens et al.,
1997; Kahler, 2000). B rucella abortus is found in cattle throughout the world and has
been reported in numerous locations including: South America, Mexico, South Africa,
and India (Erasmus, 1995; Brown and Hernandez de Anda, 1998; Isloor et al., 1998;
Samartino et al., 1999).
B rucella canis
In 1968 a new B rucella spp. was isolated that was responsible for an epizootic
o f canine abortion, epididymitis, and sterility in several large commercial breeding
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kennels (Carmichael and Kenney, 1968). B rucella cam s has been confirmed to cause
abortions in pregnant bitches between 45 and 59 days o f gestation (Carmichael, 1990;
Johnson and Walker, 1992). Besides abortion, infected bitches often present with no
clinical signs. In contrast, the stud develops epididymitis, infertility, abnormal semen
quality, and testicular atrophy (Carmichael, 1990; Johnson and Walker, 1992). The
bacteria are spread both venereal ly and by contamination o f kennel floors with
infected maternal uterine tissues and fluids (Carmichael, 1990; Johnson and Walker,
1992). Long-term antibiotic treatment can control the infection; however, recurrence
is common and the damage to the epididymis from the pathogen is often permanent
(Carmichael, 1990; Nicoletti, 1991). Due to the difficulty in treating infected animals,
whole kennel depopulation is considered the only method to ensure elimination o f the
infection (Johnson and Walker, 1992). B rucella canis has been diagnosed in the U. S.,
Japan, Germany, Spain, Czechoslovakia, Tunisia, China, Mexico, Central America,
and South America (Carmichael and Shin, 1996).
B rucella ovis
B rucella ovis is a causative agent o f epididymitis, orchitis, and infertility in
sexually mature rams (Blasco, 1990). The organism was first characterized in sheep
from New Zealand and termed B . ovis (Buddie and Boyes, 1953). B rucella o vis has
since been found in Australia, the U. S., South America, Russia, Europe, and South
Africa (Blasco, 1990; Robles et al., 1998). Infections can occur in both juvenile and
adult males; however infection rates increase with age (Blasco, 1990; Cerri et al.,
1999). Venereal transmission via the ewe and direct contact between young rams are
the main methods o f transmission (Blasco, 1990; Grillo et al., 1999). Ewes rarely
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develop clinical signs; however a small percentage do abort in the last trimester o f
pregnancy (Libal and Kirkbride, 1983; Blasco, 1990; Grillo et al., 1999).
B rucella o vis colonizes the epididymides, testicles, vesicular glands,
bulbourethral glands, and ampullae o f the infected ram (Blasco, 1990). Infected males
eventually develop severe bilateral epididymitis, resulting in permanent sterility.
While bacteriological analysis o f samples from both the semen and epididymis will
usually yield brucellae organisms, the primary method o f detection is physical
examination for epididymitis (Blasco, 1990; Blasco, 1997). Identification and
removal o f infected rams, along with vaccination o f sexually immature males, are the
main control strategies in an infected herd (Blasco, 1990; Blasco, 1997).
O ther B rucella Species
Brucella neotom ae was isolated by Stoenner and Lackman in 19S7 from a
desert wood rat; the organism has not been isolated since and no disease has been
associated with this specie (cited in Madkour, 1989). A recent development has been
the isolation o f brucellae from whales, sea otters, porpoises, seals, and dolphins
stranded on either the North American or English coasts (Foster et al., 1998; Ewalt et
al., 1998). Analysis o f the marine mammal isolates with the standard biochemical
tests used to differentiate B rucella spp. indicates that these organisms are distinct from
the six recognized species (Foster et al., 1998; Ewalt et al., 1998). It has been
suggested that the marine mammal isolates should be considered biovars o f a new
Brucella spp. (Ewalt et al., 1998; Jensen et al., 1999). Further research is needed to
clarify the taxonomic organization o f these new isolates.
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Wildlife Brucellosis
While the U.S. government nears completion o f the eradication o f B . abortus
from bovine herds, a growing concern is brucellae infected wildlife reservoirs. Bison
and elk in the Greater Yellowstone Area (GYA), infected with B . abortus, represent
the largest reservoir in the U.S. (Davis, 1990). Data indicates that 37% o f the elk and
30-40% of the bison from GYA have agglutinating antibodies to B. abortus Opolysaccharide (Cheville et al., 1998). The presence o f these antibodies is indicative
o f field strain exposure and/or infection. These free-ranging animals may contact
domestic cattle on drive trails or on surrounding pasturelands. Under controlled
conditions, non-infected cattle developed brucellosis when held in the same padlock
with experimentally infected bison (Davis et al., 1990); and similar studies were
preformed in elk (Thome et al., 1979). More importantly, co-mingling o f bison and
cattle on a ranch in North Dakota resulted in bison infected with a field strain o fB .
abortus passing the infection to naive cattle (Flagg, 1983). It is clear from this work
that bison and elk infected with B. abortus do pose a threat to the elimination o f
bovine brucellosis from the U.S. (Davis, 1990; Cheville et al., 1998). In an effort to
address this problem, research is currently being performed with potential new vaccine
candidates for brucellosis in bison and elk (Cheville et al., 1998; Elzer et al., 1998a).
Feral swine in the Southern U. S., Australia, and Germany are known to be
infected with B. suis biovar 1 (Davis, 1990; Robson et al., 1993; Heinritzi et al., 1999).
Wild hogs colonized by B . suis present with the same clinical signs as domestic pigs,
including abortion, orchitis, arthritis, osteomyelitis, and partial paralysis (Davis,
1990). In both the U.S. and Australia, hunters and abattoir employees have been
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infected with B. suis while handling hunter-killed carcasses (Robson et al., 1993;
Gibbs, 1997). Besides posing a threat to human health, feral pigs can also infect
domestic bovine and swine herds (Davis, 1990). Based on the risk to both domestic
animals and humans, new methods o f control fori?, suis are needed. Since wild hogs
in the Southern U.S. are often found in inaccessible locals, including dense forests and
swamps, removal or direct vaccine inoculation is an unrealistic option. An oral
vaccine candidate for wild hogs that could be mixed with attractive baits such as com
and pecans is currently being investigated (Edmonds et al., 2000b).
Caribou, reindeer, and moose from Alaska, Canada, and Siberia are infected
with B . suis biovar 4 based on culture and serological analysis (Dieterich, 1981; Davis,
1990; Ferguson, 1997; Edmonds et al., 1999b). The clinical signs o f rangiferine
brucellosis include abortion, stillbirth, weak fawns, orchitis, epididymitis, arthritis,
lameness, and nephritis (Dieterich, 1981; Forbes and Tessaro, 1993). The percentage
o f animals with antibodies to the O-polysaccharide varies widely between herds and
within the same herd over time with values o f 0% to 57% reported (Dieterich, 1981;
Forbes and Tessaro, 1993; Ferguson, 1997). Based on prevalence rates in caribou,
Ferguson (1997) proposes that most Inuit caribou hunters on Baffin Island, Northwest
Territories, Canada, are eventually exposed to B . su is biovar 4 (Dieterich, 1981;
Forbes and Tessaro, 1993). Based on the data presented on caribou, reindeer, moose,
feral swine, elk, and bison, it is clear that wildlife reservoirs o f B rucella spp. are a
health threat to humans and domestic livestock.
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Human Brucellosis
B rucella m elitensis, B. suis, 2?. abortus, and B . cam s are all potential human
pathogens in decreasing order o f virulence (Young, 1995). B rucella neotom ae and B.
ovis have not been reported to cause disease in humans (Madkour, 1989). B rucella
m elitensis is a serious public health threat in many areas o f the world where goats and
sheep are an important source o f food and fiber stock (Alton, 1990a; Young, 1995).
The main method o f infection with this specie and B . abortus is via ingestion o f
unpasteurized milk and cheese, and other modes o f transmission include direct
handling o f infected tissues and fluids by animal handlers and abattoir employees
(Alton, 1990a; Young, 1995). B rucella su is is a growing problem in many areas o f the
world due to the development o f large scale swine operations and the hunting o f feral
hogs, which brings humans into closer contact with infected swine (Robson et al.,
1993; Gibbs, 1997).
Human brucellosis (undulant fever) is a febrile illness that can present with a
variety o f clinical symptoms (Young, 1995). Patients often complain o f cyclic fever,
fatigue, anorexia, weight loss, depression, and back pain. Bone and joint
complications are common and can include sacroiliitis, peripheral joint arthritis,
spondylitis, osteomyelitis, and bursitis. Respiratory problems including cough and
dyspnea are reported in approximately 15% o f cases. Men infected with B . su is and B.
abortus can develop acute orchitis and epididymitis (Gibbs, 1997). Endocarditis
caused by B rucella spp. is a serious complication that occurs in less than 2% o f cases
but is responsible for the majority o f Brucella-associated deaths (Young, 1995). Rare
cases o f undulant fever can include meningitis, liver cirrhosis, ileitis, and colitis. The
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recommended treatment for human brucellosis is doxycycline (200 mg/day) plus
rifampin (600 - 900 mg/day) once daily for 6 weeks. A common problem with
brucellosis is relapse after having taken the antibiotics for the prescribed period o f
time (Young, 1995).
Pathogenesis
Overview
Infection o f domestic ungulates with B rucella species can result in abortion
during the third trimester o f pregnancy (Corbel, 1998). Following entry into the host
by the oral mucosa, nasopharynx, conjunctival sac, or genital tract, the bacteria are
phagocytosed by macrophages and neutrophils in an effort to eliminate the pathogen
(Enright, 1990; Thoen et al., 1993). Once inside these phagocytes B rucella spp.
inhibit oxidative burst and phagosome-lysosome fusion, enabling the organisms to
replicate inside these cells (Kreutzer et al., 1979; Frenchick et al., 1985; Baldwin and
Winter, 1994; Liautard et al., 1996). Macrophages containing replicating brucellae
migrate to the draining lymph node via the lymphatics (Enright, 1990; Thoen et al.,
1993). Within 2-3 weeks following infection, the lymph node becomes hemorrhagic
due to the break down o f the vasculature within the node. During this process some
macrophages are lysed, and the brucellae enter the bloodstream and a subsequent
bacteremia develops (Payne, 1959; Enright, 1990; Thoen et al., 1993). During the
bacteremic phase the organism is disseminated throughout the host, localizing in the
reticuloendothelial system.
During pregnancy, Brucella spp. will colonize and replicate to high numbers
inside the trophoblastic cells o f the placenta (Anderson et al., 1986; Enright, 1990;
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Thoen et al., 1993). The resulting tissue necrosis causes damage to the fetal
membranes, allowing transmission of the bacteria to the fetus. For reasons that are not
completely understood, infection of the fetus results in an abortion during the third
trimester o f pregnancy (Anderson et al., 1986; Enright, 1990; Thoen et al., 1993).
Following an abortion, the offspring, placenta, uterine exudate, and maternal milk
have high numbers o f bacteria that contaminate the pasture and handling facilities with
infectious organisms which poses a threat to naive animals in the same area (Enright,
1990; Bercovich, 1998).
Phagocyte Evasion
During the process o f phagocytosis o f a pathogen, the organism is engulfed
inside a vacuole termed the phagosome in which the microbe is exposed to a variety o f
bactericidal agents (Rook, 1998; Kaufmann, 1999). Upon entry into the cell, the
phagosome is exposed to reactive oxygen intermediates (ROIs), including superoxide
anions, hydroxyl radicals, hydrogen peroxide, and singlet oxygens, which are all
highly reactive forms o f oxygen that damage bacterial DNA, lipids, and proteins
(Kaufmann, 1999). In the macrophage, fusion o f the phagosome and lysosome results
in formation o f the phagolysosome. In this environment the organisms are exposed to
low pH and bactericidal products including defensins and lysozyme. Also present in
these vacuoles are nitric oxide and other reactive nitrogen intermediates (RNIs) and
the myeloperoxidase system which halogenates water to form hypochlorous acid and
chloramines which both destroy biologically important microbial proteins (Rook,
1998; Kaufmann, 1999).
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B rucella spp. are able to resist or inhibit many o f the bactericidal mechanisms
o f macrophages and neutrophils. Kreutzer et al. (1979) showed that incubation o f both
smooth and rough strains o f B . abortus with either guinea pig or human neutrophils
resulted in less than 1% o f the bacterial cells dying by 120 minutes post-infection.
Based on electron microscopy studies, degranulation and oxidative burst were
hindered after ingestion o f B rucella spp. due to either the lack o f a proper stimulus or
active inhibition by the brucellae. Since no difference was observed in percent
survival between the rough and smooth Brucella strains, the authors hypothesized that
the O-side chain o f the LPS was not responsible for the observed resistance to
intracellular killing (Kreutzer et al., 1979).
Soluble water extracts o f B . abortus strain 2308 but not B . abortus strain 19
have been found to inhibit phagosome-lysosome fusion in murine peritoneal
macrophages (Frenchick et al., 198S). Brucella abortus strain 2308 is a virulent
challenge strain that has been documented by numerous laboratories to cause abortions
in experimentally infected cattle while strain 19 is an attenuated-live cattle vaccine
(Enright, 1990; Nicoletti, 1990a; Cheville et al., 1996; Elzer et al., 1998b).
Preincubation o f murine macrophages with low (90 ng) or high (300 pg)
concentrations o f a water soluble cell envelope extract from strain 2308 caused a
significant decrease in the rate o f phagosome-lysosome fusion when compared to
untreated controls (Frenchick et al., 1985). Use o f strain 19 cell extract at
concentrations five times those o f strain 2308 failed to demonstrate a similar decrease
in percent fusion. Chemical analysis o f the cell extract found it to consist of cell
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surface material including carbohydrates, glycopeptides, lipids, and LPS (Frenchick et
al., 1985).
Research by Porte et al. (1999) indicates early acidification o f the macrophage
phagosome may be essential for the survival o f B . su is in murine macrophages. In
murine J774 cells, the pH o f phagosomes containing B . suis was found to drop from
6.0 to 4.0-4.5 by 60 min post-infection. The addition o f a vacuolar proton-ATPase
(bafilomycin Ai) prior to infection blocked the acidification o f the phagosome and
resulted in a 34-fold decrease in bacterial numbers by 6 hours post-infection (Porte et
al., 1999). The low pH o f the phagosome may act as an intracellular signal on the
regulation o f B rucella genes involved in survival and multiplication within the
macrophage. The authors hypothesize that the typical decrease in viable brucellae
during initial infection o f macrophages in vitro may result from this period o f specific
adaptation and gene regulation induced by low pH (Porte et al., 1999).
Trophobiasts
Besides being able to grow in the professional phagocytes, B rucella species are
also known to colonize and replicate inside non-professional phagocytes. An
important aspect o f B rucella virulence is the capacity o f these organisms to undergo
extensive replication in the trophoblast cells o f the placenta (Enright, 1990; Thoen et
al., 1993). The placenta develops between the fetus and dam as a means o f nutrient
and waste exchange. In ruminants there are six cellular layers separating the maternal
and fetal blood streams which are the maternal endothelium, maternal connective
tissue, uterine epithelium, the trophobiasts (the outermost fetal cell layer), the fetal
connective tissue, and the fetal endothelium (Flood, 1991; Frandson and Spurgeon,
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1992). The fetal trophoblast, connective tissue, and endothelium layers are referred to
collectively as the chorion. Inside the chorion are two fluid filled sacs that separate
the fetus from the placenta. Immediately inside the chorion is the allantoic sac that
surrounds both the fetus and inner aminotic sac. The amnion membrane forms a
barrier between the outer allantoic sac and the inner aminotic sac, in which the fetus is
suspended (Flood, 1991; Frandson and Spurgeon, 1992).
The blood from the dam and fetus do not mix, but the chorion and maternal
endothelium must be close enough to allow the exchange oxygen, nutrients, and waste.
Variations exist between animal species as to the structure and exact nature o f this
exchange. The bovine, caprine, ovine, and porcine placentas are termed
epitheliochorial since the trophoblast cells lie against the uterine epithelium (Flood,
1991; Frandson and Spurgeon, 1992). In contrast, the canine placenta is
endotheliochorial because the fetal trophoblast cells interact directly with the maternal
endothelium; the maternal connective tissue and uterine epithelium are not present.
The placenta of primates and some rodents is termed hemochorial since all three
maternal cell layers, including the endothelium, are lost and the fetal trophoblast lie
directly against the maternal blood (Flood, 1991; Frandson and Spurgeon, 1992).
The area o f placental attachment between the dam and fetus also varies
between species. A diffuse placentation occurs in the porcine placenta where almost
the entire chorion is directly in contact with the uterine epithelium (Flood, 1991;
Frandson and Spurgeon, 1992). The canine placenta is termed zonary since a band o f
fetal and uterine membrane interchange develops only at the midline o f the fetus. The
hemochorial placenta o f primates and lower rodents is discoidal since a disk-shaped
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area o f contact occurs. The placental attachment of ruminants is unique since the
epitheliochorial contact o f the fetus and uterus occurs in localized mushroom-like
areas referred to as placentomes. Outside the placentome, the fetal and uterine
membranes do not interact. The fetal portion o f the placentome is termed the
cotyledon while that o f the dam is the caruncle. The caruncles project inward from the
surface of the uterus and form small villi that interdigitate with the fetal trophoblast
cells. The bovine caruncle forms a dome that extents outward into the chorion while
that o f the ovine forms a concave bowl that the fetal villi grow into. The caprine
caruncle also projects outward into the chorion, however the maternal villi do not
extend as far into the fetal epithelium as in the bovine placenta (Flood, 1991; Frandson
and Spurgeon, 1992).
The ability o f B rucella spp. to invade and replicate to high numbers in the
chorionic trophobiasts is thought to play a major role in the abortion process (Enright,
1990; Thoen et al., 1993). In 1959, Payne documented that experimental infection o f
naive cows with a virulent strain of B . abortus resulted in ulceration o f maternal and
fetal tissue in the placentome and the multiplication o f brucellae inside the chorionic
trophobiasts (Payne, 1959). The ability o iB . abortus to replicate in the bovine
trophoblast has also been demonstrated in vitro with trophoblastic cell lines and
chorioallantoic membrane explants (Samartino, 1991; Samartino et al., 1994;
Samartino and Enright, 1996). Three trophoblastic cell lines obtained from a 13-15
day old bovine embryo, a 5-month placenta, and 8-month placenta were able to be
experimentally infected with strain 2308 (Samartino et al., 1994). While extensive
bacterial replication occurred in both the 5-month and 8-month trophoblast cell lines
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up to 30 hours post-infection, no statistically significant increase in bacterial numbers
were observed in the early-gestational cell line after 4 hours post-infection. Similar
results were obtained from chorioallantoic membrane explants obtained from earlygestational (60-120 days) and late-gestational (180-240 days) cattle (Samartino and
Enright, 1996). The increased replication rate o f B . abortus in the late-gestational
trophobiasts when compared to early-gestational cell lines is thought to play a role in
the characteristic late-term abortion o f bovine brucellosis (Samartino, 1991; Samartino
et al., 1994; Samartino and Enright, 1996).
The sugar erythritol may play a role in the tropism o f brucellae to the
reproductive tract (Sangari and Aguero, 1996). Smith et al. (1962) proposed that
erythritol caused the localization o f B . abortus in the bovine placenta based on the
presence o f the sugar in the chorion and the ability o f B . abortus to metabolize it.
However, the erythritol-sensitive-vaccine B . abortus strain 19 and virulent B . ovis,
which does not utilize erythritol, both still cause abortions (Enright, 1990; Nicoletti,
1990a; Sangari and Aguero, 1996; Corbel, 1998). Based on these data, erythritol is
not the only factor involved in the tropism o f B rucella spp. for the chorionic
trophobiasts.
Based on experimental infection of pregnant goats with B . abortus, Anderson
et al. (1986) demonstrated that B rucella spp. first gain entry into the placenta via the
erythrophagocytic trophobiasts. In the central depression o f the placentome, some
maternal blood escapes from the capillaries and is actively phagocytosed by the first
fetal layer o f cells, the erythrophagocytic trophobiasts. During the bacteremia that
occurs following Brucella infection, some erythrophagocytic trophobiasts may not
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only take up maternal erythrocytes but also live brucellae. The erythrophagocytic
trophobiasts then infect the underlying chorioallantoic trophobiasts. In the
chorioallantoic trophobiasts, the bacteria grow to excessive numbers resulting in
necrosis and spread to adjacent cells and the uterine lumen. Via hematogenous
dissemination and ulceration o f chorionic membranes, the fetus becomes infected with
brucellae (Anderson et al., 1986). Often, the net result o f fetal colonization is abortion
during the third trimester o f pregnancy.
The exact mechanism by which fetal infection by brucellae causes abortions is
unknown. The impairment o f fetal circulation due to placentitis has been suggested as
a cause o f fetal abortion (Payne, 19S9). However, considerable variation occurs in the
distribution and severity o f placental lesions following an abortion with all the
placentomes rarely being affected (Enright, 1990; Thoen et al., 1993). LPS from E .
coli has been documented as causing abortions in cattle during the first trimester o f
pregnancy, however in vitro inoculation o f bovine trophoblast cell lines with purified
Brucella LPS did not cause cellular damage or detachment (Giri et al., 1990;
Samartino et al., 1994). Preliminary data indicates that infection o f the fetus by
brucellae may alter the normal hormonal levels o f the uterus and induce delivery prior
to maturation o f the fetus (Enright, 1990). Further research is needed to determine the
critical cause o f abortion following fetal infection by B rucella spp. However, it is
clear that bacterial colonization o f the chorionic trophobiasts play an integral role in
the abortion process.

26
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Immune Response
As facultative intracellular bacteria, Brucella spp. are able to reside inside the
host’s cells undetected by the humoral immune system. Therefore, as with most
intracellular pathogens, the role o f T cells and activated macrophages in resistance to
brucellosis in paramount (Winter, 1990; Kaufmann, 1999). Immune CD4 T cells
produce interferon-y (IFN-y) for macrophage activation, and CD8 T cells recognize
infected cells via the major histocompatibility class I complex (MHC class I) receptor
resulting in cell death. During bacteremia and following lysis o f infected cells,
antibodies aid in opsonization o f extracellular bacteria and bind to the macrophage Fc
receptor which results in increased triggering o f the respiratory burst in IFN-y
activated macrophages (Winter, 1990; Elzer et al., 1994a).
Murine Brucellosis Model
The B ALB/c murine model o f brucellosis established by Montaraz and Winter
(1986) has provided much o f the current understanding o f immunity to brucellosis.
The model is valuable since the murine colonization profile o f virulent type strains and
vaccine candidates mimics what is often attenuated in the ruminant host (Montaraz
and Winter, 1986; Winter, 1990; Schurig et al., 1991; Elzer et al., 1996; Stevens et al.,
1997; Edmonds et al., 2000a; Edmonds et al., 2000b). The murine model is also
useful due to practical concerns including availability o f reagents, cost, and population
homogeneity (Montaraz and Winter, 1986; Garcia-Carrillo, 1990; Winter, 1990).
The majority o f work published on the immune response in the murine
brucellosis model has been with virulent B. abortus strain 2308 and attenuated strain
19 (Winter, 1990). Intraperitoneal (i.p.) injection o f mice with 5 x 104 colony forming

27
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

units (CFU) o f strain 2308 results in a chronic infection that is not cleared by six
months post-infection (Montaraz and Winter, 1986). B rucella abortus strain 19 at 1
week post-infection replicates to the same extent as strain 2308 and by 2 weeks post
infection is 1.5 logs higher than strain 2308. However, by 4 weeks post-infection,
strain 19 drops 1 log lower than strain 2308 and by 8 weeks is almost cleared from the
spleen (Montaraz and Winter, 1986).
Murine Immune Response
By utilizing strain 2308 and strain 19 in mice, W inter and co-workers were
able to develop a better understanding o f the murine immune response to brucellosis
(Montaraz and Winter, 1986; Montaraz et al., 1986; Araya et al., 1989; Winter et al.,
1989; Araya and Winter, 1990; Winter, 1990; Elzer et al., 1994a; Elzer et al., 1994b).
Injection of mice either i.p. or intravenously (i.v.) with strain 2308 or strain 19 results
in localization o f brucellae in the reticuloendothelial system and specifically in the
spleen, as is the case with other facultative intracellular pathogens (Montaraz and
Winter, 1986; Kaufmann, 1999). Following splenic colonization, large numbers
o f monocytes infiltrate the spleen and begin to ingest brucellae by means o f
complement receptors (Winter, 1990). These phagocytes do not attain a sufficient
state o f activation to kill either strain 2308 or strain 19 due to the lack o f activation
factors (Araya et al., 1989; Winter 1990; Zhan and Cheers, 1993; Elzer et al., 1994a;
Kaufmann, 1999). Zhan and Cheers (1993) have shown that the macrophage
activating cytokine, IFN-y, is important in the controlling and/or killing of intracellular
brucellae since depletion o f this cytokine with anti-IFN-y monoclonal antibodies
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(MAbs) resulted in a significant increase in splenic colonization compared to
nontreated controls.
By 3 weeks post-infection antibody specific for B rucella begins to appear in
the mouse (Araya et al., 1989). Elzer et al. (1994b) found that at this time, as the
numbers o f strain 19 began to decrease, IgG3 antibodies developed that were effective
at opsonizing strain 19 and that likely bind to the macrophage Fc receptor resulting in
phagocyte activation and bacterial killing. IgG3 opsonized strain 19 is unable to
replicate in this hostile environment and is quickly eliminated while opsonized strain
2308 resists the killing processes o f the macrophage as previously described (Kreutzer
et al., 1979; Frenchick et al., 1985; Araya et al., 1989; Araya and Winter, 1990; Elzer
et al., 1994a; Liautard et al., 1996).
Serum from mice vaccinated with strain 19 that contained predominately Oside chain specific antibodies, was also demonstrated to provide between 2.0-2.5 logs
o f protection against challenge when passively transferred to naive animals (Araya et
al., 1989; Araya and Winter, 1990). The serum from mice obtained prior to 3 weeks
post-vaccination was not protective, and serum obtain at 6 weeks post-vaccination
afforded the greatest protection, approximately 2.5 logs. Monoclonal antibodies
specific for the LPS O-side chain have also been shown by different laboratories to
provide significant protection against virulent challenge in mice (Montaraz et al.,
1986; Winter et al., 1989; Cloeckaert et al., 1991; Jacques et al., 1992). Antibodies
specific for the O-side chain opsonize extracellular B rucella for phagocytosis by
professional phagocytes. Based on these data, antibody to the LPS O-side chain is
important for protective immunity against murine brucellosis.
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The importance o f T cells for immunity to brucellosis was demonstrated by
Araya et al. (1989) who found that the passive transfer o f T cells from strain 19
vaccinated mice provided approximately 2.0 logs of protection against virulent
challenge in naive mice. Both the CD8 and CD4 T cell populations were required for
protection since depopulation o f either T cell type resulted in an approximate 0.S log
reduction in protection. Combined transfer o f both immune serum and T cells
enhanced protection over that observed with either T cells or serum alone by
approximately 1 log. Passive transfer o f T cells from mice vaccinated less than 4
weeks did not protect against virulent challenge (Araya et al., 1989). Zhan and Cheers
(1993) found that depletion o f endogenous IFN-y from recipient mice prior to passive
transfer o f protective T cells blocked the adoptive transfer o f resistance indicating the
importance o f IFN-y in the cell-mediated immune (CMI) response through
macrophage activation.
The long protracted infection o f strain 2308 in BALB/c mice indicates that the
presence o f protective T cells is not enough is eliminate the pathogen (Montaraz and
Winter, 1986; Araya et al., 1989). W inter (1990) proposed that recovery from strain
2308 infection might depend on the formation o f both immune T cells and the
development of antibodies with high affinity and the required isotype. Elzer et al.
(1994b) found that mice infected with B rucella demonstrated a 38 fold increase in
B rucella-specific IgG3 and a 12 fold increase in IgG2a from 4 to 8 weeks post
infection. The authors proposed that the observed increase in both IgG3 and IgG2a
was driven by IFN-y which was derived in a T cell-independent manner until
approximately 4-5 weeks post-infection when T cells became the primary IFN-y
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producers. In murine brucellosis both the humoral and CMI response are important
for protection. O-side chain specific antibodies may opsonize extracellular bacteria
and activated macrophages to a bactericidal state via the Fc-receptor. Meanwhile,
CD8 T cells lyse infected cells and CD4 T cells activate macrophages through IFN-y
production.
Ruminant Immune Response
The bovine, ovine, and caprine immune responses to brucellae have not been
as well elucidated as the murine immune response. Activated macrophages and T
cells are both required for a protective immune response in ruminants (Nicoletti,
1990b; Nicoletti and Winter, 1990; Smith, 1990). Joubert and Valette (1967) found
that macrophages from strain 19 vaccinated cattle reduced the growth o f virulent B.
abortus by 54% in vitro when compared to macrophages from naive animals. The
importance o f bovine macrophages as antigen presenting cells (APC) for T
lymphocytes was documented in vitro by incubating bovine macrophages expressing
B rucella antigens with a MAb specific for the MHC class II receptor (Splitter and
Everlith, 1986). The ability o f T cells to proliferate in response to the APC
macrophages was evaluated by measuring the incorporation o f [3H]thymidine. T cells
incubated with anti-MHC class II treated macrophages showed a 9-fold decrease in
lymphocyte proliferation when compared to untreated controls (Splitter and Everlith,
1986).
Numerous authors have shown that cattle vaccinated with either strain 19 or
the rough cattle vaccine, B. abortus strain RB51, are protected against infection and
produce lymphocytes that proliferate in response to B rucella antigens (Kaneene et al.,
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1979; Confer et al., 1985; Nicoletti, 1990a; Stevens et al., 1995; Stevens et al., 1996).
The fact strain RB51 lacks the LPS O-side chain and protects cattle against brucellosis
indicates that B rucella O-side chain specific antibody titer does not correlate with
protection in strain 19 vaccinated cattle and that antibodies to the O-side chain are not
required for a protective immune response in cattle (Kaneene et al., 1979; Nicoletti,
1990b; Stevens et al., 1995; Stevens et al., 1996). In contrast to cattle, goats
vaccinated with strain RB51 or a rough mutant o f B . m elitensis develop a limited
protective immune response to brucellosis (Elzer et al., 1998c; P.H. Elzer, personal
communication). Currently the only successful vaccine for caprine brucellosis is
smooth B. m elitensis strain Rev. 1 (Alton, 1990a; Blasco, 1997). Based on these
findings, antibodies to the O-side chain may be necessary for a protective caprine
immune response to B. m elitensis (Elzer et al., 1998c).
Vaccines
The vaccines currently used for ruminant brucellosis are all attenuated-live
mutants that were empirically derived (Adams, 1990; Nicoletti, 1990a; Nicoletti,
1990b). These vaccines exhibit limited replication in the host, and they induce a
protective immune response. They are characterized by attenuation, induction o f a
protective CMI response, and stability upon multiple passages in vivo (Adams, 1990;
Nicoletti, 1990a; Nicoletti, 1990b).
Bovine Brucellosis
In 1923, Buck isolated an attenuated-live organism termed B. abortus strain 19
from a culture o f virulent B. abortus that was left at room temperature for over one
year (cited in Graves, 1943). Work by numerous scientists has documented that strain
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19 when given subcutaneous (s.c.) at 1 x 109 to 5 x 1010 CFU to sexually immature
cattle provides 65-75% protection against abortion when challenged with a virulent
strain as adults (Cotton et al., 1934; McDiarmid, 1957; Garcia-Carrillo, 1980; Confer
et al., 1985). In a seven-year study with approximately 500 cattle kept under strict
isolation conditions, McDiarmid (1957) found that vaccination o f 6 month old calves
with strain 19 protected these animals against experimental challenge through their
fifth pregnancy. The attenuation o f strain 19 was documented as being stable
following seven i.v. passages through pregnant cattle (Taylor and McDiarmid, 1949).
In 1940 strain 19 was introduced as the official U.S. bovine brucellosis vaccine
(Stevens et al., 1997).
Although strain 19 provides protection against B. abortus, the vaccine has
several drawbacks. B rucella abortus strain 19 and virulent field strains both carry the
immunodominant LPS O-side chain (Cotton et al., 1934; McDiarmid, 1957; GarciaCarrillo, 1980; Confer et al., 1985; Nicoletti, 1990a). This is important because all
accepted, current serologic tests for the diagnosis o f brucellosis identify infected
animals by detecting antibodies against the LPS O-side chain thus making it difficult
to readily differentiate between strain 19-vaccinated and field strain-infected cattle
(Alton et al., 1988; Stevens et al., 1997). Animals under one year o f age vaccinated
with strain 19 typically lose anti-O-side chain antibodies by the time o f sexual
maturity (Nicoletti, 1990a). As a result, full dose strain 19 vaccination (5 x 1010 CFU
s.c.) is only recommended for sexually immature females (Nicoletti, 1990a).
A problem associated with strain 19 calfhood vaccination is that some cattle
become chronically infected and retain a low-level titer to the LPS O-side chain
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(Meyer and Nelson, 1969; Duffield et al., 1984). Meyer and Nelson (1969) in a threeyear study documented ten separate dairies where 11 sexually mature Holsteins had
low level titers to the LPS O-side chain and were found to secrete strain 19 in the milk
for the length o f the study. Rarely, strain 19 also induces abortions if given to
pregnant cattle at 3 x 10s to 5 x 1010 CFU s.c., as is sometimes done in areas o f high
infectivity where animals are housed together in close proximity (Nicoletti, 1976;
Beckett and MacDiarmid, 1985). In two separate studies, strain 19 s.c. vaccination o f
10,000 animals with 5 x 10l° CFU and 300 animals with 3 x 1 0 * CFU resulted in
abortion rates of <1% and <3% respectively (Nicoletti, 1976; Beckett and
MacDiarmid, 1985).
Reports exist o f three bulls vaccinated at approximately 6 months of age which
were colonized by strain 19 in the reproductive tract and developed orchitis,
epididymitis, sterility, and high titer to the LPS O-side chain by 6 months post
vaccination (Danks, 1943; Lambert et al., 1964). Due to the orchitis and persistent Oside chain antibody titer that can occur in vaccinated bulls, the use o f strain 19 is
restricted to female cattle (Nicoletti, 1990a). This vaccine can also cause undulant
fever in humans if ingested or injected (Nicoletti, 1990a; Nicoletti, 1990b; Young,
1995). These problems associated with strain 19 have lead scientists to find a new
vaccine for bovine brucellosis. This new vaccine would show decreased pathogenicity
for the host, provide levels o f protection similar to strain 19, and would not induce
anti-O-side chain antibodies.
In 1996 the U.S. Department of Agriculture, Animal and Plant Health
Inspection Service approved the new calfhood brucellosis vaccine B . abortus strain
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RB51 that was developed to overcome the serologic problems associated with strain
19 (Stevens et al., 1997). Schurig et al. (1991) reported the development o f strain
RB51, a stable, rough, rifampin-resistant, variant o f virulent strain 2308 that was
isolated by 51 serial passages o f smooth strain 2308 on rifampin-containing media
plates. This new vaccine is devoid o f the LPS O-side chain, and strain RB51
vaccinated animals do not produce antibodies to the O-side chain thus alleviating the
serodiagnostic problems associated with strain 19 (Schurig et al., 1991; Stevens et al.,
1994; Stevens et al., 1995; Stevens and Olsen, 1996; Palmer et al., 1996; Palmer et al.,
1997; Elzer et al., 1998b; Edmonds et al., 1999a). The vaccine provides protection
equal to that o f strain 19 and does not induce abortions in pregnant cattle (Cheville et
al., 1996; Palmer et al., 1996; Palmer et al., 1997; Elzer et al., 1998b; Lord et al.,
1998b). Multiple passages in vivo have shown the vaccine to be stable; and after its
use by veterinarians and scientist worldwide, strain RB51 does not appear to be
pathogenic for humans (Schurig et al, 1991; Stevens et al., 1997). Vaccination o f
bulls with strain RB51 did not result in orchitis and vaccinated dams did not shed the
organism in their secretions (Edmonds et al., 1999a). Based on these studies, strain
RB51 provides protection equal to strain 19 but without the undesirable side effects
associated with strain 19.
Caprine and Ovine Brucellosis (Brucella m elitensis1
A suitable vaccine for small ruminants against B . m elitensis did not exist until
the report o f attenuated B . m elitensis strain Rev. 1 by Elberg and Faunce in 1957 (cited
in Jones et al., 1964). B rucella m elitensis strain Rev. 1 is a smooth streptomycinindependent isolate obtained from a mutant streptomycin-dependent population o f B.
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m elitensis (cited in Jones et al., 1964). In both controlled experimental studies and in
field trials throughout the world, strain Rev. 1 has proven efficacious against virulent
B . m elitensis in either goats o r sheep when given at 1 x 109 CFU s.c. (Jones et al.,
1964; Alton, 1966; Alton, 1987; Alton, 1990a; Blasco, 1997; Garin-Bastuji et al.,
1998; Scharp et al., 1999) Six serial in vivo passages in pregnant goats with strain
Rev. 1 found no reversion to a virulent phenotype (Alton et al., 1967). Alton (1966)
documented that s.c. vaccination o f 3 to 7 month old sexually immature goats with
strain Rev. 1 provided protection against virulent challenge 2.5 years following
vaccination. Due to its capability to provide protection against abortion and infection,
the strain Rev. 1 vaccine has been utilized throughout the world, including South
America, Europe, Africa, and Asia (Alton, 1990a).
As in the case o f B . abortus strain 19 vaccine, problems do exist with the use
o f strain Rev. 1. Vaccination o f pregnant goats or sheep s.c. with the standard dose o f
1 x 109 CFU can cause abortions 40-60 days post-vaccination (Jones et al., 1964;
Alton, 1966; Alton et al., 1967; Alton, 1987; Alton, 1990a; Blasco, 1997; GarinBastuji et al., 1998). Blasco (1997) reported that during large field trials with over
200 animals, abortion rates >75% occurred when sheep were vaccinated s.c. with 5 x
108 CFU o f strain Rev. 1 during the second and third months o f pregnancy. A second
problem with the use o f smooth strain Rev. 1 is the residual antibody titer to the LPS
O-side chain (Alton, 1987; Alton 1990a; Blasco, 1997; Garin-Bastuji et al., 1998).
Alton (1987) states that 5-15% o f goats vaccinated as adults with the standard Rev. 1
dose are positive for agglutinating antibodies to the O-side chain 1-2 years post
vaccination. As a result o f the problems associated with adult vaccination with strain
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Rev. 1, full dose vaccination is recommended for only sexually immature animals
between 3 and 8 months o f age (Alton, 1987; Alton, 1990a; Blasco, 1997). B rucella
m elitensis strain Rev. 1 must also be handled carefully since s.c. injection can cause
undulant fever in humans (Blasco and Diaz, 1993).
In developing countries where management practices are limited and infection
rates are high, the recommended vaccination o f only 3-8 month old sexually immature
animals is often impractical (Blasco, 1997). As an alternative, some authors have
suggested whole-flock vaccination every two years with a reduced dose o f strain Rev.
1 (S x 104 to 1 x 106 CFU) in addition to yearly vaccination o f sexually immature
animals with the full dose (Alton, 1987; Alton, 1990a; Scharp et al., 1999).
Alternative routes o f inoculation have also been suggested, including via the
conjunctival sac which appears to reduce both the occurrences of abortions and the
production o f long-term anti-O-side chain antibodies (Alton, 1987; Alton, 1990a).
Scharp et al. (1999) reported that in Kuwait the mass vaccination o f goats and sheep
with the reduced Rev. 1 dose o f 1 x 107 CFU s.c. resulted in a 65% decrease in the rate
B. m elitensis infection in small ruminants from 1993 to 1997 (5.8% to 2.02%).
Serological analysis showed no evidence o f persistent anti-O-side chain titers and no
increases in abortions (Scharp et al., 1999).
Several authors disagree with the use o f low dose Rev. 1 mass vaccination or
conjunctival inoculation (Zundel et al., 1992; Blasco, 1997; Garin-Bastuji et al., 1998).
Blasco (1997) reported that in Spain mass s.c. vaccination with the reduced dose o f
strain Rev. 1 (1 x 106 CFU) resulted in “thousands o f vaccine-induced abortions” that
occurred usually 40-60 days post-vaccination. B rucella m elitensis strain Rev. 1 was
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consistently isolated from abortions; and as a result, both low and high dose s.c.
vaccination was suspended in Spain (Blasco, 1997). Zundel et al. (1992) found that
conjunctival vaccination o f pregnant ewes and goats with 1 x1 0 * CFU o f strain Rev. 1
resulted in a 20% abortion rate. As a result, these authors consider mass conjunctival
vaccination with 1 x 1 0 s CFU o f strain Rev. 1 unsafe for pregnant animals (Zundel et
al., 1992). Due to the problems associated with low dose vaccination, Blasco (1997)
recommends standard Rev. 1 vaccination o f 3 to 8 month old small ruminants and
conjunctival vaccination o f adults at least 1 month prior to breeding and/or after the
completion o f lactation (Alton, 1990a; Blasco, 1997; Garin-Bastuji et al., 1998).
In the field, vaccination o f adults one month prior to breeding and after
completion o f lactation is difficult and often unrealistic in remote or financially
constrained areas (Blasco, 1997; Garin-Bastuji et al., 1998). An efficacious vaccine
that could be given to both pregnant adults and sexually immature animals would be a
major advantage in developing countries. Recent work with a rough mutant o f B .
m elitensis containing a disruption in a O-side chain synthesis gene or rough/?, abortus
strain RBS1 found neither vaccine efficacious against virulent B . m elitensis (Elzer et
al., 1998c; P.H. Elzer, personal communication).
Ovine Brucellosis (Brucella ervis)
Brucella m elitensis strain Rev. 1 is considered the best vaccine currently
available for the prevention o f ovine brucellosis due to B . o vis (Blasco et al., 1987;
Blasco, 1990; Jimenez de Bagues et al., 1995). Under experimental conditions, s.c.
vaccination o f 3 to 5 month old rams with 1 x 109 CFU o f strain Rev. 1 provides
between 75-100% protection against colonization by virulent B . ovis (Blasco et al.,

38
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

1987; Blasco, 1990; Marin et al., 1990; Blasco et al., 1993). As previously mentioned,
strain Rev. 1 induces persistent anti-O-side chain antibodies and is pathogenic for both
humans and pregnant sheep (Alton, 1990a; Blasco and Diaz, 1993; Blasco, 1997). In
countries such as the U.S. where B. m elitensis has rarely been isolated, the use of
attenuated B. m elitensis strains such as Rev. 1 is not allowed (Blasco, 1990; Jimenez
de Bagues et al., 1995). Therefore in the U.S. and similar countries, no vaccines are
available for ovine brucellosis.
Porcine Brucellosis
No vaccines are currently available for 5 . suis infections o f domestic or feral
swine (Alton, 1990b). In Venezuela, Lord et al. (1998a) found that oral vaccination o f
gilts with B. abortus strain RB51 did protect against infection under field conditions
where the mating boars were secreting up to 1 x 10s CFU/ml o f B . suis in the semen.
Under experimental conditions, sows fed >1 x 1010CFU o f strain RB51 mixed with
pecans and com were transiently colonized in the draining lymph node and mounted a
detectable humoral immune response (Edmonds et al., 2000b). Based on these two
studies, it may be possible to vaccinate infected feral swine with strain RB51 using
attractive baits such as com and pecans (Lord et al., 1998a; Edmonds et al., 2000b).
W ildlife Brucellosis
One possible method to control the problem o f bison and elk infected with B .
abortus in the Greater Yellowstone Area (GYA) is vaccination. Davis et al. (1991)
showed that vaccination o f pregnant bison with B . abortus strain 19 resulted in
abortions, chronic infections, and prolonged serologic response to the LPS O-side
chain. Due to the problems associated with strain 19 in bison, the new cattle vaccine
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B. abortus strain RB51 is now being evaluated in these animals. Vaccination o f ten
adult bison bulls, seven calves, and six females in the first trimester o f pregnancy with
strain RB51 resulted in clearance o f the vaccine by 13 weeks post-vaccination and no
abortions (Elzer et al., 1998a). Initial trials with bison indicate that strain RB51 may
also be efficacious against virulent B . abortus, however additional studies are
necessary (Cheville et al., 1998; P.H. Elzer, personal communication). The Wyoming
Game and Fish Department (WGFD) has vaccinated over 36,000 elk with B . abortus
strain 19 at WGFD-managed elk feeding grounds since 198S (Cheville et al., 1998). A
50% decrease in the prevalence o f brucellosis at one WGFD feeding ground was
attributed to strain 19 vaccination (Cheville et al., 1998). Elzer et al. (cited in Cheville
et al., 1998) found that oral vaccination of female elk with B . abortus strain RBS1
resulted in a 40% decrease in abortions and 70% decrease in colonization following
challenge with virulent B. abortus. While additional studies are necessary, it is clear
that vaccination o f bison and elk is a realistic option for the control o f brucellosis in
the GYA.
Outer Membrane Proteins
Immune Response
Besides work with live vaccines, several research groups have shown in mice
that extracts o f the B rucella cell wall contain important vaccine components. Dubray
and Bezard (1980) demonstrated that boiling the B. abortus cell wall in sodium
dodecyl sulfate resulted in an insoluble cell fraction (SDS-I) that provided some
protection when administered to mice. Analysis o f this SDS-I fraction in a SDSPAGE gel revealed three major protein bands o f 37 kDa, 25 kDa, and 15 kDa (Dubray
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and Bezard, 1980). In B . abortus these proteins were later identified to be the 41-43
kDa porin protein, the 25 kDa outer membrane protein (Omp25), and a 15 kDa
lipoprotein, respectively (Verstreate et al., 1982; Dubray and Charriaut, 1983; Douglas
et al., 1984; Verstreate and Winter, 1984; Cloeckaert et al., 1996a; Cloeckaert et al.,
1996c). Each major protein from the SDS-I fraction was eluted from the gel and
contained <5% o f the other proteins (Dubray and Bezard, 1980). Chemical analysis o f
the SDS-I fraction found it to consist of 30% peptidoglycan, 20% Omp2S, 13.5%
porin, 4.5% lipoprotein, and an additional 32% o f unidentified products including a
small amount o f LPS (Dubray and Bezard, 1980).
To study the vaccine properties o f the SDS-I fraction, mice were vaccinated
with either the hydrolyzed SDS-I fraction, Omp25, porin, or lipoprotein combined
with Freund’s incomplete adjuvant (FIA) (Dubray and Bezard, 1980). As positive
controls, an additional group o f mice were vaccinated with killed-whole cells o f B .
m elitensis strain H38, which provides protection in mice (Dubray and Bezard, 1980).
Both Omp25 and the porin provided approximately 1.7 logs o f protection against
virulent B. abortus 2 weeks following challenge. In comparison, killed-whole cells o f
strain H38 provided 2.07 logs o f protection while the entire SDS-I fraction provided
approximately 2.3 logs o f protection. Based on the vaccine properties o f SDS-I,
Dubray and Charriaut (1983) concluded that Omp25, the 36 kDa porin, and LPS were
the three most important antigenic surface components in this fraction.
Following the isolation of the major outer membrane proteins (Omps) o iB .
abortus by Verstreate et al. (1982), Winter and coworkers performed a series o f
experiments testing the immunogenicity o f these Omps in both cattle and mice
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(Winter et al., 1983; Baldwin et al., 1985; Montaraz and Winter, 1986; Winter et al.,
1986; W inter and Rowe, 1988). Vaccination o f mice with the native Omps o f B.
abortus in an oil-based adjuvant was found to provide significant protection against
virulent B. abortus at 1 and 4 weeks post-challenge (Montaraz and Winter, 1986).
Vaccination o f cattle with the cell envelope from B . abortus containing Omps,
peptidoglycan, and some LPS in a oil-based adjuvant resulted in both a positive
delayed type hypersensitivity reaction to the purified Omp25 protein and the
production o f anti-Omp25 antibodies up to 7 months post-vaccination (Winter et al.,
1986). W inter and Rowe (1988) showed that vaccination o f mice with either the
native cell envelope o f B . abortus or the SDS-I fraction described previously resulted
in equivalent levels o f protection in mice 1 and 4 weeks post-challenge. Winter and
Rowe (1988) also showed that vaccination o f cattle with either B . abortus cell
envelope, purified Omps, or SDS-I fraction in combination with an oil-based adjuvant
simulated Omp25-specific lymphocyte proliferation and delayed type hypersensitivity
reactions over a 3 month period. Based on this work, Winter and Rowe (1988)
concluded that the native cell envelopes o f B . abortus and the SDS-I fraction were
vaccines o f comparable quality based on measurements o f protective immunity in
mice and o f immunogenicity in cattle.
Besides work with the SDS-I fraction and native cell envelope Omps, Jimenez
de Bagues et al. (1994a) have shown that a hot saline extract (HS-PCP) o f the B. ovis
outer membrane containing <1% LPS is protective against virulent B . ovis challenge
in mice. The HS-PCP fraction consist o f 93% protein, including high levels o f the
group 3 Omps, Omp25 and Omp31, on an polyacrylamide gel (Gamazo et al., 1989;
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Cloeckaert et al., 1996a; Cloeckaert et al., 1996b; Vizcaino et al., 1996). Vaccination
o f mice with HS-PCP plus an adjuvant was found to provide 2.57 logs o f protection
against virulent B. ovis challenge while the official ovine brucellosis vaccine, B .
m elitensis strain Rev. 1, provided 1.77 logs o f protection. The passive transfer o f both
T cells and antibodies from mice vaccinated with a hot saline extract containing 35%
R-LPS and 65% protein also provided significant protection (Jimenez de Bagues et al.,
1994a). Based on the protection seen in mice with HS-PCP, the outer membrane
proteins may be major components necessary for a protective immune response to B.
ovis.
The cloning and expression o f the om p25 gene in E . coli made it possible to
study the immunogenicity o f purified Omp25 in vivo (de Wergifosse et al., 1995;
Cloeckaert et al., 1996b; Bowden et al., 1998). Vaccination o f mice with the
denatured, purified recombinant Omp25 did not provide significant protection against
B. m elitensis nor did these mice produce B rucella-specific antibodies (Cloeckaert et
al., 1996c; Bowden et al., 1998). However, vaccination with whole-cell sonicates of
E. coli expressing Omp25 provided significant protection against rough B . m elitensis
in the murine model (Bowden et al., 1998). Mice vaccinated with the killed wholecells produced Omp25-specific antibodies from 15 to 90 days post-vaccination that
were able to bind to rough strains o f B. m elitensis more effectively than smooth
strains. Vaccination o f mice with the recombinant whole-cell lysate did not provide
significant protection against smooth strains o f B . m elitensis. Bowden et al. (1998)
concluded that antibodies to well-exposed conformational epitopes on Omp25 might
be important for protective immunity to B. m elitensis in mice. Based on work with
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cell envelope extracts containing high levels o f Omp25 and whole-cell lysates o iE .
coli expressing recombinant Omp25, this protein may play an important role in a
protective humoral and cell-mediated immune responses to Brucella spp.
Virulence Factors
Work in other pathogenic bacterial species has shown that besides being
important for a protective immune response, certain outer membrane proteins may
also be important virulence factors. Baldermann et al. (1998) have shown that the
Brucella Omp25 shares structural homology with Omps from over 25 different Gramnegative bacteria, including CadF from Campylobacterjeju n i and OmpA from E. coli.
Campylobacterjejuni is a commensal o f the intestinal tract o f chickens that is
passed to humans by eating undercooked poultry (Nachamkin, 1995). The bacteria
causes over 2 million cases of acute diarrhea in U.S. citizens each year (Nachamkin,
1995). Indicative o f the important role o f the Omps in pathogenesis, Ziprin et al.
(1999) found that a C. jejuni mutant containing a disruption in the cadF gene was
attenuated in vivo. CadF is a 37 kDa fibronectin-binding Omp that may be an
important adhesin allowing the bacteria to colonize the cecum o f chickens (Konkel et
al., 1997). In order to investigate this hypothesis in vivo, one-day-old chicks were
exposed orally to either the CadF+ parental strain or the tvcadF mutant (Ziprin et al.,
1999). At 7 days post-challenge, 43/60 chicks exposed to the parental strain were
colonized by C. je ju n i while an equal number o f chicks exposed to the bcadF mutant
were free o f infection. The lack o f CadF rendered the mutant unable to colonize the
cecum o f newly hatched chicks (Ziprin et al., 1999).
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Escherichia coli K -l is a known etiologic agent o f neonatal septicemia and
meningitis (Levine, 1984; Selander et al., 1987). The outer membrane protein A
(OmpA) o f E. coli K -l is a 35 kDa protein that is known to serve as a mediator o f Fdependent conjugation and as receptor for both colicins and phages (Nikaido and
Vaara, 1987). In an effort to investigate if OmpA was also a virulence factor for E.
coli K-l, Weiser and Gotschlich (1991) tested a AompA mutant in two models o f E.
coli K-l infection, 10-day-old embryonated chick eggs, and neonatal rats.
Inoculation o f chick embryos with 10 to 1 x 10s CFU o f the virulent parental
strain resulted in a 27 to 62% mortality rate, respectively (Weiser and Gotschlich,
1991). The AompA mutant demonstrated a three- to fivefold decrease in virulence in
the same procedure (10 to 18%) while complementation o f the ompA mutation
restored a level o f virulence equivalent to the parental strain. In a model o f
bacteremia, neonatal rats were orally inoculated with an equal mixture o f the OmpA+
parental strain and the AompA mutant. At 72 hours post-inoculation, the incidence o f
bacteremia due to the mutant decreased sevenfold compared to the parental strain
while complementation o f the ompA mutation again restored virulence (Weiser and
Gotschlich, 1991). The lack o f OmpA rendered E. coli K -l attenuated in both
neonatal rats and embryonated chick eggs. Based on these studies, Omps appear to be
important in the virulence o f both E. coli K -l and C. jeju n i.
Role of Omn2S in B rucella son.
The importance o f Omp25 for virulence in Brucella spp. is unknown. This
protein may be an important structural Omp that stabilizes the outer membrane by
binding the underlying peptidoglycan layer and outer cell membrane. Omp25 is
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known to be covalently bound to the peptidoglycan layer, and reconstitution o f
conformational epitopes on purified Omp25 requires association with LPS (Dubray
and Charriaut, 1983; Cloeckaert et al., 1992; Cloeckaert et al., 1996c). As
demonstrated with C. jeju n i CadF and E. coli K -l OmpA mutants, the absence o f
Omp25 from Brucella spp. may render these mutants attenuated in ruminants (Weiser
and Gotschlich, 1991; Ziprin et al., 1999).
However vaccination o f mice with cell envelope extracts containing high
levels o f Omp2S or whole-cell lysates o f E. coli expressing recombinant Omp25
provides some protection against brucellosis (Dubray and Bezard, 1980; Montaraz and
Winter, 1986; Winter and Rowe, 1988; Bowden et al., 1998). Inoculation o f cattle
with these same cell extracts has been shown to induce Omp2S-specific humoral and
CMI responses (Winter et al., 1986; Winter and Rowe, 1988). Therefore, the absence
o f Omp25 in Brucella spp. may alter the host’s immune response to this pathogen.
Ruminants exposed to brucellae mutants lacking Omp25 may fail to generate the
proper immune response and display an exacerbation o f disease.
In the following chapters the creation and characterization o f B. m elitensis, B.
abortus, and B. ovis t*omp25 mutants will be described. The goal o f this work is to
determine the role o f Omp2S in virulence. The lack o f this protein may render these
mutants attenuated due to the lack o f an important structural protein or inoculation o f
them into ruminants may induce heightened pathogenesis due to an altered immune
response.
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CHAPTER 3
GENERATION AND INITIAL DESCRIPTION OF Brucella m elitensis, Brucella
abortus, AND B rucella ovis MUTANTS LACKING A 25 kDa OUTER
MEMBRANE PROTEIN (Omp25)
Introduction
Brucella species (spp.) are Gram-negative, facultative, intracellular pathogens
that pose threats to both agribusiness and human health throughout the world. The
different Brucella spp. are classified by the preferred natural host and basic
biochemical tests (Meyer, 1990). Bovine and caprine brucellosis are characterized by
late-term abortions caused by Brucella abortus and Brucella melitensis, respectively
(Enright, 1990; Thoen et al., 1993). Rams infected with Brucella ovis develop orchitis
and epididymitis and subsequent infertility (Blasco, 1990). Both B . melitensis and B.
abortus are pathogenic for humans and cause the febrile illness, undulant fever.
Infected individuals can present with a variety o f clinical symptoms including pyrexia,
sacroiliitis, arthritis, spondylitis, osteomyelitis, and bursitis (Young, 199S).
Brucella spp. have three major groups o f outer membrane proteins (Omps)
termed group 1 (94 kDa), group 2 (41-43 kDa) and group 3 Omps (25-31 kDa)
(Dubray and Bezard, 1980; Verstreate et al., 1982). The group 1 Omps are considered
minor components o f the outer membrane while the group 2 Omps have been
identified as functional porins (Verstreate et al., 1982; Douglas et al., 1984). The
group 3 Omps consist o f two separate proteins o f 25 and 31 kDa. The function o f the
25 kDa Omp (Omp25) is unknown while the 31 kDa Omp (Omp31) is proposed to be
a second porin (Cloeckaert et al., 1992; Vizcaino et al., 1996).
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Omp25 is a transmembrane protein that is expressed on the outer membrane o f
brucellae and is covalently bound to the underlying peptidoglycan layer o f the cell
(Dubray and Charriaut, 1983; Cloeckaert et al., 1990; Cloeckaert et al., 1992). PCRRFLP analysis o f the omp25 gene with nine restriction enzymes indicates that the gene
is conserved in the Brucella genus (Cloeckaert et al., 199S). Two deviations in the
omp25 gene are a short 36 nucleotide deletion near the 3’ end o f the B. ovis gene and
the lack o f an E coR V restriction site in the B. melitensis gene (Cloeckaert et al., 1995).
Association o f Omp25 with Iipopolysaccharide (LPS) is required for the reconstitution
o f conformational epitopes on purified Omp25 (Cloeckaert et al., 1996c). This protein
may be a highly conserved structural Omp that stabilizes the outer membrane by
binding the underlying peptidoglycan layer and outer cell membrane.
In addition to the structural role o f this protein, Omp25 is also antigenic in both
mice and cattle. Vaccination of mice with B rucella cell envelope extracts containing
concentrated levels o f Omp25 or normal cell envelope levels o f Omp25 in an oil-based
adjuvant provides significant protection against virulent challenge (Dubray and
Bezard, 1980; Montaraz and Winter, 1986; Winter and Rowe, 1988). Bowden etal.
(1998) demonstrated that whole cell lysates o f Escherichia coli expressing
recombinant Omp25 could protect mice against challenge with divergent rough strains
o f B. melitensis. Cattle vaccinated with the native Omp25 from B. abortus in an oilbased adjuvant demonstrated Omp2S-specific lymphocyte proliferation and delayed
type hypersensitivity reactions over a 3 month period (Winter and Rowe, 1988).
As a transmembrane protein spanning the outer cell membrane and
peptidoglycan layer, the lack o f Omp25 in Brucella spp. may affect the ability o f these
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organisms to cause disease in the ruminant host. Alternatively, the absence o f Omp25
may alter the host’s immune response to this pathogen. Brucellae lacking Omp25 may
fail to generate a typical cell-mediated or humoral immune response in infected
animals resulting in an exacerbation o f disease. To determine the role o f Omp2S in
brucellae, mutants of B. abortus, B. m elitensis, and B. ovis lacking the Omp25 protein
were created. To determine the pathogenic potential o f each mutant in vivo, the
murine B ALB/c brucellosis model was utilized.
M aterials an d M ethods
Bacterial Strains
Three Brucella strains were utilized for these studies. Brucella abortus strain
2308 is a virulent challenge strain used by several different laboratories that is
documented to cause abortions in cattle (Enright, 1990; Cheville et al., 1996; Elzer et
al., 1998b). Brucella melitensis strain 16M is also a virulent challenge strain causing
caprine abortions (Phillips et al., 1997; Elzer et al., 1998c). Brucella ovis strain
LSU99 was isolated from the semen o f a ram experimentally infected with B. ovis
strain PA. Brucella ovis strain PA was isolated from a naturally infected ram and
passaged in mice prior to experimental inoculation o f the ram. At the time strain
LSU99 was isolated, the ram had developed bilateral epididymitis and subsequent
infertility.
Plasm ids
In order to obtain deletion mutants, suicide plasmids containing a disrupted
omp25 gene from either B. ovis strain 63/290 (plasmid pAC2555) o r B . m elitensis
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strain 16M (plasmid pAC2S53) were provided by Dr. Axel Cloeckaert, Institut
National de la Recherche Agronomique, Nouzilly, France (Appendix 1).
Electroporation
Glycerol stocks o f B. abortus strain 2308, B. m elitensis strain 16M, and B . ovis
strain LSU99 were thawed and plated on Schaedier agar (Difco Laboratories, Detroit,
MI) supplemented with 5% bovine blood. Whole bovine blood was obtained from a
healthy steer with no brucellosis vaccination history. Following incubation for three
days at 37°C in a 5% CO 2 atmosphere, fresh brucella broth (Difco) was inoculated
with either i?. abortus strain 2308 or B. melitensis strain 16M and incubated overnight
in a shaking water bath at 37°C. Following overnight growth, 30 ml o f either B.
abortus strain 2308 or B. m elitensis strain 16M inoculated broth was divided into
micro-centrifuge tubes and spun at 15,000 x g for 5 min (min) to pellet the bacteria.
The resulting pellets were combined into a total volume o f 1.2 ml o f sterile distilled
water (dH20) and subsequently washed three additional times with 0.5 ml o f sterile
dH20 to remove any salts that would interfere with the electroporation. Following the
final wash, the resulting bacterial pellet was resuspended in 0.1 ml o f sterile (IH2 O.
Due to its slow growth and inability to grow in broth, B. ovis strain LSU99 w as grown
on Schaedier blood agar plates (SBA) for four days and the plates subsequently
harvested with 30 ml o f sterile (IH2O. Following harvest, the brucellae were washed
as previously described.
To perform the electroporations, an Eppendorf 2510 Electroporator (Eppendorf
Scientific Inc., Madison, WI) was used with Eppendorf cuvettes containing a 2-mm
gap width and total potential volume o f 0.4 ml. To 40 til o f washed bacteria
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suspended in sterile (IH2 O, 2 pi o f either pAC2553 (pUC19 containing the disrupted
omp25 o f B. m elitensis strain 16M) or pAC25S5 (disrupted omp25 o f B . avis strain
63/290) was added. Both plasmids were provided purified and resuspended in sterile
(IH2O. The resulting mixture was electroporated at 2500 V for approximately 5 to 6
milliseconds. Immediately following electroporation, the bacteria were resuspended
in 0.5 ml of sterile SOC-B broth and placed in a 37°C shaking water bath overnight.
The SOC-B broth was filter sterilized prior to use and consisted o f 6% Tryptic Soy
Broth (TSB) (Difco), 10 mM NaCl, 2.5 mM MgCfo, 10 mM MgSC>4, and 20 mM
glucose. Following electroporation the inoculated broth was plated on SBA plates
containing 45 pg/ml kanamycin (Sigma Chemical Company, St. Louis, MO). The
plates were incubated at 37°C in a 5% CO 2 atmosphere for 2 weeks. Any colonies
that appeared were subsequently patched to kanamycin plates and transferred to SBA
plates containing 100 ng/ml o f ampicillin (Sigma).
The presence o f the 5’ and 3 ’ ends o f native omp25 in the suicide vectors
allows for homologous recombination to occur between the native gene and the
disrupted omp25 on pAC2553 or pAC2555. Insertion o f the omp25 gene from the
suicide vector would prevent Omp25 production due to the replacement o f the internal
159 bp Styl fragment o f omp25 with the 1.3 kb insertion containing the kanamycin
resistance gene from pUC4K. Single-crossover mutants will be kanamycin resistant
(Kan1) and ampicillin resistant (Amp1) due to the presence o f both the kanamycin
resistance determinant and the penicillin beta-lactamase gene bla. However, a double
crossover mutant will remain Kanr due to the insertion and will be ampicillin sensitive
(Amp*) since the bla gene o f pUC19 is found outside the 5’ and 3’ ends o f the
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disrupted omp25 gene. Isolates that were both Ampr and Kanr or only Kanr were
frozen in 25% sterile glycerol and 75% brucella broth and held at -80°C. Isolates were
never passaged more than three times in the laboratory before returning to the original
glycerol stock.
Double-crossover mutants were complemented via electroporation with
plasmids pAC2580 and pAC2581 containing the complete omp25 gene from B.
melitensis strain 16M and B. ovis strain 63/290 inserted into the multiple cloning site
o f the broad-host-range plasmid pBBRlM CS4 (Kovach et al., 1994). The
complementation plasmids were provided by Dr. Axel Cloeckaert. Transformants
were selected on SBA plates containing 100 pg/ml of ampicillin (Sigma). Previous
studies have found this plasmid to be highly stable in all six Brucella species both in
vivo and in vitro (Elzer et al., 1995).
Western Immunoblot
To verify that Kanr isolates were Brucella spp., western immunoblot was
performed with polyclonal serum from animals experimentally infected with either
virulent B. abortus expressing the LPS O-polysaccharide side chain (O-side chain) or
divergent, rough spp. lacking the O-side chain. To confirm that Kanr isolates were not
expressing Omp25, immunoblot was performed with a series o f monoclonal antibodies
(MAbs) specific for Omp25.
Cell lysates o f suspected isolates were obtained by thawing and plating original
glycerol stocks onto SBA and incubating for three to four days as described
previously. All isolates were streaked for isolation and observed daily prior to harvest
to ensure no contamination. Plates were harvested with 2ml o f sterile dHjO and the
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resulting suspension sonicated with a Heat Systems-Ultrasonics W-38S Sonicator
(Farmingdale, NY) using a tapered microtip with a 1 second (sec) pulse for 10 min.
After sonication, the resulting cell lysate was then diluted 1:2 with Laemmli sample
buffer (Tris-HCl 62.5mM, 2% SDS, 25% glycerol, 0.01% Bromophenol Blue)
(BioRad, Hercules, CA) and boiled for 10 min (Laemmli, 1970).
Electrophoresis was performed with a BioRad Mini-Protean n unit utilizing
the Laemmli discontinuous SDS-PAGE method with 0.5 pi to 5 |xl o f cell lysate per
20 |il well depending on cell lysate concentration (Laemmli, 1970). For
electrophoresis Tris-HCl 10 - 20% acrylamide linear gradient gels with a 4% stacking
gel were used (BioRad). Electrophoresis was terminated when the dye front was
approximately 1 cm from the bottom o f the gel. BioRad Kaleidoscope prestained
standards were used as molecular weight markers with 5 pi per lane. Cell lysates were
analyzed for LPS O-side chain utilizing western immunoblot.
Nitrocellulose transfer was performed for 1 hour (h) with 100 V in a MiniTrans-Blot Electrophoretic Transfer Cell (BioRad). After transfer, the blots were
blocked with 0.25% cold water fish skin gelatin (Sigma) for 30 min followed by
washing with Tris-buffered saline (TBS) solution containing 0.5% Tween-20.
Following blocking, the nitrocellulose blot was incubated with polyclonal serum from
a cow experimentally infected with smooth B. abortus strain 2308. The LPS O-side
chain o f B rucella spp. produces a nondiscrete, ladder-like smear from 29 to 68 kDa
based on protein markers which migrate concurrently on the same gel (Edmonds et al.,
1999b). Cell lysates were also analyzed for internal non-O-side chain associated
proteins using polyclonal serum from a cow vaccinated with the rough vaccine B.
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abortus strain RB51. Cell lysates from both smooth and rough Brucella spp. produce
numerous discrete bands when incubated with anti-RBSl polyclonal serum (Edmonds
et al., 1999a). Each blot was incubated overnight at room temperature (RT) with a
1:40 dilution o f the polyclonal serum in TBS. The blots were then washed and
incubated with rabbit anti-bovine IgG horseradish-peroxidase-conjugate (Sigma) at a
dilution o f 1:800 for 45 min in TBS. After washing, the substrate 4-chloro-1-naphthol
(Sigma) was added for color development.
A set o f murine MAbs specific for Omp25 were described and provided by Dr.
Axel Cloeckaert (Cloeckaert et al., 1990). While the specific epitope for each MAb is
unknown, competitive inhibition assays have shown that they do not bind to the same
epitope (Cloeckaert et al., 1996c). Monoclonal antibodies were diluted 1:800 and
rabbit anti-mouse IgG horseradish-peroxidase-conjugate was used as the secondary
antibody and the blots were then prepared as described previously. As a positive
control, purified Omp25 was included on each gel. Purified Omp25 was provided by
Dr. Alex Winter, Department o f Veterinary Microbiology, Immunology and
Parasitology, New York State College o f Veterinary Medicine, Cornell University,
Ithaca, NY.
Genomic DNA Preparation
Large-scale genomic DNA was extracted from Kanr isolates and from the
parental strains for analysis by polymerase chain reaction (PCR) and Southern
blotting. A 100 ml brucella broth culture o f each isolate was grown overnight in a
shaking water bath at 37°C. Following incubation an equal volume o f acetone was
added to each culture and stirred overnight under a fume hood. Cells were harvested
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by centrifugation at 6,000 x g for 30 min and washed 3 times with 0.2 x saline EDTA
buffer (SEDTA) (0.15 M NaCl, 0.01 M EDTA pH 8.0). The cells were resuspended
in 25 ml o f 0.2 x SEDTA and mixed with 75 ml o f chloroform and stirred for 1 h at
RT. The aqueous phase containing the bacteria was removed, and the cells harvested
by centrifugation at 2,000 x g for 15 min and washed three times with 2.5 ml o f 0.2 x
SEDTA The cells were resuspended in 2.5 ml of 0.2 x SEDTA and incubated for I h
at 37°C with 30 nl o f a 50 mg/ml concentration o f lysozyme (Sigma). Following the
lysozyme treatment, 30 pi o f a 20 mg/ml concentration o f proteinase K (Sigma) was
added for 1 h at 37°C. The cells were then lysed by the addition o f SDS to a final
concentration o f 1%.
The lysed suspension was extracted twice using an equal volume o f phenolchloroform. Following a 5 min incubation the aqueous phase was removed from the
chloroform by centrifugation at 17,000 x g for 10 min. Following the second
extraction, the DNA was resuspended in SEDTA and precipitated by the addition 0.7
v/v isopropanol followed by centrifugation at 17,000 x g for 30 min. The resulting
precipitate was resuspended in 0.5 ml o f 1 x TE buffer (10 mM Tris-Cl, 1 mM ED TA
pH 7.5) and mixed with 0.1 ml o f Dnase-free Rnase (1 mg/ml stock) (Sigma) and
incubated for 1 h at 37°C. The phenol-chloroform extraction was repeated as
previously described. For the final precipitation, 10 M ammonium acetate was added
until a final concentration o f 2 M was achieved along with 0.7% isopropanol. After
centrifugation at 17,000 x g for 30 min, the pellet was resuspended in 1-4 ml o f 1 x TE
depending on pellet size.

55

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Plasmid Preparation
Small-scale isolation o f plasmid DNA was performed as previously described
(Elzer et al., 1995). A 1.5 ml overnight broth culture o f each isolate carrying the
desired plasmid was harvested by centrifugation in a micro-centrifuge at 15,000 x g
for 10 min and resuspended in 100 pi o f Tris buffered solution (50 mM glucose, 10
mM EDTA, 25 mM Tris-Cl, pH 8.0). The bacteria were killed by the addition o f an
equal volume o f chloroform for 5 min. The cells were centrifuged at 15,000 x g, and
the aqueous phase removed and plasmid DNA isolated by the alkaline lysis “miniprep” procedure o f Birboim and Doly (1979). To do this, the bacteria were first
resuspended in 100 pi o f ice-cold Tris buffered solution containing 5 mg/ml lysozyme
(Sigma). Following incubation at RT for 5 min, 200 pi o f fresh 0.2 N NaOH and 1%
SDS w/v were added for lysis; and the solution incubated for 5 min on ice. Cellular
debris was then precipitated with 150 pi o f 5 M potassium-acetate and 11% w/v
glacial acetic acid. The aqueous phase containing plasmid DNA was then extracted
with phenol-chloroform as previously described and precipitated with 0.7 v/v
isopropanol. The resulting pellet was resuspended 1 x TE and stored at -20°C for later
use.
Polymerase Chain Reaction
Polymerase chain reaction was utilized to determine if the omp25 gene was
disrupted with the 1.3 kb Kanr insertion. The use of PCR primers to the 5’ and 3’ ends
o f omp25 from B. ovis strain LSU99 should amplify an approximately 600 bp
fragment. In contrast, use o f the same primers on a mutant containing the disrupted
omp25 gene should generate a product o f approximately 1.75 kb. To verify insertion
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of the Kanr gene, primers were devised to the S’ and 3 ’ ends of the published
nucleotide sequence for omp25 from B. ovis (Cloeckaert et al., 1996b). The sequence
chosen is the same in all six Brucella species (Cloeckaert et al., 1996b). The two 24mer primers chosen were OMP25F (5’-ATGCGCACTCTTAAGTCTCTCGTA-3’)
and OMP25R (5’-CGCGTCGGCATCGGCTACAAGTTC-3’).
To further confirm the insertion o f the disrupted omp25 gene, primers were
also devised for the kanamycin resistance gene from pUC4K (Amersham Pharmacia
Biotech). Using the published sequence in GenBank (accession number X06404) the
devised primers should amplify an internal 700 bp sequence (Taylor and Rose, 1988).
The two 21-mer primers chosen were KANF (5’-GCTGATTTATATGGGTATAAA3 ) and KANR (5 -C AAT ACC AT ATTTTTGAAAAA-3 ’).
To verify the Kanr and Amp* isolates were double-crossovers mutants, primers
were also contrived for the bla gene from pUC19. Such primers would yield a gene
product in the case o f single-crossover mutants. As mentioned before, the Ampr
cassette o f pUC19 is found outside the S’ and 3’ ends o f the disrupted omp25 gene and
hence Ampr is lost in double-crossover mutants. As a positive control, genomic DNA
was isolated from a single-crossover mutant o f B. abortus that was Kanr and Ampr.
The two primers were chosen based on the published nucleotide sequence o f the betalactamase from pBR322 (GenBank Accession Number VOl 119) from which the
Ampr in pUC19 is derived (Sutcliffe, 1979). The two primers were AMP1 (5’GGGATTTT GGTC AT GAG ATT-3 ’) and AMP2 (5 ’-GG AACCCCTATTTGTTTA3’). Primers for omp25 and bla were produced by Integrated DNA Technologies, Inc
(Coralville, LA) while primers for the kanamycin determinant were made by GeneLab
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in the Department o f Veterinary Microbiology and Parasitology at the Louisiana State
University School o f Veterinary Medicine (Baton Rouge, LA).
Amplification reactions were prepared in 100 pi volumes containing 10 mM
Tris-HCl (pH 8.3), 50 mM KC1 (10 x PCR buffer), 1% DMSO, 200 pM (each) dNTPs,
0.2 pM of each primer, approximately 200 ng genomic DNA, 2.5 U AmpliTaq DNA
Polymerase, and 1.5 mM MgCb (Perkin-Elmer, Branchburg, NJ) (Mullis and Fallen,
1987). Most reactions were performed on a PTC-100 thermocycler (M J Research Inc.,
Watertown, MA) while amplification for the kanamycin determinant was performed
on a BioRad Gene Cycler. Amplification o f the omp25 gene was performed with a
95°C denature for 4 min followed by 34 repetitions o f a 95°C denature for 30 sec, 30
sec annealing cycle at 65°C, and a 72°C extension for 2 min. A final extension for 10
min at 72°C was also performed. Amplification o f the kanamycin and ampicillin
resistance genes was performed with the same protocol but at an annealing
temperature o f 45°C and 50°C, respectively.
Agarose Gel Electrophoresis
Following PCR, amplification products were visualized with agarose gel
electrophoresis. For each gel, 20 pi o f reaction mixture was added to 3 pi o f glyceroldye loading buffer to facilitate loading. The results o f both the omp25 and bla
reactions were visualized on 0.7% agarose / TAE (40 mM Tris-acetate, 2mM EDTA,
pH 8.5) gels while the small size of the kanamycin product necessitated a 0.9%
agarose / TAE gel. A 90 V charge was utilized for the agarose gel in a BioRad DNA
Sub Cell and stopped when the dye neared the far edge o f the gel. As molecular
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weight standards, 10-15 til o f X DNA digested with HindSSL were visualized on each
gel (BioRad). Upon completion, gels were incubated with 10 pg/ml ethidium bromide
for 3 min followed by destaining overnight in (IH2O. Bands were detected with an UV
transilluminator and documented with a digital camera.
Southern Blot Analysis
As a method to validate the results from PCR, Southern blot analysis was also
performed with the suspected B. abortus mutant. Genomic DNA from the mutant,
parental strain, and control plasmids was digested with the restriction enzyme E coB l
(Amersham-Pharmacia) using a reaction o f 20 pi o f genomic DNA, 120 U o f enzyme,
and 10 pi of EcoRI buffer in a total volume o f 100 pi. Digestions were incubated
overnight in a shaking 37°C water bath. Digested DNA was then visualized on a 1.2%
agarose gel, and the genomic DNA analyzed by the Southern blot technique
(Southern, 1975).
In preparation for transfer, the genomic DNA was partially depurinated with
0.25 M HC1 for 15 min and subsequently denatured with 0.4 M NaOH for 25 min.
The gel was then transferred to a nylon membrane utilizing the alkaline buffer
technique with a Stratagene vacuum blotter (La Jolla, CA) utilizing 0.4M NaOH. The
transfer was performed for 2 h with the addition of new solution approximately every
5 min. Following completion o f a successful transfer, the nylon was washed with 2 x
SSC (3.75 M NaCl and sodium citrate dihydrate, pH 7.0) and dried at 60°C for 20
min. The blot was then prehybridized with 40 ml of hybridization buffer (0.25 M
disodium phosphate, pH 7.2, 7% SDS, 1 mM EDTA) at 65°C for 1 h using a
rotisserie hybridizer.
59
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

To use as a probe, omp25 from the complementation vector pAC2581 carrying
the complete omp25 gene was amplified via PCR as described previously. The omp2S
probe was denatured in boiling H 2 O for 5 min and immediately transferred to ice for 5
min. Approximately 25 ng o f denatured probe was then biotinylated with 10 til o f
biotinylated random octamers, 5 pi o f dNTP containing Bio-dUTP, and 1 pi o f DNA
polymerase 1 - large (Klenow) fragment as via the manufacture’s instructions (Tropix,
Bedford, MA). The reaction was incubated overnight at 37°C and stopped the next
day with 30 pi o f stop solution (22 pi o f 10 M sodium acetate, 5 pi tRNA, 3 pi 0.25 M
EDTA) and 150 pi o f ethanol (EtOH). The mixture was incubated at 4°C for 30 min
and precipitated with 70% EtOH.
Following prehybrization o f the blot, 10ml of hybridization buffer was added
containing the biotinylated probe and incubated overnight at 65°C in rotisserie
hybridizer. The next day the blot was washed three times with 2 x SSC and 1% SDS
at RT for 5 min followed by one wash at 65°C with 0.1 x SSC and 1% SDS for 15
min. As a final step prior to chemiluminescent detection, the blot was washed two
times with 1 x SSC at RT for 5 min. For chemiluminescent detection the Tropix
Southern-Light system containing the CSPD Ultra-Pure alkaline phosphatase substrate
was utilized. The blot was first washed two times with blocking buffer (0.2% casein,
1 x PBS, 0.5% SDS) for 5 min and then incubated with the same buffer for 10 min at
RT. Next, alkaline phosphatase conjugated to streptavidin was diluted 1:5,000 and
incubated with the blot for 20 min at RT with constant rotation. The blot was again
washed one time for 5 min with blocking buffer followed by three washes with rinse
buffer (1 x PBS and 0.5% SDS). Next, assay buffer (0.1 M diethanolamine, 1 mM
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MgCfe) was added twice for 2 min. Finally, the chemiluminescent substrate, CSPD,
was added at a concentration o f 0.25 mM and incubated for S min. All excess solution
was drained off the blot, and the blot wrapped in Saran Wrap. Bands were
immediately visualized by exposure to autoradiographic film (Hyperfilm-ECL,
Amersham Pharmacia Biotech) and developed. Exposure times o f 30 sec were found
to provide optimal results.
Standard Identification Tests
Suspected mutants were also checked with several common techniques used to
differentiate Brucella spp. from other Gram-negative organisms. The production o f
indophenol oxidase was recorded using the oxidase test (Becton Dickinson and
Company, Cockeysville, MD). In this reaction, indophenol oxidase in the presence o f
atmospheric oxygen oxidizes the redox dye (N,N,N’,N’-tetramethyl-pphenylenediamine dihydrochloride) resulting in a color change from yellow to purple
(Alton et al., 1988). The ability to hydrolyze urea was determine with a modified
Christensen’s agar medium (Becton Dickinson and Company) (Alton et al., 1988).
Smooth and rough isolates were differentiated by the acriflavine test (Alton et al.,
1988). A 1:1000 dilution o f neutral acriflavine (Sigma) is mixed with a loop full o f
brucellae; rough colonies quickly clump while smooth colonies remain in solution.
Isolates were also characterized by Gram-stain, colony morphology, and growth rate.
Brucella melitensis strain 16M and B. abortus strain 2308 are both urease positive,
oxidase positive, Gram-strain negative, smooth, and grow to isolated colonies in
approximately three days on SBA plates at 37°C with a 5% CO2 atmosphere (Alton et
al., 1988). Unlike B . abortus and B. melitensis, B. ovis strain LSU99 is rough, urease
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negative, oxidase negative, and grows to isolated colonies in four days under the same
conditions.
A common method used to differentiate Brucella spp. from each other is
sensitivity to various dyes (Alton et al., 1988). All isolates and the respective parental
strains were tested for sensitivity to azure A, basic fuchsin, crystal violet, pyronin,
safranin, and thionin using commercial reagents (Key Scientific Products, Round
Rock, TX). Approximately S x 105 colony forming units (CFU) o f bacteria were
plated onto a Trypticase Soy Agar (Difco) supplemented with 5% equine serum. The
six dye tablets were placed at equal distances throughout the plate. Unlike B.
melitensis, B. abortus is inhibited by both azure A and thionin (Alton et al., 1988).
Inoculation Doses
Inoculation doses were made o f all three parental strains, complemented
mutants, and potential omp25 deletion mutants as described previously (Elzer et al.,
1996). From original glycerol stocks, fresh three-day cultures were obtained by
methods previously described. Bacteria were harvested into sterile brucella broth and
the resulting suspension adjusted with a spectrometer (Baush and Lomb, Rochester,
NY) to an O.D. reading o f 0.15 at 600X. or approximately 1 x 109 CFU/ml. The
inoculum was divided into smaller aliquots and snap frozen in liquid nitrogen prior to
being stored at -80°C. Exact viability counts were obtained by serial dilution and
plating on SBA.
Mice
Female B ALB/c mice at approximately 6 to 8 weeks o f age were obtained
from the Division o f Laboratory Animal Medicine in the Louisiana State University
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School o f Veterinary Medicine (Baton Rouge, LA) and held at least one week prior to
use. All animals were housed in a restricted access facility. All mice were used in
accordance with the Animal Care and Use Committee at Louisiana State University
and approved protocols were followed.
Murine Neutrophil Killing Assay
To investigate if the B . abortus mutant exhibited increased sensitivity to killing
by neutrophils, a previously described murine neutrophil killing assay was utilized
(Elzer et al., 1996). Mice were injected with 1 ml o f warm thioglycolate broth (3
gm/100 ml) intraperitoneally to elicit neutrophils into the peritoneal cavity. Four h
post-injection the mice were euthanized by halothane inhalation, and the peritoneal
cavity injected with 8 ml o f cold media (R P M I1640, 10% fetal calf-serum (FCS), 200
U/ml heparin) (Sigma). The recovered cells were centrifuged at 250 x g for 10 min
and subsequently washed and centrifuged twice more with cold media. The recovered
pellet was resuspended in 3 ml o f cold media, and viability counts obtained via trypan
blue exclusion (Sigma)
The enriched neutrophil population was immediately transferred to 96-well
plates with 2 x 10s cells/well. The resistance o f both the suspected mutant and
parental strain to killing by murine neutrophils was determined. Prior to infection,
both bacterial strains were opsonized with 10% normal murine serum (complement
preserved) for 10 min at 37°C. Following opsonization, 2 x 107 CFU/well o f either
strain were added to the neutrophils and incubated at 37°C with 5% CO 2 . At 10, 30,
60, and 120 min post-infection, the neutrophils were lysed by the addition o f 0.1%
deoxycholate (Sigma) for 4 min at RT. Subsequently, viable counts o f bacteria were
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performed by serial dilution and plating on SBA. Four replicate wells for each strain
were evaluated per time point. The entire experiment was repeated four times. The
percent survival for each strain was determined by dividing the number o f bacteria
present at a particular sampling time by the number o f brucellae added to the
neutrophils at time zero and multiplying by 100.
Murine Macrophage Killing Assay
The murine macrophage killing assay was carried out to evaluate the ability of
both the B. abortus mutant and parental strain to survive and replicate inside murine
macrophages. As described previously (Elzer et al., 1996), mice were euthanized by
halothane inhalation and 8 ml of cold media injected into the peritoneal cavity. Media
used contained RPM I 1640, 10% FCS, and Pen-Strep (100 U penicillin, and 0.1 mg
streptomycin) (Gibco, Grand Isle, NY). The recovered cells were centrifuged 250 x g
for 10 min and subsequently washed and centrifuged twice more with cold media.
The recovered pellet was resuspended in 3 ml o f cold media and viability counts
obtained via trypan blue exclusion. Ninety-six well plates were inoculated with 5 x
10s cells/well, and the cells incubated overnight at 37°C in a humidified atmosphere
containing 5% CO 2 .
After overnight culture, the macrophages were washed three times with 200
plAvell o f warm PBS containing 1% FCS to remove nonadherent cells and any
residual antibiotic. Immediately prior to performing the assay, inoculation doses o f
both the B. abortus mutant and the parental strain were opsonized for 30 min at 37°C
with murine hyperimmune serum specific for B. abortus. The washed cells were then
inoculated with 5 x 107 CFU/well o f the opsonized mutant or parental strain.
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Following a 2-h period of phagocytosis at 37°C, all extracellular bacteria were killed
by the addition o f SO pg/ml o f gentamicin (Sigma) for 1 h at 37°C. Following this 1-h
treatment, the high-concentration gentamicin was removed and replaced with media
containing a low concentration o f gentamicin (12.5 pg/ml). At 0, 4, 24, and 48 h
following high-concentration gentamicin treatment, the macrophages were washed
three times with warm PBS containing 1% FCS. Cells were then lysed with 0.1%
deoxycholate and the number o f viable intracellular brucellae determined by serial
dilution and plating on SBA. Percent survival was calculated by dividing the number
of bacteria present at a particular sampling time by the number o f brucellae added to
the macrophages at time zero and multiplying by 100. Statistics were performed on
four replicate wells per time point and the entire experiment repeated four times.
Pathogen G row th Curves in Mice
The murine BALB/c brucellosis model was utilized to assess the pathogenic
potential o f all three mutants in vivo. Frozen inoculums o f the mutant, parental strain,
and complemented mutant were thawed and diluted to 5 x 10s CFU/ml. Mice were
then injected intravenously (i.v.) with 100 pi o f this inoculum or 5 x 104 CFU.
Inoculation doses were verified by serial dilution and plating on SBA. At various time
points post-infection, mice in groups of five were euthanized by halothane overdose.
At necropsy, the whole spleen was removed by aseptic technique for bacteriological
analysis while blood was obtained for serological analysis. The spleen was
homogenized with a Sorvall Omni-Mixer (Newton, CT) in sterile PBS and
subsequently serially diluted and plated on SBA. Mutants were also plated on media
containing the appropriate antibiotic to ensure that problems did not occur with
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stability in vivo. All plates were incubated at 37°C in a 5% CO 2 atmosphere for 3 to 4
days until isolated colonies appeared.
Murine serum was analyzed with both the Card test and western immunoblot
(Alton et al., 1988). The Card test (or Rose Bengal Plate Test) is a standard
agglutination test used by the United States Department o f Agriculture - Animal and
Plant Health Inspection Service (USDA-APHIS) for field screening. Thirty
microliters of plasma is added to 30 pi o f killed B. abortus cells stained with Rose
Bengal. Infection with smooth Brucella strains produces anti-O-side chain antibodies
that agglutinate the stained cells. The sample is mixed, allowed to incubate for 4 min,
and read as positive if agglutination occurs (Alton et al., 1988). The western
immunoblot was performed as previously described with the following modifications.
Electrophoresis was performed with a Tris-HCl 15% acrylamide resolving gel with a
4% stacking gel containing one 450 pi well and an additional well for the molecular
weight standard (BioRad). For each gel, 50 pi o f cell lysate was added evenly across
the well and electrophoresis performed at 80 V. Serum from mice infected with B.
abortus was screened with cell lysates from smooth B. abortus strain 2308 and rough
B. abortus strain RB51. Serum from mice infected with B. melitensis was analyzed
with cell lysate from smooth B. melitensis strain 16M and rough B. abortus strain
RB51. Since B. ovis lacks the LPS O-side chain, serum from mice infected with this
strain was only analyzed with B. ovis strain LSU99 cell lysate. To visualize the
complete area o f cell lysate transmission on the nitrocellulose blot, pyronin-Y (Sigma)
was added at 1 pi (0.1 % stock) per 50 pi o f cell lysate. Following transfer, the
nitrocellulose blot was cut in small strips, and each ribbon incubated with a different
66
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serum sample as previously described. For the five mice infected with the same strain
at each time point, serum samples were combined.
Statistics
For neutrophil and macrophage killing assays, statistical comparisons between
experimental groups were performed with the Student /-test with P<0.05 being
considered significant (Snedecor and Cochran, 1989). Data from the murine splenic
colonization studies was compared using a one-way analysis o f variance (ANOVA)
with a Student-Newman-Keuls pairwise multiple comparison procedure when three
strains were present at the same time point. If two strains were present at a time point,
the Student /-test was utilized. For the ANOVA and /-test, P<0.05 were considered
significant (Snedecor and Cochran, 1989). All statistics were performed with the
Sigma Stat program (Sigma Stat for Windows, Version 1.0, Jandel Scientific, 19921994).
Results
Mutant Strains
Electroporation o f B . abortus strain 2308 with pAC2555 containing the
disrupted omp2S gene from B. ovis strain 63/290 resulted in isolation o f a Kanr and
Amp* colony that was named strain BA25 for P. abortus om p25 mutant.
Subsequently, additional experiments using the plasmid pAC2553 carrying the
disrupted omp2S gene from B. melitensis strain 16M resulted in the isolation o f strain
BM2S from strain 16M. Also, utilizing pAC2555, a mutant o f B. ovis strain LSU99
was also obtained and termed B02S. All three strains were verified as Amp* and
Kanr.
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The three isolated mutants were also electroporated with the complementation
vectors pAC2581 and pAC2580 carrying the complete omp25 gene from B. ovis strain
63/290 and B . m elitensis strain 16M, respectively. Ampicillin resistant isolates were
obtained from BM25 and BA2S with pAC2580 and termed BM25p80 and BA25p80,
respectively. An Ampr isolate was also obtained from B02S utilizing pAC2581 and
termed B025p81.
Western Immunoblot
Analysis o f the mutants, complemented mutants and parental strains for LPS
O-side chain was performed via western immunoblot utilizing bovine anti-O-side
serum (Figure 3.1). Brucella abortus strain 2308 along with BA25 and BA25p80
produced the typical O-side chain ladder-like smear (Figure 3.1). Brucella m elitensis
strains 16M, BM25, and BM25p80 also all produced similar O-side chain smears.
Brucella ovis strains LSU99, B02S, and B025p81 did not demonstrate a ladder-like
smear due to the lack o f O-side chain (Figure 3.1). Analysis o f all the cell lysates with
bovine serum specific for internal non-O-side chain associated antigens produced
typical banding patterns for Brucella spp. (Figure 3.2). While the banding pattern for
BA25p80 is light due to the cell lysate concentration, some similar bands are visible.
To verify that the Omp25 protein was not expressed by the three mutants, western
immunoblot was performed with five MAbs specific for Omp25. Analysis o f BA2S,
BM25, and B 02S cell lysates with MAb A59/05F01/C09 failed to detect the Omp25
protein (Figure 3.3; Lanes 3, 6, 9). Omp25 was recognized in BA25p80,
BM25p80, and B025p81 indicating that complementation for Omp25 was successful
(Figure 3.3; Lanes 4, 7, 10). As positive controls, purified Omp25 was recognized and
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Figure 3.1. Western immunoblot analysis o f cell lysates from Aomp25 mutants with
anti-O-side chain polyclonal serum.
Lane 1: B. abortus strain 2308
Lane 2: B. abortus strain BA25
Lane 3: B. abortus strain B A25p80
Lane 4: B. melitensis strain 16M
Lane 5: B. melitensis strain BM25
Lane 6: B. melitensis strain BM2Sp80
Lane 7: B. ovis strain LSU99
Lane 8: B. ovis strain B025
Lane 9: B. ovis strain B025p81
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Figure 3.2. Western immunoblot analysis o f cell lysates from Aomp25 mutants with
anti-RBSl polyclonal serum.
Lane 1: B. abortus strain 2308
Lane 2: B. abortus strain BA2S
Lane 3: B. abortus strain BA25p80
Lane 4: B. melitensis strain 16M
Lane 5: B. melitensis strain BM25
Lane 6: B. melitensis strain BM25p80
Lane 7: B. ovis strain LSU99
Lane 8: B. ovis strain B02S
Lane 9: B. ovis strain B025p81
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Figure 3.3. Western immunoblot analysis o f cell lysates from Aomp25 mutants with
MAb A59/05F01/C09 specific for the Omp25 protein.
Lane 1: Molecular weight standards
Lane 2: B. abortus strain 2308
Lane 3: B. abortus strain BA2S
Lane 4: B. abortus strain BA25p80
Lane S: B. m elitensis strain 16M
Lane 6: B. m elitensis strain BM2S
Lane 7: B. m elitensis strain BM25p80
Lane 8: B. ovis strain LSU99
Lane 9: B. ovis strain B02S
Lane 10: B. ovis strain B025p81
Lane 11: Purified native Omp25
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the protein was also detected in cell lysates from all three parental strains (Figure 3.3;
Lanes 2, S, 8, 11). While the molecular weight o f Omp25 in the/?, m elitensis strains
16M and BM25p80 appears shifted, this apparent increase is due to insufficient
removal o f peptidoglycan during cell lysate preparation (Figure 3.3; Lanes 5, 7).
Analysis o f these cell lysates with an additional four MAbs specific for Omp25
verified the absence o f the protein from each mutant (Appendix 2).
Polymerase Chain Reaction
To verify that the omp25 gene was disrupted with the Kanr insertion, PCR
primers specific for the S’ and 3’ ends o f omp25 were employed. As shown in Figure
3.4, this resulted in generation o f a roughly 1.8 kb product from the genomic DNA o f
BA2S, BM25, and B02S (Lanes 3, 5, 7). Also, an approximate 0.6 kb fragment was
amplified from all three parental strains (Figure 3.4, Lanes 2, 4,6). These results
agree with the anticipated amplification o f a 1.75 kb product from the mutants and a
600 bp fragment from the paternal strains. As positive controls, a 0.6 kb gene product
was amplified from the complementation vector pAC2581 and an approximate 1.7S kb
product was produced from the suicide vector pAC2555 (Figure 3.4, Lanes 8, 9). The
size shift o f the amplified product is due to replacement o f the 159 bp S tyl internal
fragment with the 1.3 kb insertion containing the Kanr gene.
To provide additional data that the omp25 gene had been disrupted, PCR was
also performed with primers specific for an internal 700 bp sequence from the pUC4K
kanamycin determinant. As shown in Figure 3.5, an approximate 700 bp fragment
was amplified from BA25, BM25, and B 025 (Lanes 3, 5, 7). A 700 bp sequence was
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Figure 3.4. Amplified PCR products utilizing primers specific for the S’ and 3’ ends
o f the omp25 gene.
Lane 1: Molecular weight standards
Lane 2: B. abortus strain 2308
Lane 3: B. abortus strain BA2S
Lane 4: B. m elitensis strain 16M
Lane S: B m elitensis strain BM2S
Lane 6: B. ovis strain LSU99
Lane 7: B. ovis strain B02S
Lane 8: pAC2581
Lane 9: pAC2555
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Figure 3.5. Amplified PCR products utilizing internal primers for the kanamycin
resistance gene from pUC4K.
Lane 1: Molecular weight standards
Lane 2: B. abortus strain 2308
Lane 3: B. abortus strain BA25
Lane 4: B. m elitensis strain 16M
Lane 5: B. m elitensis strain BM25
Lane 6: B. ovis strain LSU99
Lane 7: B. ovis strain B 025
Lane 8: pAC2555
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also generated from the suicide vector pAC2555 (Figure 3.5, Lane 8). A similar
product was not amplified from the parental strains (Figure 3.5, Lanes 2,4,6).
Polymerase chain reaction was also performed with primers for the pUC19 bla
gene. Amplification was attempted on genomic DNA from B . abortus strain 2308,
BA25, and a B . abortus Kanr Ampr isolate. As shown in Figure 3.6, an approximate
900 bp sequence was generated from both the B . abortus Ampr isolate and from the
suicide vector pAC2555 (Lanes 3, 5). A gene product was not amplified from either
strain 2308 or BA25 (Figure 3.6; Lanes 2, 4).
Southern Blot Analysis
Southern blot analysis was also performed on genomic DNA from both BA25
and B. abortus strain 2308 to verify that the om p2S gene was disrupted. Purified DNA
from both BA25 and strain 2308 digested with EcoKL was probed with the complete
omp25 gene. This resulted in annealing of the probe to an approximate 4 kb fragment
in strain 2308 (Figure 3.7, Lane 1) and the detection o f two fragments from BA25
migrating at approximately 1.5 kb and 2 kb (Figure 3.7, Lane 2). The identification o f
Omp25 in a 4 kb fragment from genomic DNA digested with EcoR I is in accord with
previous findings in other laboratories (A. Cloeckaert, personal communication). The
annealing of the om p25 probe to two smaller fragments in genomic DNA from B A25
occurred due to the presence o f both the 5’ and 3 ’ ends o f omp2S and the inclusion o f
an EcoKL site in the Kanr insertion. As a positive control, the PCR generated probe
did anneal to itself (Figure 3.7, Lane 4). In this experiment, genomic DNA from a
second B . abortus single-crossover mutant (BA25-2) was also probed and produced
results equal to BA25 (Figure 3.7, Lane 3). The omp2S probe also annealed to a 700
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Figure 3.6. Amplified PCR products utilizing internal primers for the ampicillin
resistance gene (bid) from pUC19.
Lane 1: Molecular weight standards
Lane 2: B. abortus strain 2308
Lane 3: B. abortus single-crossover mutant (Kanr, Ampr, OmpZS*)
Lane 4: B. abortus strain BA2S
Lane 5: pAC2555
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Figure 3.7. Southern blot analysis o f genomic DNA from B. abortus strains 2308 and
BA2S with an omp25 probe.
Lane 1: B. abortus strain 2308
Lane 2: B. abortus strain BA25
Lane 3: B. abortus strain B A25-2
Lane 4: omp25 probe
Lane 5: pAC2581
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bp sequence in the complementation vector pAC2581 along with several non-specific
fragments (Figure 3.7, Lane 5). Southern blot analysis verified that the om p25 gene
was disrupted in BA2S. The disruption o f the omp25 gene in each mutant is hereafter
referred to as a Aomp25 mutation.
Standard Identification Tests
Following verification that BA2S, BM25, and B02S did not express the
Omp25 protein and that the omp25 gene was disrupted, each strain was analyzed with
standard biochemical tests used to discriminate Brucella spp. from other Gramnegative organisms. Analysis o f all three strains for urease and oxidase reactions
found no difference between each Aomp25 mutant and parental strain. All o f the B .
m elitensis and B. abortus strains were urease and oxidase positive while the B . ovis
strains were negative. Acriflavine testing supported the previous findings by western
immunoblot that B02S is rough and that BA25 and BM25 contain LPS O-side chain.
Furthermore, examination o f colony morphology, growth rate, or Gram-stain reaction
failed to find any discrepancies between each mutant and parental strain. All three
Aomp25 mutants were also tested for inhibition against six different dyes used to
differentiate the B rucella spp. Again no discemable variance w as observed between
each Somp25 mutant and the parental strain. The 5. abortus strains were inhibited by
azure A and thionin while the B. m elitensis strains were able to grow in the presence
o f all six dyes. B rucella ovis strain LSU99 and B02S were both inhibited by all the
dyes tested expected for pyronin.
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M urine Neutrophil K illing A m v
To investigate if the lack o f Omp25 would render BA25 more sensitive to the
bactericidal mechanisms o f the neutrophil, a series o f murine neutrophil killing assays
was performed. The results o f one representative experiment are shown in Figure 3.8.
By 10 min post-infection both B . abortus strain 2308 and the tsomp25 mutant, BA2S,
remained near 100% percent survival (Figure 3.8). However, by 30 min post-infection
both strains decreased in viable numbers to less than 50% o f the inoculum. After 30
min post-infection, the rate o f killing for both strains decreased, reaching a mean o f
35% survival at 60 min. At 120 min post-infection, strain 2308 recovered to 40%
survival while the Aomp25 mutant decreased to 27% o f the inoculum. Statistical
analysis o f individual time points with the Student /-test failed to find any statistical
difference between BA25 and strain 2308. At each time point in Figure 3.8, the data
presented is the mean o f five individual wells containing bacteria and cultured
phagocytes. The entire experiment was repeated four times with no significant
deviations being observed between trials.
Murine Macrophage Killing Assay
To determine the ability o f the B . abortus Aomp25 mutant, BA25, to survive
and replicate in murine macrophages, a macrophage killing assay was performed. One
representative experiment is shown in Figure 3.9. By 4 h post-infection, both
abortus strain 2308 and the Aom p2S mutant decreased in viable numbers to less than
9% o f the inoculum (Figure 3.9). At 24 h following infection, both BA25 and strain
2308 exhibited less than 3% survival. However, by 48 h while strain 2308 had
recovered to 101% o f the initial infection, BA25 had recovered to only 60% survival.
79
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

120

100

«-»

c

tt

2u
a.

40
20

0

10

30

60

120

Time in Minutes

Figure 3.8. Killing o f B . abortus strains 2308 and B A25 opsonized with normal
murine serum by cultured murine neutrophils. The data presented are the results o f a
representative experiment with five repetitions per strain at each time point. Vertical
bars indicate standard error, closed circles strain 2308, and open circles BA2S.

80
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

1000

••
9

100

3
C/i
-w

c
V

a
a,u

10

1
0

24

4

48

Time in Hours

Figure 3.9. Killing o f B . abortus strains 2308 and B A25 opsonized with
hyperimmune murine serum by cultured, resident, peritoneal murine macrophages.
The data presented are the results of a representative experiment with five repetitions
per strain at each time point. Vertical bars indicate standard error, closed circles strain
2308, and open circles BA25. **/><0.01, based on a /-test, n = 5.
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Analysis with the Student /-test found the difference in percent survival at 48 h to be
significant with a P O .O l (n = 5 per treatment group). A statistically significant
difference in percent survival between the two strains was not observed at 4 o r 24 h
post-infection. The data presented in Figure 3.9 is the mean o f five individual wells.
The entire experiment was repeated four times with no significant variations being
observed between trials.
Pathogen Growth Curves in Mice
To assess the pathogenic potential o f the B . abortus &omp25 mutant, BA2S, in
vivo, BALB/c mice were infected with B . abortus strain 2308, BA2S, or BA25p80. At
1, 3, 6, and 20 weeks post-infection, the data presented represents five mice per strain
at each time point (Figure 3.10). At 2, 4, 8, 12, and 18 weeks, the data presented for
BA2S and strain 2308 represents ten mice per strain at each time point and is the
combination o f tw o experiments. The two trials w ere combined since a statistically
significant difference was not observed between groups o f mice infected with the
same strain from either experiment. From 1 to 12 weeks post-infection, no significant
difference was observed in mean CFU/spleen between B . abortus strain 2308, BA2S,
or BA25p80 (Figure 3.10). All three strains increased in mean CFU from 1 to 4 weeks
and then decline gradually out to 12 weeks post-infection.
At 18 and 20 weeks post-infection, the Aom p25 mutant BA2S is nearly cleared
from a total o f IS mice while the parental strain remains at a mean CFU/spleen o f 4.1
logs by 20 weeks following infection (Figure 3.10). At both o f these time points, the
number CFU o f BA25 is approximately 0. IS logs greater than the 2.1072 log limit o f
detection for this assay. The difference in mean CFU/spleen o f BA2S and strain 2308
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Figure 3.10. Splenic colonization o f BALB/c mice by B . abortus strains 2308, BA25,
and BA25p80. Ten mice per BA25 and strain 2308 groups at 2, 4, 8, 12, and 18 weeks
post-infection. At all other time points mice are in groups of five. Vertical bars
indicate standard error, closed circles strain 2308, open circles BA2S, and triangles
BA25p80. **P<0.01, ***P<0.001, using an ANOVA for three data points and a t-test
for two data points.
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infected mice was statistically significant at 18 (P<0.001, n = 10) and 20 weeks post
infection (P<0.01, n = S). Complementation o f Omp25 production in BA2S restored
the mean CFU/spleen to that o f the parental strain at 20 weeks post-infection (Figure
3.10). Serological analysis found that all mice, regardless o f the inoculation strain,
produced antibodies against both the LPS O-side chain and internal B rucella protons.
Mice were also infected with the B. m elitensis Aomp25 mutant, BM2S, to
assess splenic colonization (Figure 3.11). The experiment was carried out to 8 weeks
post-infection and included the parental strain, B . m elitensis 16M, and complemented
mutant, BM25p80. As shown in Figure 3.11, by 4 and 6 weeks post-infection a
statistically significant difference was observed in mean CFU/spleen between BM2S
infected mice and animals inoculated with the other two strains (P<0.05, n = 5 per
treatment group). This difference continued at 8 weeks post-infection for strain 16M
infected mice (P<0.01, n = 5 per treatment group). Complementation o f BM2S again
restored the mean CFU/spleen to levels equal to the parental strain at 4 and 6 weeks
post-infection. The growth o f BM25p80 in mice was not ascertained at 8 weeks post
infection. Serological analysis demonstrated that all mice, regardless o f the B.
m elitensis strain used, did produce antibodies against both the LPS O-side chain and
internal B rucella proteins.
The colonization profiles o f B. ovis strain LSU99 and the Aomp25 mutant
B025 were assessed in mice up to 14 weeks following inoculation. At 1 week post
infection, strain LSU99 replicated to an approximate mean log o f 7.1 CFU/spleen
from an inoculum o f 4.5 logs (Figure 3.12). In contrast, at 1 week following exposure,
B025 replicated to a mean o f 5.8 log CFU/spleen (P<0.01, n = 5). By 2 weeks
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Figure 3.11. Splenic colonization o f BALB/c mice by B . m elitensis strains 16M,
BM2S, BM25p80. Five mice per group at each time point. Vertical bars indicate
standard error, closed circles strain 16M, open circles BM25, and open triangles
BM2Sp80. *P<0.05, **/><0.01, using an ANOVA for three data points and a /-test for
two data points, n = 5.
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Figure 3.12. Splenic colonization o f B ALB/c mice by B . ovis strains LSU99, B02S,
andB025p81. Five mice per group at each time point. Vertical bars indicate standard
error, closed circles strain LSU99, open circles B 025, and triangles B02Sp81.
**/><0.01, ***P<0.001, using an ANOVA for three data points and a /-test for two
data points, n = 5.
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post-infection, while strain LSU99 was >7.5 logs per spleen, B025 had decreased to a
mean CFU/spleen o f 5 logs (P<0.001, n = 5). As shown in Figure 3.12, this decrease
in mean CFU/spleen o f B025 continued until by 8 weeks post-infection no brucellae
could be detected from the spleens o f B02S mice while the parental strain remained at
5.5 logs (P<0.01, n = 5). Complementation o f B 0 2 5 for Omp25 production did not
restore the mean CFU/spleen to levels equal to the parental strain. Statistical analysis
o f B025p81 and B 025 infected mice at 2 ,4 , and 8 weeks post-infection did not find
any difference in mean CFU/spleen between the tw o groups. Serological analysis did
detect antibodies against B. ovis in all infected mice regardless of the inoculation
strain and antibodies to the LPS O-side chain were not found.
Discussion
Mutants o f B . abortus (BA25), B. m elitensis (BM25), and B. ovis (B 025)
containing a disruption in the omp2S gene (Aom p25 mutants) were successfully
created. Western immunoblot analysis o f cell lysates from all three mutants with five
MAbs specific for the Omp25 protein verified that it was not expressed. Polymerase
chain reaction with primers specific for the om p25 gene and for the kanamycin
resistance determinant verified that the omp2S gene was disrupted in all three Aomp25
mutants. Complementation of each mutant with a broad-host-range plasmid
pBBRlMCS4 carrying the complete omp25 gene restored expression o f the Omp25
protein. Analysis o f all three mutants with the standard biochemical tests used to
differentiate B rucella spp. failed to find any phenotypic difference due to the lack o f
the Omp25 protein.
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To assess the pathogenic potential o f each Somp25 mutant in vivo, the BALB/c
murine brucellosis model was utilized. In this model o f splenic colonization, virulent
type strains and vaccine candidates often mimic in the mouse what is observed in the
ruminant host (Montaraz and Winter, 1986; Winter, 1990; Schurig et al., 1991; Elzer
et al., 1996). Inoculation o f mice with virulent B . abortus strain 2308, the parental
strain o f BA25, resulted in a chronic infection that was at a mean CFU/spleen o f S.S
logs by 18 weeks post-infection (Figure 3.10). This is in agreement with previous
studies o f strain 2308 in BALB/c mice (Montaraz and Winter, 1986; Winter, 1990).
At the same time point, mice infected with B A25 had mean CFU/spleen counts that
were at the 2.1 log limit o f detection for this assay (P<0.001, n = 10) (Figure 3.10).
Mice infected with the B . m elitensis mutant BM2S showed a significant decrease in
mean CFU/spleen at 4, 6, and 8 weeks post-infection when compared to the virulent
parental strain (P<0.05, n = 5) (Figure 3.11). The colonization profile o f the virulent
parental strain, B . m elitensis 16M, was in agreement with previous findings (Phillips et
al., 1995). Complementation of both BA25 and BM25 for Omp25 restored the
number o f CFU/spleen to levels equal to the respective, virulent parental strain (Figure
3.10; Figure 3.11).
Mice infected with the B. ovis mutant B025 were consistently colonized with
fewer bacteria from 1 to 8 weeks following infection than mice inoculated with the
virulent parental strain, LSU99. At 1 week post-infection, while strain LSU99
replicated to >7 logs per spleen, the Aom p25 mutant replicated to approximately 5.8
logs {P<0.01, n = 5) (Figure 3.12). By 8 weeks post-infection, the mutant was below
the limit o f detection while the virulent parental strain remained at >5 logs per spleen
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(P<0.01, n = 5) (Figure 3.12). The growth o f virulent B . ovis to >7 logs in the spleens
o f B ALB/c mice has been demonstrated previously (Jimenez de Bagues et al., 1994a).
Unlike the B . abortus and B. m elitensis mutants, complementation o f B 02S did
not restore virulence in the mouse model (Figure 3.12). The B. ovis mutant was
attenuated from 1 week post-infection while the Aomp25 mutants BM25 and B A25
did not show statistically significant differences from the parental strains in mean
CFU/spleen until 4 and 18 weeks post-infection, respectively. The cell envelope o f B .
ovis may be responsible for the increased attenuation o f B02S in mice when compared
to the other two B rucella mutants. Unlike B . abortus and B . m elitensis, naturally
occurring strains o f B . ovis do not express the LPS O-side chain (Blasco, 1990).
Therefore, the loss o f an important structural Omp that binds the underlying
peptidoglycan and outer cell membrane may have profound effects on the stability o f
the B . ovis cell envelope. Complementation may not have been successful in B 02S
due to abnormal expression o f the Omp25 protein in the O-side chain deficient LPS o f
B. ovis. To determine if the B. ovis Aomp25 mutant is attenuated in ruminants, studies
are currently underway in both rams and ewes. Based on this data from the mouse
model, the lack o f the Omp25 protein may render B 025 attenuated in the ovine host.
An important component of brucellae virulence in both ruminants and mice is
the capacity o f these pathogens to survive and replicate inside professional
phagocytes. Upon natural exposure o f a ruminant to brucellae, the pathogen is
phagocytosed by neutrophils and macrophages which migrate via the lymphatics to the
draining lymph node (Enright, 1990; Thoen et al., 1993). Injection o f mice i.v. with
virulent brucellae results in localization o f the organism in the reticuloendothelial
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system and specifically in the spleen, as is the case with other facultative intracellular
pathogens (Montaraz and Winter, 1986; Kaufmann, 1999). In the spleen, large
numbers o f macrophages phagocytize the brucellae in an effort to control the infection
(Winter, 1990). Indicative o f the important role o f macrophages in murine brucellosis,
Zhan and Cheers (1993) demonstrated that in the mouse model, depletion o f the
macrophage activating cytokine interferon-y (IFN-y) with anti-IFN-y MAbs results in a
significant increase in splenic colonization compared to inoculated, nontreated
controls.
Incubation o f the B. abortus mutant BA2S or virulent parental strain 2308 with
cultured murine neutrophils produced no difference in percent survival up to 2 h post
infection (Figure 3.8). A significant difference was observed between the ability o f
BA2S and strain 2308 to replicate inside murine macrophages (Figure 3.9). Both
strains demonstrated a similar decrease in viable numbers from 4 to 24 h post
infection. However, by 48 h the virulent parental strain had replicated to >100%
survival while BA25 had recovered to 60% o f the inoculum (P<0.01, n = 5). The
inability o f the B . abortus Aomp25 mutant to replicate as efficiently as the parental
strain, in murine macrophages in vitro, may partially explain the observed attenuation
in vivo. While not tested in professional phagocytes, the B. m elitensis mutant may
also be unable to replicate inside the macrophage as quickly as the parental strain.
The proposed inability o f the both the B . m elitensis and B . abortus mutants to
adjust to the intracellular environment o f the macrophage may not be the only factor
rendering these mutants attenuated in vivo. Mice infected with BM25 and BA2S
exhibit CFU/spleen counts that are equivalent to the respective, virulent parental strain
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up to 3 and 12 weeks post-infection, respectively. In the mouse model, IgG3
antibodies effective at opsonizing extracellular brucellae are known to develop 3-4
weeks following infection (Elzer et al., 1994b). These antibodies are proposed to bind
to the macrophage Fc receptor resulting in phagocyte activation and bacterial killing.
Brucellae that are released by lysed cells are opsonized by these antibodies and
phagocytosed by activated macrophages (Elzer et al., 1994b). In the case o f the B.
m elitensis Aomp25 mutant, at 4 weeks post-infection and continuing through 8 weeks,
a significant decrease in the number o f viable brucellae was observed when compared
to the virulent parental strain (P<0.05, n = S). This decrease in the number o f
CFU/spleen may represent an inability o f IgG3-opsonized BM25 to survive inside the
activated macrophage.
A significant difference in the mean CFU/spleen of mice infected with the B.
abortus mutant or parental strain 2308 did not occur until 14 weeks following the
development o f opsonizing IgG3 antibodies. Mice infected with virulent strain 2308
exhibit a long chronic infection that does not clear with the arrival o f protective T cells
at approximately 6 weeks post-infection (Montaraz and Winter, 1986). Therefore,
Winter (1990) proposed that recovery from strain 2308 infection may depend on the
formation o f both immune T cells and the development o f antibodies with high affinity
and the required isotype, specifically IgG2a and IgG3. Conceivably, the observed
attenuation o f BA2S in vivo may be due to an increased sensitivity to this combined
humoral and cell-mediated immune response. Following opsonization o f BA25 by
antibodies o f the correct isotype and affinity, an increased killing by activated
macrophages may occur.
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The attenuation o f both the B . abortus and B . m elitensis mutants in mice
supports further studies o f these mutants in the ruminant hosts. If BA2S is unable to
replicate as efficiently as the virulent parental strain in bovine phagocytes, it could
impair the ability o f this organism to colonize the ruminant host and to induce
abortions. Following initial entry into the host, the bacteria could be eliminated in the
primary lymph node preventing spread o f the pathogen throughout the dam. Likewise,
the data generated in mice with the B . m elitensis mutant BM25 indicates that this
mutant might also be attenuated in pregnant goats. The lack of the Omp2S protein
may render BM25 unable to colonize or cause abortions in the caprine host. In the
subsequent tw o chapters, the virulence o f the B . abortus and B . m elitensis Aom p25
mutants will be examined in the ruminant hosts.
Based on these studies in the murine model, the lack o f the Omp25 protein did
not result in an exacerbation o f disease. In contrast, all three Aomp25 mutants were
attenuated in the mouse model when compared to the respective, virulent parental
strain. The lack o f the Omp2S protein did render B A25, BM25, and B02S attenuated
in BALB/c mice and indicates that these strains might also be attenuated in the
ruminant hosts.
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CHAPTER 4
A B rucella abortus \om p25 MUTANT IN CATTLE
Introduction
Brucellosis or Bang’s disease is a serious economic threat to beef and dairy
cattle producers throughout much o f the world. The etiological agent, B rucella
abortus, is a Gram-negative, facultative, intracellular pathogen that causes cattle to
abort during the last trimester o f pregnancy (Anderson et al., 1986; Enright, 1990;
Thoen et al., 1993). B rucella abortus is also pathogenic for man causing a variety o f
possible symptoms, including intermittent fever, arthritis, osteomyelitis, and
spondylitis (Young, 1995).
This pathogen gains entry into the host via the mucosal surfaces and is
phagocytosed by macrophages and neutrophils in an effort by the host to eliminate the
organism (Smith and Ficht, 1990). However once inside the professional phagocyte,
B . abortus is able to survive and replicate (Kreutzer et al., 1979; Frenchick et al.,
1985; Baldwin and Winter, 1994; Liautard et al., 1996). The phagocyte migrates, via
the lymphatic system, to the draining lymph node where brucellae infection causes cell
lysis and eventual lymph node hemorrhage about 2-3 weeks following exposure
(Enright, 1990). During this period o f vascular damage, some o f the bacteria enter the
blood stream; and a subsequent bacteremia develops which results in dissemination o f
the pathogen throughout the host, including localization in the reticuloendothelial
system (Enright, 1990; Smith and Ficht, 1990; Thoen et al., 1993).
If the infected animal is pregnant, B. abortus will also colonize and replicate to
high numbers in the chorionic trophoblasts o f the developing fetus (Anderson et al.,
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1986; Enright, 1990; Smith and Ficht, 1990; Thoen et al., 1993). The resulting tissue
necrosis to the fetal membranes allows transmission o f the bacteria to the fetus
(Anderson et al., 1986; Enright, 1990; Thoen et al., 1993). The net effect o f chorionic
and fetal colonization is the premature delivery o f a dead calf during the last trimester
o f pregnancy. The exact mechanism by which colonization o f the chorionic
membranes and fetus results in a late-term abortion is unknown. The impairment o f
fetal circulation, resulting from placentitis has been suggested as a cause o f fetal
abortion (Payne, 19S9). However, considerable variation occurs in the distribution
and severity o f placental lesions following abortions with all the placentomes rarely
being affected (Enright, 1990; Thoen et al., 1993). The exact nature o f the induced
abortion may be a combination o f factors, which produces sufficient alteration o f the
fetal/maternal relationship. This alteration results in an abortion occurring during the
last trimester o f pregnancy.
The predilection o f B. abortus for late-gestational chorionic trophoblasts has
also not been fully explained. Evidence does exist that hormones and possibly the
sugar erythritol may play an important role in the tropism o f brucellae to the
reproductive tract (Smith et al., 1962; Enright, 1990; Sangari and Aguero, 1996).
Late-gestational chorionic trophoblasts, when compared to trophoblasts obtained from
early-gestational placentas, produce higher levels o f erythritol and different
concentrations o f hormones (Smith et al., 1962; Enright, 1990). B rucella abortus is
also known to invade and replicate poorly in early-gestational trophoblasts when
compared to late-gestational cells (Samartino et al., 1994). The penchant o f B . abortus
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to invade and replicate inside bovine trophoblasts is an important step in the abortion
process.
Three major groups o f outer membrane proteins (Omps) have been identified
in Brucella species (spp.) (Dubray and Bezard, 1980; Verstreate et al., 1982). The
group 1 Omps (94 kDa) are considered minor components o f the outer membrane
while the group 2 Omps (41-43 kDa) are functional porins (Verstreate et al., 1982;
Douglas et al., 1984). The group 3 Omps range from 25-31 kDa and consist o f two
different proteins o f 25 (Omp25) and 31 kDa (Omp31), respectively (Verstreate et al.,
1982; Cloeckaert et al., 1996a). Unlike the other Brucella spp., B . abortus lacks
Omp31 due to a large chromosomal deletion (Vizcaino et al., 1996; Vizcaino et al.,
1999). While no function has been described for Omp25, the omp25 gene has been
sequenced and cloned from B. abortus (de Wergifosse et al., 1995). The Omp25
protein is highly conserved throughout the Brucella genus (Cloeckaert et al., 1996a).
This protein is also covalently bound to the peptidoglycan layer o f the cell envelope
and is expressed on the outer membrane in association with lipopolysaccharide (LPS)
(Dubray and Charriaut, 1983; Cloeckaert et al., 1990; Cloeckaert et al., 1992;
Cloeckaert et al., 1996c).
To determine the role o f Omp25 in virulence, a mutant o f virulent B. abortus
strain 2308 containing a disruption in the omp25 gene was created (Aomp25 mutant).
The resulting isolate was termed BA25 for B . abortus Aomp25 mutant. A significant
decrease was observed in the ability o f BA25 to replicate inside cultured murine
macrophages at 48 hours (h) post-infection, when compared to the virulent parental
strain (P<0.01, n = 5). Analysis o f this mutant in the murine B ALB/c brucellosis
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model indicated that BA2S was attenuated. Inoculation o f mice with BA2S resulted in
mean colony forming units (CFUyspleen counts that were at the 2.1 log limit o f
detection by 18 weeks post-infection. In comparison, mice infected with the parental
strain, B . abortus 2308, had >2 logs more bacteria at the same time point (P<0.001, n
= 10). Complementation o f BA2S with the broad-host-range plasmid pBBRlMCS4,
containing the complete omp25 gene, restored the CFU/spleen counts to that o f strain
2308 infected mice.
Based on these studies in mice with the B . abortus Aom p25 mutant, it was
hypothesized that the lack o f the Omp25 protein would render B A25 attenuated in the
ruminant host. To determine if the B . abortus mutant was attenuated, in vitro and in
vivo experiments were instituted with BA2S in cattle. The ability o f the mutant to
survive and replicate in bovine professional phagocytes and chorionic trophoblasts in
vitro was assessed. Cattle in late-gestation were also infected with BA2S to ascertain
the potential o f the mutant to colonize and cause abortions in the ruminant host.
Materials and Methods
Bacterial Strains
B rucella abortus strain 2308 is a virulent challenge strain used by several
different laboratories that is documented to cause abortions in pregnant cattle (Enright,
1990; Cheville et al., 1996; Elzer et al., 1998b). The creation and initial
characterization o f the B. abortus bom p25 mutant, BA2S, from strain 2308, has been
described previously. Infectious doses containing approximately 1 x 109 and 1 x 1011
CFU/ml were prepared as described previously and snap frozen in liquid nitrogen
prior to storage at -80°C. Immediately prior to animal inoculation, samples were
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thawed and diluted in sterile saline to the appropriate concentration. Doses were
verified by serial dilution and plating on Schaedler agar containing 5% bovine blood
(SBA) (Difco Laboratories, Detroit, MI).
Bovine Neutrophil Enrichment
Bovine peripheral blood was obtained from a donor with no history o f strain 19
or RBS1 vaccination and which was negative on the Card test for agglutinating
antibodies to B . abortus (Alton et al., 1988). Blood was collected in EDTA-treated
tubes and centrifuged at 1000 x g for 30 minutes (min). Following centrifugation, 1
ml o f blood was collected from under the buffy coat and the red blood cells lysed by
dilution in 9 ml o f sterile distilled water with gentle agitation for 15 seconds (sec).
Subsequently, 1 ml o f 10 x Dulbecco’s Phosphate Buffered Saline, calcium and
magnesium free (PBS) (Sigma Chemical Company, S t Louis, MO), was added, and
the suspension centrifuged at 200 x g for 10 min. The resulting pellet w as suspended
in water followed by 10 x PBS to ensure complete red blood cell lysis. The cells were
washed three times with 1 x PBS and centrifuged at 200 x g for 10 min. The resulting
cells were suspended in RPMI media (Sigma) with 5% fetal calf serum (FCS) (Gemini
Bio-Products, Calabasas, CA) and cell viability assessed by Trypan blue exclusion and
counting on a hemacytometer.
Bovine Neutrophil Killing Assay
The enriched neutrophil population was immediately transferred to 96-well
plates with 2 x 10s cells/well. The resistance o f both B . abortus strain 2308 and BA25
to killing by cultured bovine neutrophils was determined by incubating each strain
with these cells. Prior to each infection, both bacterial strains were opsonized with
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10% normal murine serum (complement preserved) for 30 min at 37°C. Following
opsonization, 2 x 107 CFU/wel! o f either BA2S or strain 2308 were added to the
neutrophils and incubated at 37°C with 5% CO 2 . At 10, 30, 60, and 120 min post
infection, the neutrophils were lysed by the addition o f 0.1% deoxycholate (Sigma) for
4 min at room temperature (RT). Subsequently, viable counts o f bacteria were
acquired by serial dilution and plating on SB A. Four replicate wells for each strain
were evaluated at each time point, and the experiment was repeated three times. The
percent survival for each strain was determined by dividing the number o f bacteria
present at a particular sampling time by the number o f brucellae added to the
neutrophils at time zero and multiplying by 100.
Bovine M acrophage Enrichm ent
The same donor used to obtain neutrophils was also employed to acquire
bovine macrophages. Whole blood was collected in EDTA-treated tubes and
subsequently diluted 1:2 in PBS. Twenty ml o f the diluted blood was layered onto IS
ml of Sigma Histopaque 1077 (Sigma) and centrifuged at 800 x g for 40 min at RT.
The buffy coat was collected and pelleted at 200 x g for 10 min at RT. The resulting
cells were washed six times with PBS and resuspended in RPMI media containing 5%
FCS, 100 U/ml penicillin (Gibco, Grand Isle, NY), and 0.1 mg/ml streptomycin
(Gibco). Cell viability was evaluated by Trypan blue exclusion and counting on a
hemacytometer. Ninety-six well plates were seeded with 5 x 10s cells/well, and the
cells incubated for 72 h at 37°C in a humidified atmosphere containing 5% CO 2 .
Following 24 and 48 h o f incubation spent media was replaced.
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Bovine Macrophage Killing Assay
The capacity o f BA2S and B . abortus strain 2308 to survive and replicate in
cultured bovine macrophages was determined. Immediately prior to performing the
assay, inoculation doses o f the bom p25 mutant and virulent parental strain were
opsonized for 30 min with subagglutinating murine hyperimmune serum specific for
B. abortus at 37°C. After 72 h o f culture, the macrophages were washed three times
with 1 ml/well o f warm PBS containing 1% FCS to remove nonadherent cells and any
residual antibiotic. The washed cells were then inoculated with 5 x 107 CFU/well o f
opsonized BA25 or strain 2308. Following a 2-h period o f phagocytosis at 37°C, all
extracellular bacteria were killed by the addition o f 50 pg/ml o f gentamicin (Sigma)
for 1 h at 37°C. Following this 1-h treatment, the high-concentration gentamicin was
removed and replaced with media containing gentamicin at a low concentration (12.5
pig/ml).
At 0, 24, and 48 h following high-concentration gentamicin treatment, the
macrophages were washed three times with warm PBS containing 1% FCS. Cells
were then lysed with 0.1% deoxycholate, and the number o f viable intracellular
brucellae determined by serial dilution and plating on the appropriate media. Percent
survival was calculated by dividing the total number viable intracellular bacteria,
present at a particular sampling time, by the number of brucellae added to the
macrophages at time zero, and multiplying by 100. Time zero was defined as the
point when the high-concentration gentamicin was removed from the cells. Statistics
were performed on four replicate wells at each time point, and the experiment was
repeated three times.
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Bovine Trophoblast Cell Lines
Three bovine trophoblast cell lines were used in this study. Dr. D.
Stringfellow generously furnished an early-gestational trophoblast cell line that was
established from a 13-15 day old bovine embryo (Stringfellow et al., 1987). A midgestational cell line derived from the placentomal tissue o f a bovine placenta in the
fifth month o f gestation was charitably provided by Dr. L. Munson (Munson et al.,
1988). A late-gestation trophoblast cell line w as established by Dr. L. Samartino from
the placenta o f bovine dam in the eighth month o f gestation and was supplied by Dr.
F. Enright (Samartino, 1991; Samartino et al., 1994).
All three cell lines were maintained in a complete medium consisting o f a 1:1
mixture o f Ham’s F12 nutrient medium (Sigma) and Dulbecco’s modified Eagle
medium (DMEM) (GIBCO) (pH 7.3). The media was supplemented with 5 ng/ml
selenium, 5 |ig/ml transferrin, 5 pg/ml insulin, 10 ng/ml epidermal growth factor
(Sigma), 100 IU/ml penicillin, 100 ng/ml streptomycin, and 10% fetal bovine serum
(FBS) (Hyclone, Logan, UT). All cells were grown in 25 cm2 flasks at 37°C in a
humidified atmosphere containing 5% CO2 . Following formation o f confluent
monolayers, cells were detached with 0.25% trypsin-EDTA and viable counts
determined with Trypan blue exclusion (0.04%) and a hemacytometer. Cells were
subcultured 1:2 in 4 ml o f media at 5.5 x 10s cells per 25 cm2 flask. Following two to
three subpassages, the cells usually reached confluence by four days and were deemed
ready for experiments. Subsequent subcultures were split 1:3 into 25 cm2 flasks.
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Bovine Trophoblast Infection Assay
Prior to infection, each cell line was passaged from the 25 cm3 flasks into 24well plates at a concentration o f 1 x 10s cells/well with 1 ml o f antibiotic-free media
per well. Twenty-four h following cell passage, inoculation doses o f both B. abortus
strain 2308 and the Aomp25 mutant BA25 were thawed and diluted in warm,
antibiotic-free cell media. Either bacterial strain was added to the trophoblasts at 1 x
107 cells/well resulting in a 1:100 ratio o f cells to bacteria. The bacteria were
incubated with the trophoblasts for 10 h at 37°C with 5% CO?.
At 10 h post-infection, media was removed and all extracellular bacteria killed
by incubation at 37°C with high-concentration gentamicin (50 pg/ml) diluted in warm
DMEM or RPMI media. One h later, the high-concentration gentamicin media was
removed and replaced with the complete culture media containing a low concentration
o f gentamicin (12.S pg/ml). At 0, 12, 24, 36 and 48 h following completion of highconcentration gentamicin treatment, the cells were gently washed with 1 ml of warm
PBS containing 1% FCS. Following one wash, 800 pi o f PBS was added to each well
and the entire plate frozen at -80°C for later bacteriological analysis. All three cell
lines were inoculated with both bacterial strains with three replicates per time point.
The entire experiment was repeated three times.
Following the completion o f each experiment, the 24-well plate was thawed at
37°C and 0.1% deoxycholate added to each well to lyse the cells. Following a 5 min
incubation at RT, the cells were serially diluted in PBS and plated on SBA to obtain
the viable CFU/ml. Percent survival was calculated by dividing the number of
bacteria present at a particular sampling time by the number o f brucellae added to the
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trophoblasts at time zero and multiplying by 100. Time zero was defined as the point
when the high-concentration gentamicin was removed from the cells.

Caflk
Twenty pregnant, mixed-breed cows were obtained from private herds. All
animals were negative for Brucella-specific antibodies by standard Card test and had
no previous history o f strain 19 or RBS1 vaccination. Serological analysis with the
western immunoblot utilizing both smooth and rough B. abortus cell lysate failed to
find evidence o f previous vaccination with strain 19 or RB51 (Edmonds et al., 1999a).
Throughout the course o f the study, all cattle were housed in an United States
Department o f Agriculture/Animal and Plant Health Inspection Service
(USDA/APHIS) approved, restricted-access, large animal isolation facility located at
Louisiana State University AgCenter, Baton Rouge, Louisiana. At the conclusion o f
the study, the adult cows were euthanized at a government-inspected abattoir by use o f
the captive bolt and exsanguination method. Live calves were euthanized at the
research facility by the captive bolt and exsanguination method and disposed of by
approved methods.
Bovine Study
At approximately 220 days gestation, each cow was inoculated with 1 x 107
CFU of either B. abortus strain 2308 or BA2S by introducing SO pi o f the inoculum
into the conjunctival sac o f each eye. Ten cows were inoculated with the virulent
parental strain while an additional ten animals were inoculated with the &omp25
mutant. Following inoculation, animals were monitored daily for parturition.
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The birth status o f the calf was recorded as either healthy, weak, or an
abortion. Within 12 h o f parturition a necropsy was performed on the calf. Samples
taken from the calf for bacteriological analysis included the abomasal fluid and lung.
Tissue samples were frozen at -4°C for later analysis, while the abomasal fluid was
swabbed the day o f collection on Farrell’s selective medium (Farrell, 1974). Two
days following birth, milk samples from all four quarters o f the mammary gland and
intrauterine fluid samples were obtained from the dam. Both fluid samples were
swabbed the day o f collection on Farrell’s selective medium. I f B . abortus was not
cultured from either the milk or uterine fluid, a second sample was obtained 2 weeks
later for additional bacteriological analysis. At approximately 35 days postparturition, the dams were necropsied and tissue samples obtained from the
supramammary lymph node, spleen, and liver for the culture o f brucellae. Serum was
also obtained prior to infection, following parturition, and at necropsy for serological
analysis.
Bacteriological and Serological Analysis
All tissue samples were thawed and homogenized in a sterile saline (0.9%
NaCl) solution and plated onto Farrell’s selective medium containing 5% bovine
blood; the limit o f detection with this system is 13 CFU/gm o r ml. The plates were
incubated for 14 days at 37°C in a 5% CO2 atmosphere. B rucella abortus was
identified on the basis o f urease and oxidase reactions, colony morphology, growth
rate, smooth phenotype by acriflavine, and Gram-stain reaction (Alton et al., 1988).
BA25 was differentiated from B. abortus strain 2308 by being kanamycin resistant
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(45 ug/ml). Serum w as analyzed for 5 . abortus specific antibodies by the Card test
and western immunoblot. Both tests were performed as previously described.

SWialw
For neutrophil, macrophage, and trophoblast assays, statistical comparisons
between experimental groups were performed with the Student /-test for parametric
data and the Mann-Whitney Ranked Sum Test for nonparametric data (Snedecor and
Cochran, 1989). The rate o f abortion between cattle inoculated with strain 2308 or
BA25 was compared with a Fisher Exact Probability Test, while median CFU/gm o f
tissue was compared with the Mann-Whitney Ranked Sum Test (Snedecor and
Cochran, 1989). A P<0.05 was considered significant for all three tests. All statistics
were performed with the Sigma Stat program (Sigma Stat for Windows, Version 1.0,
Jandel Scientific, 1992-1994).
Results
Bovine Neutrophil K illing A «» v
To determine if the lack o f the Omp2S protein would render BA25 more
susceptible to killing by professional phagocytes, the bomp25 mutant and virulent
parental strain were exposed to cultured bovine neutrophils. The results o f one
representative experiment are shown in Figure 4.1. The difference in percent survival
between BA25 and strain 2308 was not significant at 10,30, 60, or 120 min post
infection. At 30 min post-infection, the percent survival for both strains decreased to
approximately 30% and remained statistically the same thereafter (Figure 4.1). At
each time point in Figure 4.1, the data presented is the mean o f four replicates. The
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Figure 4.1. Killing o iB . abortus strains 2308 and BA2S opsonized with normal
murine serum by cultured bovine neutrophils. The data presented are the results o f a
representative experiment with four repetitions at each time point. Vertical bars
indicate standard error, closed circles strain 2308, and open circles BA2S.
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experiment was repeated three times with no significant deviations being observed
between trials.
Bovine Macrophage K illing Assay
To ascertain if in the bovine host, the Som p2S mutant would be more
susceptible to the bactericidal mechanisms o f the macrophage, a series o f in vitro
killing assays was performed with freshly isolated bovine macrophages. One
representative experiment is shown in Figure 4.2. By 24 h following infection, the
parental strain had decreased in viable numbers by 28% while BA25 had decreased
93% (PO.OOl, n = 4) (Figure 4.2). At 48 h post-infection, strain 2308 replicated to
549% while the mutant recovered to only 33% (P<0.01, n = 4) (Figure 4.2). The
experiment was repeated three times; and while individual variances were observed,
BA25 was consistently killed at a higher rate than B. abortus strain 2308.
Bovine Trophoblasts Infection Assay
The B . abortus Aomp25 mutant was cultured in early, mid, and late-gestational
bovine trophoblasts to determine if the lack o f Omp25 rendered BA25 attenuated in
these chorionic cells. In the early-gestational cell line, no distinction was observed
between the survival rates o f the two strains at 12 or 24 h post-infection (Figure 4.3).
While strain 2308 and BA25 decreased to less than 16% survival at 12 h, both
recovered to >100% o f the inoculum by 36 h. Unlike the previous time points, at 36 h
significant differences occurred between the two strains in percent survival (P<0.05, n
= 3). By 48 h, strain 2308 had replicated more than 1.5 logs greater than BA25
(PO.OOl, n = 3) (Figure 4.3). Two additional replicates o f this assay produced no
significant variations.
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Figure 4.2. Killing of B. abortus strains 2308 and BA25 opsonized with
hyperimmune murine serum by cultured bovine macrophages. The data presented are
the results o f a representative experiment with four repetitions at each time point.
Vertical bars indicate the 25% and 75% quardles, closed circles strain 2308 median,
and open circles B A25 median. **/><0.0l, ***P<0.001, based on a Mann-Whitney
Rank Sum Test o f nonparametric data, n = 4.
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Figure 4.3. Replication o f B . abortus strains 2308 and BA2S in early-gestational
bovine chorionic trophoblasts. The data presented are the results o f one representative
experiment with three replicates at each time point. Vertical bars indicate standard
error, closed circles strain 2308, and open circles BA2S. *P<0.05, ***P<0.001, based
on a /-test, n = 3.
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In a mid-gestational trophoblast cell line, the percent survival for B A25 was
consistently lower than B . abortus strain 2308 from 12 to 48 h post-infection (Figure
4.4). At 12 h following infection, both strains decreased in percent survival with 2308
at 2.69% and BA2S at 0.38% (F<0.01, n = 3). By 24 h post-infection, while the
tuomp25 mutant recovered to 25% o f the inoculum, strain 2308 had replicated to 241%
survival (P<0.05, n = 3). While at consistently lower numbers than the parental strain,
the mutant was able to replicate, surpassing the inoculum at 36 and 48 h post-infection
(Figure 4.4). In two repetitions o f this experiment, similar results were obtained.
In the late-gestational cell line, the bom p25 mutant again replicated at lower
numbers than the parental strain at 24, 36, and 48 h following infection (Figure 4.5).
By 24 h post-infection, strain 2308 replicate to 469% survival while B A25 recovered
to 85% survival (P<0.001, n = 3). Significant differences in percent survival between
the two strains were also observed at 36 h (i*<0.01, n = 3) and 48 h post-infection
(P<0.001, n = 3). While the mutant did not replicate to the same extent as strain 2308,
BA25 was able to surpass the inoculum at 36 and 48 h post-infection (Figure 4.5).
Cattle Study
To assess the pathogenicity o f BA25 in the ruminant host, pregnant cattle in
late-gestation were exposed to either the Aomp25 mutant or the virulent parental
strain, B. abortus 2308. The results o f this study are presented in Table 4.1.
Inoculation o f ten pregnant cows with virulent strain 2308 resulted in 5/10 (50%) o f
the dams aborting. In contrast, only 1/10 (10%) cows inoculated with BA25 aborted
(P<0.05, n = 10). The virulent parental strain was cultured from every strain 2308
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Figure 4.4. Replication o f 2?. abortus strains 2308 and BA25 in mid-gestational
bovine chorionic trophoblasts. The data presented are the results o f one representative
experiment with three replicates at each time point. Vertical bars indicate standard
error, closed circles strain 2308, and open circles BA2S. *P<0.05, **P<0.01,
***P<0.001, based on a /-test, n = 3.
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Figure 4.5. Replication o f B . abortus strains 2308 and BA25 in late-gestational
bovine chorionic trophoblasts. The data presented are the results of one representative
experiment with three repetitions at each time point. Vertical bars indicate standard
error, closed circles strain 2308, and open circles BA25. **P<0.01, ***P<0.001,
based on a /-test, n = 3.
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Table 4.1. Abortion rate, colonization rate, and serologic response o f 20 pregnant
cows inoculated with either Brucella abortus strain 2308 or BA25.
______
Strain 2308 Group (n = 10)
BA2S Group (n = 10)
Abortion Rate
10%*

50%

20%***

100%

30%*

90%

Uterine Fluid

30%**

100%

Milk

50%*

100%

Calf: colonization
Abomasal Fluid
Fetal Lung
Cow: colonization

Supramammary LN
Liver / Spleen

40%* (3/7)*

90% (9/10)

0%

0%

60%

100%

Serologic Analysis"
+ Response

All data is presented as the percentage o f cows positive out o f ten animals per
treatment group. Liver and spleen tissue were homogenized and cultured
together.
‘Only seven tissue samples were cultured.
'’Detection o f antibodies specific for the O-side chain by western immunoblot, see
text for description.
*P<0.05, **/*<0.01, ***/><0.001 by the Fischer Exact Probability Test, n = 10.
LN = lymph node.
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inoculated dam and calf. The Som p25 mutant was cultured from S/10 (50%) dams
and 3/10 (30%) calves ( / ’<0.05, n = 10) (Table 4.1). In this study, 4/10 (40%) o f the
BA25 exposed dams did not develop antibodies to B. abortus nor were they colonized
by the mutant. All o f the strain 2308 inoculated animals developed antibodies to B .
abortus and were colonized.
The median CFU/gm o f tissue obtained from the two experimental groups was
compared with a Mann-Whitney Ranked Sum Test. The three supramammary lymph
nodes colonized by BA25 did have a statistically lower median CFU/gm o f tissue than
the strain 2308 infected animals (P<0.05, n = 3). The median CFU/gm o f tissue for
the 2308 dams was 1000 CFU with 25% and 75% quartiles o f 192 CFU and 3250
CFU, respectively. In contrast, the three colonized tissue samples from the BA25
infected dams had a median o f 60 CFU/gm with 23 CFU and 128 CFU for quartiles.
Discussion
Based on the in vitro analysis o f BA25 in bovine phagocytes and chorionic
trophoblasts, this mutant may be unable to adjust to the intracellular environment as
quickly as virulent B. abortus strain 2308. As in murine macrophages, incubation o f
BA25 with bovine macrophages resulted in a significant decrease in percent survival
at 48 h post-infection (P<0.01, n = 4). The data from murine and bovine macrophages
indicates that the lack o f Omp25 may have influenced the capacity o f BA25 to adjust
to the bactericidal environment o f the activated macrophage.
In bovine trophoblasts from early, mid, and late-gestation, the Aomp25 mutant
again did not replicate inside the cell to the same extent as the virulent parental strain,
B. abortus 2308. In all three cell lines, both strains decreased by more than half a log
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at 12 h post-infection. This may reflect a period o f adjustment where the bacterium
modulates the expression o f different genes involved in intracellular growth. While
the trophoblast does not have the anti-microbial activity o f the macrophage, the
conditions inside this cell are different from extracellular growth on a media plate.
Inside the trophoblast, B . abortus preferentially metabolizes the sugar erythritol, which
is implicated in the tropism o f brucellae to the uterus (Smith and Ficht, 1990). The
Aomp25 mutant can metabolize erythritol in vitro (data not shown). The inability o f
BA25 to adjust to the intracellular environment o f the trophoblast is reflected in the
lower percent survival o f the Aomp25 mutant at 36 and 48 h post-infection.
The growth o f BA25 in macrophages and trophoblasts may explain the
attenuation o f this mutant in vivo. If the Aom p25 mutant is unable to survive and
replicate inside the bovine macrophage, the organism may be eliminated from the
draining lymph node, preventing dissemination and eventual colonization o f the
developing fetus. Furthermore, the inability o f BA2S to replicate inside the lategestational bovine trophoblast to the same extent as strain 2308 may also have
important consequences in the late-term abortion process. I f the bacteria can not
replicate efficiently in the chorionic membranes, the chance o f fetal infection and
subsequent abortion is lowered.
In the ruminant host, the B. abortus &omp25 mutant was attenuated when
compared to the virulent parental strain. O f the ten bovine dams exposed to BA25,
four did not develop antibodies to B . abortus nor did the bacteria colonize them.
These animals may have eliminated the mutant in the draining lymph node thus
preventing spread throughout the host. One animal did develop antibodies to B .
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abortus, but both the dam and calf were negative for the culture o f brucellae
organisms. This animal was colonized for sufficient time to develop antibodies but
was able to eliminate the mutant prior to parturition. The inability of BA25 to
replicate to the same extent as strain 2308 in bovine macrophages may have resulted
in 5/10 pregnant cattle eliminating the mutant prior to parturition.
The remaining five pregnant dams inoculated with the bom p25 mutant were
colonized by B A25 but had only three calves that were positive for brucellae
organisms. The fact that only 3/S colonized dams had calves that were likewise
positive for B. abortus may reflect the inability o f B A25 to replicate efficiently inside
the late-gestational trophoblast. Following enhanced killing o f the mutant by activated
macrophages in the draining lymph node, lower numbers o f the Aomp25 mutant were
disseminated throughout the host. Those bacteria that did succeed in colonizing the
chorionic membrane were unable to replicate as efficiently as the virulent parental
strain. As a result, the necrosis to fetal membranes was decreased and only 3/5 calves
were colonized in utero. Only one abortion occurred possibly due to alteration o f the
fetal/matemal relationship, relating to the lower numbers o f bacteria present in the
placenta.
The lack o f the Omp25 protein did render BA25 attenuated in the ruminant
host. In the future, the role o f Omp25 in the replication o f B . abortus in bovine
macrophages and trophoblasts needs to be furthered explored. A detailed
understanding o f the physiological role o f this proton would provide additional
information on the pathogenesis o f Brucella spp. By understanding the role o f Omp25
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and other proteins in Brucella, the development o f new vaccine candidates lacking key
virulence factors is possible.
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CHAPTER 5
A B ru cella m elitensis Som p25 M UTANT IN GOATS
Introduction
Brucella m elitensis is a pathogenic, zoonotic agent found primarily in small
ruminants throughout the world (Alton, 1990a; Blasco, 1997; Garin-Bastuji et al.,
1998). The primary hosts for 5 . m elitensis are goats and sheep, in which the organism
causes abortions during the third trimester o f pregnancy. The pathogen goes
undetected in infected flocks until lambing season when colonized dams abort (Alton,
1990a; Blasco, 1997; Garin-Bastuji et al., 1998). Following an abortion, the infected
female excretes copious amounts of the bacteria in both uterine exudate and milk.
This state results in spread o f the organism throughout the flock and to human
caretakers. B rucella m elitensis is the most virulent B rucella spp. for man and is also
the least species-specific, infecting goats, sheep, cows, camels, and dogs (Young,
1995). In man, B. m elitensis causes the disease undulant fever which is characterized
by a variety o f possible symptoms including pyrexia, arthritis, osteomyelitis,
spondylitis, dementia, and in rare cases endocarditis or meningitis (Young, 1995).
Brucella m elitensis contains three groups o f major outer membrane proteins
(Omps) (Dubray and Bezard, 1980; Verstreate et al., 1982; Cloeckaert et al., 1996a).
The group 1 Omps (94 kDa) are considered minor components o f the outer membrane
while the group 2 Omps (41-43 kDa) are functional porins (Verstreate et al., 1982;
Douglas et al., 1984; Cloeckaert et al., 1996a). The group 3 Omps range from 25-31
kDa and consist o f two different proteins o f 25 (Omp25) and 31 kDa (Omp31),
respectively (Verstreate et al., 1982; Cloeckaert et al., 1996a). The Omp31 protein is
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proposed to be a porin while no function has yet been described for Omp25 (Vizcaino
et al., 1996).
The Omp25 protein is expressed on the outer cell membrane o f each B rucella
spp. (Cloeckaert et al., 1996c). The protein is bound to the peptidoglycan layer by a
covalent bond, and association o f Omp25 with lipopolysaccharide (LPS) is important
for the maintenance o f conformational epitopes on the protein (Dubray and Charriaut,
1983; Cloeckaert et al., 1992; Cloeckaert et al., 1996c). Analysis o f the om p25 gene
with PCR-RFLP and nucleotide sequencing indicates that the gene is highly conserved
among the Brucella spp. (Cloeckaert et al., 199S; Cloeckaert et al. 1996b).
To investigate if the lack o f the Omp25 protein would render B rucella spp.
attenuated in the ruminant host, a B . m elitensis mutant containing a disruption in the
omp25 gene was created (tuomp25 mutant) as described previously. In the BALB/c
mouse model, the B . m elitensis Aomp25 mutant, BM25, displayed significant
attenuation at 4 ,6 and 8 weeks post-infection (P<0.05, n = 5). At 6 and 8 weeks post
infection, mice inoculated with the virulent parental strain, B . m elitensis 16M, had
mean colony forming units (CFU)/spleen counts that were approximately 1 log greater
than mice receiving the Aom p2S mutant (P<0.01, n = S). Complementation o f BM25
with the broad-host-range plasmid pBBRlMCS4, carrying the complete om p25 gene,
restored protein expression and virulence in the mouse model.
The attenuation o f BM25 in mice indicated that the Aom p25 mutant might also
be attenuated in the ruminant host. Previous studies have found that strains o f
brucellae that are attenuated in the ruminant host are also often attenuated in the
mouse (Montaraz and W inter, 1986; Winter, 1990; Schurig et al., 1991; Elzer et al.,
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1996). Therefore, it was hypothesized that the lack o f the Omp25 protein would
render BM25 attenuated in pregnant goats. The ability o f the B . m elitensis mutant to
colonize and cause abortions in the ruminant host was determined in tw o experiments.
M aterials and Methods
Bacterial Strains
B rucella m elitensis strain 16M has been documented to cause abortions in
pregnant goats (Phillips et al., 1997; Elzer et al., 1998c). The creation and initial
characterization o f the B. m elitensis Aomp25 mutant, BM2S from strain 16M has been
described previously. Infectious doses containing approximately 1 x 109 and 1 x 10u
CFU/ml were prepared as described (Elzer et al., 1994c) and snap frozen in liquid
nitrogen prior to storage at -80°C. Immediately prior to animal inoculation, samples
were thawed and diluted in sterile saline to the appropriate concentration. Doses were
verified by serial dilution and plating on Schaedler agar containing 5% bovine blood
(SBA) (Difco Laboratories, Detroit, MI).
Animals
Thirty sexually mature female Angora goats were obtained from a commercial
herd. All goats were negative for B rucella-specific antibodies based on western
immunoblot (Edmonds et al., 1999a) and the Card test (Alton et al., 1988).
Throughout the study, the animals were housed in a restricted access, large-animal
isolation facility operated under guidelines approved by the United States Department
o f Agriculture/Animal and Plant Health Inspection Service (USD A/APHIS). At the
conclusion o f each study the adult animals were euthanized by the captive bolt and
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exsanguination method. Any kids bom alive at parturition were euthanized and
exsanguinated. These animals were used in the following two studies.
Colonization Study
Six non-pregnant Angora goats were inoculated with approximately 1 x 109
CFU of B. m elitensis strain 16M by placing SO pi o f the inoculum into each
conjunctival sac. Nine other non-pregnant goats were inoculated with a one log higher
dose (1 x 1010 CFU) o f the &omp25 mutant, BM25, via the same method. At 4, 7, and
14 days post-infection, two strain 16M and three BM25 goats were euthanized; and
various samples obtained for bacteriological and serological analysis. Tissue samples
were obtained from preferred sites o f brucellae localization, including the parotid
lymph node which drains the site o f inoculation, the supramammary lymph node, and
the spleen. Following collection, samples were frozen at -4°C and prepared as
described below.
Abortion Study
Goats in late-gestadon, approximately 124 days, were divided into two groups.
The first group o f six females was inoculated with 1 x 107CFU o f the virulent parental
strain 16M, by placing 50 pi o f the inoculum in each conjunctival sac. At this dose
and route o f infection, strain 16M has been documented to cause abortions (Phillips et
al., 1997; Elzer et al., 1998c). An additional group o f nine females were inoculated
with an equal dose o f BM25, via the same method. Following inoculation, animals
were monitored daily for delivery. At parturition, the birth status o f the kid was
recorded as either an abortion or live-healthy kid. Within 12 h following parturition,
the dam was euthanized, as was the kid if bom alive. During necropsy samples were
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obtained from the dam o f the parotid lymph node, prescapular lymph node, prefemoral
lymph node, supramammary lymph node, internal iliac lymph node, spleen, liver, and
milk for bacteriological analysis. Samples obtained from the kid included the
prehepatic lymph node, lung, liver, spleen, thymus, and abomasal fluid. All tissue
samples were frozen at -4°C prior to analysis, while the milk and abomasal fluid were
plated the day o f collection on Farrell’s selective medium (Farrell, 1974). Prior to
infection and at necropsy, serum samples were obtained from the adult females for
serological analysis.
Bacteriological and Serological Analysis
All tissue samples were thawed and homogenized in a sterile saline (0.9%
NaCl) solution and plated onto Farrell’s selective medium containing S% bovine
blood; the limit o f detection with this system is 13 CFU/gm or ml. The plates were
incubated for 14 days at 37°C in a 5% CO 2 atmosphere. B rucella m elitensis was
identified on the basis of urease and oxidase reactions, colony morphology, growth
rate, presence o f LPS O-polysaccharide (O-side chain) by acriflavine and Gram-stain
reaction (Alton et al., 1988). BM25 was differentiated from B. m elitensis strain 16M
by being kanamycin resistant (45 pg/ml). Serum was analyzed for B . m elitensis
specific antibodies by the Card test and western immunoblot. Both tests were
performed as previously described (Alton et al., 1988; Edmonds et al., 1999a).
Statistics
The number o f abortions, colonized dams and colonized kids were compared
between the two groups in each study with a Fisher Exact Probability Test, with a
P<0.05 being considered significant (Snedecor and Cochran, 1989). All statistics
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were performed with the Sigma Stat program (Sigma Stat for Windows, Version 1.0,
Jandel Scientific, 1992-1994).
Results
Colonization Study
To establish if the B. m elitensis Aomp25 mutant could colonize non-pregnant
goats, a short-term colonization study was carried o u t Inoculation o f nine non
pregnant goats with 1 x 1010CFU ofBM 25 resulted in colonization o f the parotid
lymph node at days 4, 7, and 14 post-infection (Table S. 1). By day 7 post-infection,
BM25 was also obtained from the spleens o f 2/3 goats inoculated with the B .
m elitensis Aom p25 mutant. The supramammary lymph node was colonized by BM25
at 14 days post-infection. The virulent parental strain, B . m elitensis 16M,
administered at a 1 log lower dose (I x 109 CFU) also colonized the goats (Table S.l).
Abortion Study
To assess the pathogenicity o f BM2S in the ruminant host, pregnant goats in
late-gestation were exposed to either the Aom p25 mutant or the virulent parental
strain. The results o f this study are presented in Tables 5.2 and 5.3. Inoculation o f six
pregnant goats with strain 16M resulted in 6/6 (100%) abortions (Table 5.2). In
contrast, none (0/9) o f the dams inoculated with BM25 aborted (P<0.001, n = 6). The
virulent parental strain was cultured from every strain 16M inoculated dam and kid.
The Aomp25 mutant was cultured from 4/9 (44%) dams and 2/9 (22%) o f the kids
(P<0.05, n = 6) (Table 5.2). O f the four dams and two kids colonized by BM25, one
dam-kid pair were positive for the culture o f brucellae organisms from most o f the
tissue samples taken (Table 5.3). The two kids colonized by BM25 were from dams
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Table 5.1. Colonization study: bacteriological and serological analysis o f nonpregnant Angora goats inoculated with either B rucella m elitensis strain 16M or BM25.
Parotid LN
Spleen
Supramammary
Serologic
Strain
Days
LN

Response*

Neg

Neg

Neg

PostInfection
BM25b

4

3/3
4892 +/-2372c

16Md

4

Neg

Neg

Neg

Neg

BM25

7

3/3

2/3

Neg

Neg

7947 +/- 4248

111+/-90

2/2

Neg

Neg

Neg

16M

7

1066+/-331
BM25

16M

14

14

3/3

3/3

3/3

9704 +/- 2657

3648+/- 1150

2615 +/- 1352

2/2

1/2

3367 +/- 709

224 +/- 0

Neg

‘Positive serologic response to B. m elitensis strain 16M cell lysate via western
immunoblot, see text for description.
bInoculum = 1 x 1010 CFU into the conjunctival sac.
°Mean CFU/gm +/- the standard error.
dInoculum = 1 x 109CFU into the conjunctival sac.
LN = Lymph node, Neg = negative.
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3/3

2/2

Table 5.2. Abortion study: abortion rate, colonization rate, and serologic response of
Challenge

Abortion

Adult Colonization

Kid Colonization

Serologic

Strain*

Rate

Rate

Rate

Response1*

BM25

0/9***

4/9*

2/9**

9/9

0%

44%

22%

100%

6/6

6/6

6/6

6/6

100%

100%

100%

100%

16M

in i

it

-

.

.1

_"

''Positive serologic response to B . m elitensis strain 16M cell lysate via western
immunoblot, see text for description.
*.P<0.05, **P<0.01, ***P<0.001, n = 6, based on a Fischer Exact Probability
Test.
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Table S3. Abortion study: colonization of BM25 inoculated adults and kids.
Adult Sample

Number Infected

Kid Sample

Number Infected

Parotid LN

4/9

Abomasal Fluid

2/9

Supramammary LN

2/9

Lung

1/9*

Internal Iliac LN

2/9

Thymus

1/9*

Milk

2/9

PrehepaticLN

0/9

Spleen

1/9“

Spleen

1/9*

Liver

1/9“

Liver

1/9*

Lung

1/9*

Prescapular LN

1/9*

LN = lymph node.
‘Same dam-kid pair.
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that were colonized in the both the supnunammary and internal iliac lymph nodes.
The remaining two dams infected with BM25 were colonized in only the parotid
lymph node and had kids that were negative for the culture o f brucellae organisms
(Table 5.3). Serological analysis o f samples taken prior to infection and during
necropsy, found B rucella-specific antibodies in all the test animals (Table 5.2).
Discussion
A short-term colonization experiment was performed with the B . m elitensis
Aomp25 mutant to determine if it could survive in the ruminant host. Inoculation o f
nine non-pregnant goats verified that BM25 was capable o f transient in vivo
colonization. Since the Aomp25 mutant was capable o f short-term colonization in the
non-pregnant caprine host, an abortion study was performed. The B. m elitensis mutant
induced no abortions (0/9) while the virulent parental strain, B . m elitensis 16M,
induced a 100% (6/6) abortion rate (P<0.001, n = 6). The Aomp25 mutant also
colonized fewer dams (P<0.05, n = 6) and kids (P<0.01, n = 6) than strain 16M. O f
the four dams colonized by BM25, only two had kids that were colonized upon
parturition.
The B rucella m elitensis Aomp25 mutant did cause 100% sero-conversion,
indicating that BM25 was not quickly eliminated from the draining lymph node. In
contrast, the B rucella abortus bamp25 mutant, BA25, while causing one abortion in
vivo, did not induce B rucella-specific antibodies or colonize 40% o f the bovine dams
(Table 4.1). Also, inoculation o f non-pregnant goats with 1 x 1010 CFU o f the B.
m elitensis mutant (3 logs greater than that used in the abortion study), resulted in the
colonization o f lymph nodes distant from the site of inoculation including the
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supramammary and internal iliac. Based on this data, the attenuation o f BM25 in vivo
may be due to several factors. As proposed previously for the B . abortus mutant, the
B. m elitensis Aomp25 mutant may be unable to replicate as efficiently as strain 16M in
both caprine macrophages and chorionic trophoblasts. I f BM25 is unable to adjust to
the intracellular environment o f the caprine trophoblast, then significant alteration o f
the fetal/maternal relationship may not occur. Future in vitro studies need to be
performed with the B. m elitensis bomp2S mutant in caprine trophoblasts and
phagocytes to determine if BM25 is attenuated in these cell types.
The capacity o f the B . m elitensis mutant to transiently colonize the ruminant
host while inducing no abortions makes this mutant an attractive vaccine candidate.
The current vaccine for caprine brucellosis is the live-attenuated B . m elitensis strain
Rev. 1 (Blasco, 1997; Garin-Bastuji et al., 1998). While it provides protection against
infection, this vaccine can also cause dams to abort if given during pregnancy. (Alton,
1990a; Blasco, 1997; Garin-Bastuji et al., 1998). The fact that BM25 does not induce
abortions raises the possibility that it could be an alternative to strain Rev. 1. In the
following chapter, the potential o f BM25 as a vaccine for small ruminants will be
analyzed.
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CHAPTER 6
VACCINE TRIALS W ITH B rucella m eliten sis AND BruceUa a vis M UTANTS
LACKING A 25 ld)a OUTER MEMBRANE PROTEIN (Om p25)
Introduction
B rucella m elitensis is a serious economic and public health threat in
many countries throughout the world (Corbel, 1998). Infection o f pregnant goats and
sheep with B. m elitensis results in abortion during the third trimester o f pregnancy.
Humans infected with this pathogen develop undulant fever, which is characterized by
pyrexia, arthritis, osteomyelitis, and spondylitis (Young, 199S). The attenuated-live
vaccine B . m elitensis strain Rev. 1 has been used successfully in goats and sheep to
prevent B. m elitensis infection (Jones et al., 1964; Alton, 1966; Alton, 1987; Alton,
1990a; Blasco, 1997; Garin-Bastuji et al., 1998; Scharp et al., 1999). Subcutaneous
(s.c.) vaccination o f three to seven month old sexually immature goats with strain Rev.
1 provides protection against virulent challenge up to 2.5 years following vaccination
(Alton, 1966). This vaccine has also been demonstrated to have a stable, attenuated
phenotype upon six serial passages in vivo (Alton et al., 1967).
However, although attenuated, strain Rev.

1

does cause abortions if given to

pregnant goats or sheep s.c. during later stages o f gestation (Alton, 1990a; Blasco,
1997; Garin-Bastuji et al., 1998). Based on field trials, some authors have proposed
using a reduced dose and/or conjunctival inoculation, which provides immunity while
decreasing the risk o f abortion (Scharp et al., 1999). However, controlled
experimental studies have found that while conjunctival vaccination induces fewer
premature deliveries, the abortion rate o f approximately 2 0 % is still to high to ignore
the pregnancy status o f the dam at the time o f vaccination (Zundel et al., 1992; Blasco,
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1997). As a result, vaccination o f mature females is not recommended during the
lambing season o r less than one month prior to mating (Alton, 1990a; Blasco, 1997;
Garin-Bastuji et al., 1998). In areas with an extended breeding season or poor
management practices, vaccination is therefore limited to only young animals between
three and eight months o f age (Blasco, 1997). In endemically infected flocks,
vaccination o f young lambs does not prevent infected adults from spreading the
organism to other mature females and/or animal caretakers (Blasco, 1997). Therefore
an efficacious vaccine that could be given to sexually mature and possibly pregnant
goats or sheep without fear o f abortion would be a major benefit.
The ovine pathogen, B rucella avis, is different from B . m elitensis in cell
envelope structure, host preference, and pathology. Unlike B . m elitensis, B . avis, a
rough organism, lacks the O-polysaccharide (O-side chain) sugar found on the
lipopolysaccharide (LPS) o f smooth Brucella strains (Blasco, 1990). B rucella avis is
also primarily a disease o f rams where it induces epididymitis and subsequent
infertility (Blasco, 1990; Cerri et al., 1999). Only rarely does this B rucella specie
induce abortions in pregnant ewes (Libal and Kirkbride, 1983; Grillo et al., 1999).
Brucella ovis is also non-pathogenic for humans (Blasco, 1990). Ovine brucellosis
can have a serious economic impact on the producer since the infection often goes
undetected until significant decreases in pregnancy rates are discovered (Blasco,
1990). Subsequent analysis o f the breeding rams finds the majority are infected and
permanently sterile. This forces the producer not only to lose valuable breeding stock
but to also find methods to prevent infection o f newly introduced rams.
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B rucella m elitensis strain Rev. 1 is considered the best vaccine for ovine
brucellosis (Blasco et al., 1987; Jimenez de Bagues et al., 199S). Recent work with
two attenuated-live vaccines, B rucella abortus strain RBS1 and Brucella suis strain 2,
have failed to protect rams against virulent challenge with B . ovis (Blasco et al., 1993;
Jimenez de Bagues et al., 1995). While strain Rev. 1 is efficacious, several problems
exist with its use. In countries such as the U.S., the use o f attenuated B . m elitensis
strains is prohibited due to the absence o f virulent B . m elitensis in the field.
Therefore, in the U.S. and other countries free o f B . m elitensis, but where ovine
brucellosis is a problem, no vaccines are available (Blasco, 1990; Jimenez de Bagues
et al., 1995). B rucella m elitensis strain Rev.

1

can also cause abortions in pregnant

ewes and is pathogenic for humans (Alton, 1990a; Blasco and Diaz, 1993; Blasco,
1997; Garin-Bastuji et al., 1998). Strain Rev. 1 is a smooth strain and does induce
anti-O-side chain antibodies that are detected on the accepted sero-diagnostic tests
(Jimenez de Bagues et al., 1995). In areas attempting to eradicate B. m elitensis from
infected sheep, an animal vaccinated with strain Rev. 1 can not be serologically
distinguished from one infected with virulent, wild-type B . m elitensis.
The negative aspects o f strain Rev. 1 vaccination for the control o f both B .
m elitensis and B . ovis support the development o f new vaccine alternatives. The B .
m elitensis Som p2S mutant, BM25, described previously, is a viable option for the
prevention o f B . m elitensis infection. Inoculation o f B ALB/c mice with BM25
resulted in a significant decrease in the mean colony forming units (CFUyspleen from
4 to

8

weeks post-infection, when compared to the virulent parental strain, B.

m elitensis 16M (P<0.05, n = 5). Furthermore, inoculation o f nine pregnant caprine

130
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

dams in late-gestation with BM25 resulted in no abortions while the virulent parental
strain caused abortions in 6 / 6 pregnant females (P<0.001, n = 6 ). The Aomp25 mutant
colonized 4/9 dams and 2/9 kids, while strain 16M colonized

6 /6

dam-kid pairs

(P<0.05, n = 6 ). A colonization study o f non-pregnant female goats also determined
the BM25 can transiently colonize the ruminant host. Since, BM25 does not appear to
cause abortions in pregnant caprine dams but is capable o f transient colonization,
vaccine efficacy trials were performed in both mice and goats.
The B. ovis Aom p25 mutant, B025, described previously, is also attenuated in
the mouse model. Mice infected with B02S were consistently colonized with fewer
bacteria from

1

to

8

weeks following infection than mice inoculated with the virulent

parental strain, B . o vis LSU99. At 1 week post-infection, while strain LSU99
replicated to >7 logs per spleen, the Aomp25 mutant replicated to approximately 5.8
logs (PO .O l, n = S). By

8

weeks post-infection, the mutant was below the limit o f

detection while the virulent parental strain remained at >5 logs per spleen (P<0.01, n =
5).
To ascertain the vaccine efficacy o f BM25 and B025, both mutants were
evaluated in the BALB/c mouse model. The potential o f the B . m elitensis Aom p25
mutant to protect against virulent challenge was also assessed in the ruminant host.
The hypothesis for this work is that B rucella Aomp25 mutants will be efficacious
against challenge with the homologous and heterologous virulent parental strains o f
brucellae.
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Materials and Methods
Bacterial Strains
For these studies nine different B rucella strains were utilized. Virulent B .
abortus strain 2308, B . m elitensis strain 16M, and B . ovis strain LSU99 have been
described previously. B rucella suis strain 1330 is an established virulent biovar 1
challenge strain in swine and mice (Bosseray and Plommet, 1990). B rucella canis
strain RM 6 - 6 6 was generously provided by Dr. Leland E. Carmichael, Department o f
Veterinary Microbiology, Cornell University, Ithaca, NY. This strain has been
documented to cause abortions in experimentally-infected canines (Carmichael, 1990).
The official USDA cattle vaccine, rough B . abortus strain RB51 (Schurig et al., 1991),
was provided by Dr. Gerhardt G. Schurig, Department o f Biomedical Sciences and
Pathobiology, Virginia-Maryland Regional College o f Veterinary Medicine, Virginia
Polytechnic Institute and State University, Blacksburg, VA. Brucella m elitensis
vaccine strain Rev. 1 was obtained from the manufacturer, Rhone-Merieux, Lyon,
France. The creation and initial characterization o f the B . m elitensis (BM25) and B .
ovis (B025) Aom p25 mutants has been described previously. All challenge strains
were grown on Schaedler blood agar plates (SBA) (Difco Laboratories, Detroit, MI) at
37°C in a 5% CO2 atmosphere. BM2S and B02S were grown on SBA supplemented
with 45 ng/ml kanamycin (Sigma Chemical Company, S t Louis, MO). Inoculation
doses of each strain were prepared as previously described. Immediately prior to
infection, frozen inoculums were thawed and diluted to the appropriate concentration
with sterile physiological saline. All doses were verified as correct by serial dilution
and plating on the appropriate media.
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M ice
Female B ALB/c mice at approximately 6 to

8

weeks o f age were obtained

from the Division o f Laboratory Animal Medicine at the School o f Veterinary
Medicine at Louisiana State University (Baton Rouge, LA) and held at least one week
prior to use. All animals were housed in a restricted access facility. All mice were
used in accordance with the Animal Care and Use Committee at Louisiana State
University and approved protocols were followed.
M urine BM2S Vaccine Efficacy Trials
Mice were vaccinated intravenously (i.v.) with S x 104 CFU o f the B .
m elitensis Aomp25 mutant, BM2S. Initially, five mice were infected with BM2S and
were found to have cleared the infection by

10

weeks post-infection. For every group

o f five mice vaccinated with BM2S an additional five non-vaccinated, age-matched
mice were held in the same location until challenge. As positive controls, some
additional mice were vaccinated with either 5 x 104 CFU o f B . m elitensis vaccine
strain Rev.

1

i.v. or 3 x 10s CFU o fB. abortus vaccine strain RBS1 intraperitoneal

(i.p ). Doses o f each strain were based on previously published work in B ALB/c mice
(Montaraz and Winter, 1986; Jimenez de Bagues et al., 1994a; Jimenez de Bagues et
al., 1994b). Prior to vaccination and 8 weeks post-vaccination, mice were bled and the
serum was pooled for each group.
Ten weeks following vaccination with either BM2S, B . m elitensis strain Rev.
1, orB. abortus strain RBS1, both vaccinated and non-vaccinated mice were
inoculated with one o f the challenge strains. Animals in groups o f five were infected
with 5 x 104 CFU i.v. o f either B. m elitensis strain 16M, B . abortus strain 2308, B . suis
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strain 1330, B . cam s strain RM 6 -6 6 , or B. a vis strain LSU99 (Montaraz and Winter,
1986; Jimenez de Bagues et al., 1994a; Jimenez de Bagues et al., 1994b). Two weeks
post-challenge, all mice were euthanized by halothane overdose. At necropsy, the
whole spleen was removed by aseptic technique for bacteriological analysis while
blood was obtained for serological analysis. Spleens were homogenized with a
Sorvall Omni-Mixer (Newton, CT) in sterile phosphate-buffered-saline (PBS) and
subsequently serially diluted and plated on SBA. Cell homogenate from BM2S
vaccinated mice was also plated on SBA with 45 pg/ml kanamycin to ensure that the
mutant had been cleared. All plates were incubated at 37°C in a 5% CCh atmosphere
for 3 to 4 days until isolated colonies appeared.
M urine BQ2S Vaccine Efficacy Trials
Mice in groups of five were vaccinated i.v. with 5 x 104 CFU o f the B . ovis
Aomp25 mutant B025. Age-matched mice were also obtained and held as nonvaccinated controls until challenge. As positive controls, additional mice were
vaccinated with either strain Rev. 1 or strain RB51 as previously described. For
comparison, mice were also vaccinated with BM25 as described previously. Mice
vaccinated with B025, strain Rev. 1 or strain RB51 were challenged with all five
strains

8

weeks post-vaccination. Mice vaccinated with BM25 were challenged 10

weeks post-vaccination as previously described. Two weeks following vaccination,
the mice were euthanized and prepared as previously described. Serum samples were
obtained prior to vaccination,

6

weeks post-vaccination, and at necropsy for

serological analysis.
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Goats
Twenty-four sexually mature female Angora goats were obtained from
commercial herds. Prior to beginning any experiments, all goats were negative for
Brucella-specific antibodies based on western immunoblot (Edmonds et al., 1999a)
and the Card test (Alton et al., 1988). Throughout the study the animals were housed
in a restricted access, large-animal isolation facility operated under guidelines
approved by the United States Department o f Agriculture/Animal and Plant Health
Inspection Service (USDA/APHIS). At the conclusion o f each study, the adult
animals were euthanized by the captive bolt and exsanguination method. Any kids
bom alive were euthanized and exsanguinated.
Goat BM25 Vaccine Efficacy T rial
Twenty-four mature, non-pregnant females were divided into three groups.
Nine animals were vaccinated s.c. with 1 x 109 CFU o f BM25. A second group o f
seven animals w ere vaccinated s.c. with 1 x

106

CFU o f the vaccine B . m elitensis

strain Rev. 1. Previous experiments in goats have shown that this dose o f strain Rev.
1 provides protection against challenge with virulent B . m elitensis strain 16M (Elzer et
al., 1998c). A third group of eight animals served as controls and was injected s.c.
with 1 ml o f the saline diluent. Four weeks following vaccination, a fertile male goat
was added to each group. Following confirmation o f pregnancy with ultrasound, all
animals were challenged at approximately 100 days gestation with 1 x 107CFU o f
virulent B . m elitensis strain 16M into the conjunctival sac. Following inoculation,
animals were monitored daily for delivery. At parturition, the birth status o f the ldd
was recorded as either an abortion or a live-healthy kid. W ithin 24 h following
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parturition, the kid was euthanized if bom alive and samples obtained for bacteriologic
analysis from the liver, lung, spleen, and abomasal fluid. Two to seven days following
parturition, adult females were euthanized; and samples taken from the parotid lymph
node, prescapular lymph node, supramammary lymph node, internal iliac lymph node,
liver, spleen, milk, and uterine fluid. Tissue samples were frozen at -4°C for later
analysis, while milk and uterine fluid were swabbed the day o f collection on Farrell's
selective media (Farrell, 1974). Serum samples were obtained prior to vaccination, at
challenge, and at necropsy for serological analysis.
Caprine Bacteriological Analysis
All tissue samples were thawed and homogenized in a sterile saline (0.9%
NaCl) solution and plated onto Farrell's selective medium containing 5% bovine
blood; the limit o f detection with this system is 13 CFU/gm o r ml. The plates were
incubated for 14 days at 37°C in a 5% CO 3 atmosphere. B rucella m elitensis was
identified on the basis o f urease and oxidase reactions, colony morphology, growth
rate, presence o f O-side chain by acriflavine, and Gram-stain reaction (Alton et al.,
1988). BM25 was differentiated from B . m elitensis strain 16M by being kanamycin
resistant at 4S pg/ml.
Serological Analysis
Serum samples from both mice and goats were analyzed for O-side chain
specific antibodies by both the Card test and western immunoblot. The Card test has
been described previously (Alton et al., 1988). Pre-vaccination and post-vaccination
serum samples from BM25 vaccinated mice were analyzed by western immunoblot
utilizing cell lysate for both smooth B . m elitensis strain 16M or rough B . abortus strain
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RB51. Serum from mice vaccinated with B02S were analyzed prior to challenge with
cell lysate from B . ovis strain LSU99. Post-challenge serum samples from mice
exposed to either

abortus strain 2308 or B . suis strain 1330 were analyzed with cell

lysate from both B. abortus strain 2308 and B . abortus strain RB51. Similar serum
samples from B . melitensis-cYaBenged mice were analyzed with B. m elitensis strain
16M and strain RB51 cell lysates. Finally, serum samples from all mice challenged
with either rough B. canis strain RM6-66 or B . ovis strain LSU99 were analyzed with
cell lysate from rough B. ovis strain LSU99. Western immunoblots were performed as
previously described.
Statistics
For the murine vaccine efficacy trials, median CFU/spleen was obtained for
each experimental group following logio conversion. Due to the occurrence o f
unequal variances between experimental groups, a Kruskal-Wallis Ranked ANOVA
utilizing a Dunn’s multiple comparisons versus a control test was used to compare
median CFU/spleen between experimental groups (Snedecor and Cochran, 1989).
When only two experimental groups were present, the Mann-Whitney Ranked Sum
Test was utilized (Snedecor and Cochran, 1989). For both tests, P<0.05 was
considered significant. Log units o f protection were obtained by subtracting the
median CFU/spleen count for the control group from the corresponding median
CFU/spleen count for each treatment group. For the caprine BM2S vaccine efficacy
trial, a Kruskal-Wallis Ranked ANOVA utilizing a Dunn’s multiple comparisons
versus a control test was employed with a P<0.05 being considered significant
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(Snedecor and Cochran, 1989). All statistics were performed with the Sigma Stat
program (Sigma Stat for Windows, Version 1.0, Jandel Scientific, 1992-1994).
Results
Murine BM25 Vaccine Efficacy Trials
Mice were vaccinated with the B. m elitensis &omp25 mutant, BM2S, to
determine if the attenuated-live mutant would be efficacious against virulent
challenge. The results o f this experiment are shown in Table 6.1. Mice vaccinated
with the current caprine vaccine, B . m elitensis strain Rev. 1, or the B . m elitensis
Aomp25 mutant, BM2S, had significant levels o f protection against challenge with
virulent B. m elitensis strain 16M (P<0.01, n = 5). Vaccination with either strain
resulted in over 2 logs o f protection against the challenge strain. In contrast, the
current bovine vaccine, rough B. abortus strain RBS1, did not provide significant
protection against strain 16M, with a 0.77 median log reduction in bacterial load
(Table 6.1).
The B . m elitensis mutant was also efficacious against the heterologous virulent
challenge strains B . abortus 2308 and B. su is 1330 (P<0.01, n = 5) (Table 6.1). Strain
BM2S afforded approximately 2 logs o f protection against B. abortus strain 2308 and
1 log against B. suis strain 1330 (Table 6.1). Serological analysis with western
immunoblot and the Card test detected antibodies specific for the B rucella LPS O-side
chain in mice vaccinated with strain Rev. 1 and BM2S. Anti-O-side chain antibodies
were not detected in serum samples from mice vaccinated with rough B . abortus strain
RB51.
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Table 6.1. Murine BM25 vaccine efficacy trial
Exp.

Vaccine

Challenge

Median logio brucellae per

Log units of

Group

Strain*

Strainb

spleen*

protection4

1

BM25

B. m elitensis

3.38+ /-(3.15-3.89)**

2.29

Rev. 1

3.22 +/- (3.05 - 3.48)**

2.45

RB51

4 .9 0 + /-(4 .5 3 -5.58)r

0.77

None*

5.67 +/- (5.41 - 5.93)

BM25

2

B. abortus

5 .6 5 + /-(5 .1 8 -5 .7 9 )

None

BM25

3

None

In

1.99

3 .6 6 + /-(3 .5 7 -3 .7 4 )* *

B . suis

1.04

4.71 +/- (4.12 —4.75)**
5 .7 5 + /-(5 .6 9 -5 .7 5 )

: ■n

if

- - :

strain RB51 at 3 x 10* CFU i.p.
bBrucella m elitensis strain 16M, B. abortus strain 2308, B . su is strain 1330 at 5 x 104
CFU i.v., 10 weeks post-vaccination. Mice were necropsied 2 weeks post-challenge.
'Group median CFU/spIeen +/- (25% - 75% quardles), logio conversion.
dLogs protection = median CFU for non-vaccinated controls - median CFU for
treatment group.
*n = 10 for this group.
**P<0.01, *No statistical difference, n = 5 unless noted.* A Kruskal-Wallis Ranked
ANOVA utilizing a Dunn’s multiple comparisons versus a control test was utilized
for experimental group 1. A Mann-Whitney Ranked Sum Test was utilized for
experimental groups 2 and 3.
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Murine BQ2S Vaccine Efficacy Trials
Based on the observed attenuation o f the B. ovis Aomp25 mutant in mice, a
murine vaccine efficacy trial was performed with B 02S. Mice vaccinated with the B .
ovis mutant had S.6S logs o f protection against the virulent parental strain, B . ovis
LSU99 (Table 6.2). In mice vaccinated with B02S, the median CFU/spleen o f strain
LSU99 was 2.11 logs, which is the limit o f detection for this assay. In two separate
murine trials, vaccination with B 025 resulted in complete protection against strain
LSU99 (P O .O l, n = 10). The vaccine strains B . m elitensis Rev. 1, B. abortus R B 51,
and B. m elitensis BM2S did not afford the same level o f protection as B02S against
virulent B. ovis (Table 6.2).
The B . ovis Aomp25 mutant also provided significant protection against the
other naturally occurring rough B rucella species (spp.), B . cam s strain RM6-66
(^<0.05, n - 10) (Table 6.2). However, the logs o f protection provided by B02S
(1.15 logs) were below that o f strain Rev. 1 (1.95 log) or the B . m elitensis mutant
BM25 (1.62 logs). The rough cattle vaccine B. abortus strain RB51 was not
efficacious against virulent B . canis (Table 6.2). The B . ovis Aomp25 mutant did not
afford significant protection against challenge with the smooth Brucella spp., B .
m elitensis strain 16M, B. abortus strain 2308, or B . suis strain 1330 (data not shown).
Serological analysis detected anti-O-side chain antibodies in mice vaccinated with
BM25 and strain Rev. 1. Utilizing B . ovis strain LSU99 cell lysate in a western
immunoblot, B rucella-specific antibodies were detected in strain RB51 and B 025
vaccinates.
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Table 6.2. Murine BQ25 vaccine efficacy trial.________________________________
Exp.
Vaccine
Challenge
Median logio brucellae per
Log units o f
Group

Strain*

Strain**

spleen6

protection*1

B025*

B . ovis

2 .1 1 + /-(2 .1 1 -2 .1 1 r * *

5.65

Rev. 1

5.00 +/- (4.53 - 5.49)**

2.76

RB51

6.49 +/- (5.73 - 7.0)**

1.27

BM25

5.33+ /-(4.75-6.51)**

2.43

None*

7.76+/-(7.63 - 7.84)

B . cams

5.80+/-(4.90 - 6.52)*

1.15

Rev. 1

5.00 +/- (4.53 - 5.49)*

1.95

RB51

6.49 +/-(5.73 - 7.0)*

0.46

BM25

5.33 + /-(4.75-6.51)*

1.62

None*

6.95 +/- (6.62 - 7.24)

B025*

*Brucella ovis strain B02S, B. m elitensis strains Rev. 1 and BM2S at 5 x 104 CFU i.v.
B rucella abortus strain RB51 at 3 x 10* CFU i.p.
bBrucella ovis strain LSU99 and B. a m is strain RM6-66 at 5 x 104 CFU i.v., 8 weeks
post-vaccination. Mice were necropsied 2 weeks post-challenge.
cGroup median CFU/spleen +/- (25% - 75% quartiles), logio conversion.
**Logs protection = median CFU for non-vaccinated controls - median CFU for
treatment group.
en = 10 for this group.
fLimit of detection, represents clearance.
*n = 15 for this group.
*P<0.05, **P<0.01, *No statistical difference, n = 5 unless noted.*'* AKniskalWallis Ranked ANOVA utilizing a Dunn’s multiple comparisons versus a control test
was utilized.
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Caprine BM25 Vaccine Efficacy Trail
To determine if the B . m elitensis 6om p25 mutant was efficacious against
virulent challenge in the ruminant host, a caprine vaccine efficacy trial was performed.
The results of this study are presented in Tables 6.3 and 6.4. The rate of abortions in
non-vaccinated dams that were challenged with virulent B . m elitensis strain 16M w as
63% (S/8). In contrast, none o f the BM25 or strain Rev. 1 vaccinates aborted (P<0.05,
n = 7). Bacteriological analysis found 88% (7/8) o f the kids from non-vaccinated
controls were colonized by the challenge strain, while only 1 kid from each vaccine
group was colonized. The one kid colonized by BM25 had <. 200 CFU/gm o f liver
and spleen while the non-vaccinated controls had a median o f 44000 CFU/gm
(P<0.01, n = 7). The challenge strain was also cultured from 100% (8/8) of the nonvaccinated dams. In comparison, only 14% (1/7) o f the strain Rev. 1 vaccinates and
44% (4/9) o f the BM25 vaccinates were colonized by strain 16M. A significant
difference in the median CFU/gm o f tissue was demonstrated between each vaccine
group and the non-vaccinated controls (/*<0.05, n = 7) (Table 6.3). No statistical
difference was found between the two vaccine groups.
Serological analysis with

m elitensis strain 16M cell lysate found all the

vaccinated animals to have a positive serologic response post-vaccination with either
BM25 or strain Rev. 1 (Table 6.4). The number of animals vaccinated with either
BM25 or strain Rev. 1 that had detectable anti-O-side chain antibodies decreased w ith
time. However, at 18 weeks post-vaccination, 58% o f the BM25 vaccinates had
detectable antibodies to the O-side chain while none o f the strain Rev. 1 vaccinated
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Table 6.3. Caprine BM25 vaccine efficacy trial, abortion and colonization rates.*
Vaccine Strain*
BM25

Rev. 1

Saline Controls

0/9

0/7

5/8

(0%)*

(0%)*

(63%)

0/9c (0%)

1/7 (14%)

7/8 (88%)

0 (0)***4

0 (0)**-*

300(64 - 850)

0/9 (0%)

0/7 (0%)

7/8 (88%)

0 (0)**

0 (0)**

>300000 (6400 - 3 0 0 0 0 0 /

1/9(11% )

0/7 (0%)

7/8 (88%)

0 (0)****

0 (0)**

44000 (2095 - 300000)

4/9 (44%)

1/7 (14%)

8/8 (100%)

0 (0 - 196)*

0 (0)*’*

745(390 - 995)

3/9 (38%)

0/7 (0%)

8/8 (100%)

0 (0 -3 3 5 )* * *

0 (0)***

5750(1650-2 1 0 0 0 )

Abortion Rate

Colonization Kids
Abomasal Fluid

Lung

Liver/Spleen

Colonization Adults
1° LN

2° LN
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Table 6.3 Continued
Liver/Spleen

4/9 (44%)

1/7 (14%)

8/8 (100%)

0 (0 - 120)*

0 (0)*-*

150 (54 - 2000)

‘Challenge inoculum was B . m elitensis strain 16M at 1 x 107 CFU in the conjunctival
sac.
hB rucel!a m elitensis strains Rev. 1 at 1 x 106 CFU s.c. and BM25 at 1 x 109 CFU s.c.
cNumber colonized / number in treatment group.
dMedian CFU/gm o f tissue, (25% - 75% quartiles).
cOne animal had £ 25 CFU.
fMaximum limit of detection.
®One animal had < 200 CFU.
*P<0.05, **P< 0.01, ***P<0.001, tN o statistical difference, n = 7. Based on a
Kruskal-Wallis Ranked ANOVA, with a Dunn’s Test. N o statistical difference was
found between the vaccine treatment groups.
1°LN = Parotid and prescapular lymph nodes, 2°LN = Supramammary and internal
iliac lymph nodes.
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Table 6.4. Caprine BM25 vaccine efficacy trial, serological analysis.*
Vaccine Group*
BM25

Rev. 1

Saline Controls

Prior-Vaccination

0/9 (0%)c

0/7 (0%)

0/8 (0%)

2 wks post-vaccination

9/9 (100* /.)

7/7 (100%)

0/8 (0%)

5 wks post-vaccination

9/9 (100%)

5/7 (71%)

0/8 (0%)

13 wks post-vaccination

5/9 (56%)

1/7 (14%)

0/8 (0%)

18 wks post-vaccination4

5/9 (56%)

0/7(0% )

0/8(0% )

2 wks post-challenge

4/9 (44%)

2/7 (29%)

1/8 (13%)

Necropsy

4/9 (44%)

2/7 (29%)

4/8 (50%)

ii . .

•.

i

n

conjunctival sac.
bB rucella m elitensis strains Rev. 1 at 1 x 106 s.c. and BM25 at 1 x 109 s.c.
‘Percentage o f animals with positive serologic response to B. m elitensis strain
16M cell lysate via western immunoblot, see text for description.
‘'Day o f challenge with B. m elitensis strain 16M.
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animals did. B rucella-spccific antibodies were not detected in the saline controls until
after challenge with virulent strain 16M (Table 6.4).
Discussion
In the mouse model, the B . ovis bom p25 mutant, B02S, was found to provide
significant protection against both B. avis strain LSU99 and B . canis strain RM6-66.
B025 was able to provide 5.64 logs o f protection following challenge with virulent B.
ovis. The mice vaccinated with B025 had CFU/spIeen counts that were below the
limit o f detection (2.11 logs). The current ovine vaccine, strain Rev. 1, resulted in
2.78 mean logs o f protection while B025 provided twice this level. The reported
efficacy o f strain Rev. 1 for virulent B. ovis is in agreement with previous studies
(Jimenez de Bagues et al., 1994a; Winter et al., 1996).
The ability o f the B . avis mutant to protect against two naturally occurring
rough B rucella spp., B . ovis and B . canis, was demonstrated. However, B 025 did not
afford protection against the smooth B rucella spp., B . abortus, B . m elitensis, and B .
suis. The importance o f antibodies to the LPS O-side chain for a protective murine
immune response to smooth Brucella spp. has been demonstrated previously (Araya et
al., 1989; Araya and Winter, 1990). Monoclonal antibodies specific for the LPS Oside chain have also been demonstrated by different laboratories to provide significant
protection against virulent challenge in mice (Montaraz et al., 1986; Winter et al.,
1989; Cloeckaert et al., 1991; Jacques et al., 1992). Therefore, the inability o f rough
B025 to protect against the smooth Brucella spp. is conceivably due to the absence o f
the LPS O-side chain on the outer membrane. Mice vaccinated with B 025 do not

146

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

produce antibodies to the O-side chain and therefore are not protected against smooth
brucellae.
The vaccine efficacy results of B02S in mice indicate that this mutant might be
a promising vaccine candidate for B. ovis infection in small ruminants. I f the B . ovis
Aomp25 mutant is efficacious for ruminants, it would have several important
advantages over the current B . ovis vaccine, B . m elitensis strain Rev. 1. Unlike strain
Rev. 1, a B. ovis mutant possibly could be approved for field use in the U.S. and other
countries free o f B . m elitensis but endemic for B . ovis. Being a B . ovis derivative the
strain should also pose no threat to humans, unlike B . m elitensis strain Rev. 1 (Blasco
and Diaz, 1993). The lack o f LPS O-side chain on B02S means that vaccinated
animals will not produce anti-O-side chain antibodies which are detected in the
accepted serological assays for B. m elitensis (Alton, 1990a). Based on the vaccine
efficacy data in mice with B 02S and the potential for field use, both safety and
vaccine efficacy studies are currently being performed in our laboratory with sexually
mature rams and ewes. W hile not reported in this study, this data will determine if
B02S is a viable vaccine alternative for rams and ewes against B . ovis infection.
Vaccination o f both mice and goats with the B . m elitensis Bomp25 mutant,
BM25, afforded protection against virulent B. m elitensis strain 16M at levels equal to
the current caprine vaccine, B . m elitensis strain Rev. 1 (Blasco, 1997; Garin-Bastuji et
al., 1998). Mice vaccinated with BM25 or strain Rev. 1 had more than a 2 log
reduction in bacterial load o f the challenge strain (P<0.01, n = S). The vaccine strains
Rev. 1 and RBS1 have been reported previously to provide approximately a log
greater protection in mice against virulent B . m elitensis strain 16M than was observed

147

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

in this study (Jimenez de Bagues et al., 1994a; Jimenez de Bagues et al., 1994b;
Winter et al., 1996). The lowered efficacy o f both vaccine strains may be due to
differences in the B ALB/c mice. Variances in BALB/c mice with regard to
colonization by standard B rucella strains has been reported previously (Winter et al.,
1989). While the level o f protection afforded by strain Rev. 1 was lower than previous
studies, both strain Rev. 1 and BM25 significantly lowered the bacterial load of
vaccinated mice (P<0.01, n = S).
The vaccine efficacy o f the B . m elitensis Aomp25 mutant has also been tested
in goats. Vaccination with BM25 or strain Rev. 1 provided 100% protection against
abortion following challenge in late-gestation with virulent B . m elitensis strain 16M
(PcO.OS, n = 7). Vaccination with either strain also resulted in a significant decrease
in the number of colonized dams and lrids (/*<0.05, n = 7). The results o f this study
indicate that BM25 could be advantageous to strain Rev. 1 in situations where
vaccination o f pregnant females is warranted. Unlike strain Rev. 1, BM25 does not
induce abortions when given to pregnant animals (Alton, 1990a; Blasco, 1997; GarinBastuji et al., 1998). Blasco (1997) reported that during large field trials with over
200 animals, abortion rates >75% occurred when sheep were vaccinated s.c. with 5 x
10* CFU o f strain Rev. 1 during the second and third months o f pregnancy.
Conjunctival inoculation o f nine pregnant goats in late-gestation with 1 x 107 CFU of
BM25 resulted in no abortions while virulent strain 16M induced 6/6 inoculated
animals to abort (Table 5.2).
In heavily infected flocks, vaccination o f only the sexually immature females
with strain Rev. 1 will not prevent spread of the infection among adults or infection o f
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the fetus in utero. Non-vaccinated, infected adults will continue to excrete copious
amounts o f B . m elitensis following parturition, which will result in spread o f the
infection to naive animals and animal caretakers. While test and slaughter could
remove these infected adults, lack o f financial resources in many countries limits this
possibility. Also, without vaccination, test and slaughter often fails to eradicate the
infection due to abnormal serological responses from some infected animals (Blasco,
1997). Often the only successful measure to obtain control without vaccination is via
complete herd depopulation, which is financially unfeasible in many developing
countries. A vaccine such as BM25 that could be given to both sexually mature and
immature females, without the risk o f abortion, would be a major advantage.
B rucella m elitensis strain Rev. 1 was empirically derived and the genetic basis
for its in vivo attenuation is unknown (Alton, 1990a). Through the advent o f modem
molecular biology, our understanding of the genetics o f B rucella spp. has increased
dramatically. In recent years, numerous genes with a wide variety o f functions have
been characterized (Sangari and Aguero, 1996). Based on this knowledge, it is now
possible to construct potential vaccine candidates with defined genetic disruptions.
These new strains can also carry specific genetic and phenotypic markers not found in
virulent field strains (Sangari and Aguero, 1996). By targeting one or more genes
involved in either virulence or basic cell physiology, attenuated B rucella strains can be
produced with the proper balance between safety for the host and the capacity to
induce long-term immunity. Strains BM25 and B02S both carry defined disruptions
in the omp25 gene; and unlike the virulent field strains, the attenuated mutants are
kanamycin resistant.
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Current ongoing studies in our laboratory are evaluating the capacity o f BM25
to protect sheep against B. m elitensis. If BM25 were found to be a safe and
efficacious ovine vaccine, the mutant would be useful in areas where sheep and goats
commonly intermingle. This would provide a safe and efficacious vaccine for both
sheep and goats against B. m elitensis. Based on this study, the B. m elitensis Aomp25
mutant, BM25, may be efficacious in the ruminant host against B. m elitensis.
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CHAPTER 7
ASSESSMENTS AND PERSPECTIVES
B rucella species (spp). are Gram-negative, facultative intracellular pathogens
that impact both man and animals (Corbel, 1998). Both B rucella abortus and Brucella
m elitensis cause major zoonotic infections in humans and abortions in cattle and goats,
respectively (Enright, 1990; Young, 1995). Epididymitis and infertility are hallmarks
o f B rucella ovis infection in rams (Blasco, 1990). All Brucella spp. carry a 25 kDa
major outer membrane protein termed Omp25 (Cloeckaert et al., 1996a). This protein
may be an important structural outer membrane protein (Omp) that stabilizes the outer
membrane by binding the underlying peptidoglycan layer and outer cell membrane.
Vaccination o f mice with Brucella cell envelope extracts containing high levels o f
Omp25 or whole-cell lysates of E scherichia coli expressing recombinant Omp25
provides some protection against brucellosis (Dubray and Bezard, 1980; Montaraz and
Winter, 1986; W inter and Rowe, 1988; Jimenez de Bagues et al., 1994a; Bowden et
al., 1998). Inoculation o f cattle with these same cell extracts has been shown to
induce Omp25-specific humoral and cell-mediated immune responses (W inter et al.,
1986; Winter and Rowe, 1988). The absence o f Omp2S from B rucella spp. may
render these mutants attenuated in ruminants due to the lack o f an important structural
Omp. Alternatively, animals inoculated with brucellae mutants lacking Omp25 may
display an exacerbation o f disease resulting from an altered immune response. To
determine the role o f Omp25 in virulence, Aomp25 mutants were created in B .
abortus, B. m elitensis, and B. ovis.
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A suicide plasmid containing the omp2S gene from either B . m elitensis or B .
ovis disrupted with a kanamycin resistance gene from pUC4K was electroporated into
each Brucella spp. Following electroporation, B. abortus (BA25), B . m elitensis
(BM25), and B. ovis (B 025) mutants containing a disruption in the omp2S gene were
obtained (Aomp25 mutants). The murine B ALB/c brucellosis model was utilized to
evaluate each mutant in vivo. Mice injected with the virulent parental strains exhibited
normal splenic colonization profiles. However, mice infected with the B. abortus
bamp25 mutant, BA25, exhibited an approximate 3 log reduction in mean colony
forming units (CFU)/spleen at 18 and 20 weeks post-infection as compared to the
virulent control. In mice, the B . m elitensis mutant BM2S displayed a significant
decrease in bacterial load at 4, 6, and 8 weeks post-infection compared to the parental
strain (P<0.01, n = 5 per treatment group). The B. ovis mutant B02S exhibited
reductions in mean CFU/spleen from 1 week post-infection to 8 weeks post-infection
(P<0.01, n = 5 per treatment group). At 8 weeks post-infection, B 02S was cleared
from the mice while the parental strain remained at approximately 5. 1 logs o f bacteria
per spleen.
Cattle in late-gestation were infected with either B A25 or virulent parental B .
abortus 2308 to assess their respective abilities to colonize maternal tissues and to
induce abortions. Significant decreases in the abortion and colonization rates o f BA2S
cattle were observed when compared to strain 2308-infected animals (P<0.05, n = 10).
Brucella abortus strain 2308 colonized 10/10 cow-calf pairs, caused a 50% abortion
rate, and induced B rucella-specific antibodies in 100% o f the test animals. However,
strain BA25 colonized 5/10 dams and 3/10 calves, induced a 10% abortion rate, and
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caused 60% o f the dams to develop antibodies to B. abortus. In this study, 40% (4/10)
o f the dams exposed to BA2S never sero-converted to B . abortus nor were they
colonized, an additional animal was not colonized but developed antibodies.
Experiments were performed in goats with the B . m elitensis mutant BM25.
Inoculation o f IS non-pregnant goats verified that BM25 w as capable o f transient in
vivo colonization. Goats in late-gestation were infected with either BM25 or virulent
B. m elitensis strain 16M. The Aomp25 mutant

no abortions (0/9) while the

parental strain induced a 100% (6/6) abortion rate. BM25 also colonized a
significantly lower number o f dams (4/9) than did strain 16M (6/6) (/*<0.05, n = 6).
O f the four adult females colonized with BM2S, only two delivered infected kids
whereas all o f the females exposed to strain 16M aborted infected kids.
Based on studies in both mice and ruminants, inoculation o f animals with these
Brucella bom p25 mutants did not resulted in an exacerbation o f disease due to an
altered immune response. In contrast, these mutants were attenuated in both
ruminants and in the mouse model. The lack o f Omp25 may have rendered these
mutants attenuated due to the lack o f an important structural Omp that possibly plays
an significant role in the ability o f brucellae to replicate inside professional phagocytes
and chorionic trophoblasts.
A significant component o f brucellae virulence is the ability o f these bacteria
to survive and replicate inside professional phagocytes (Enright, 1990; Thoen et al.,
1993). Incubation o f BA25 with macrophages from either cattle or mice resulted in a
significant reduction in the number o f colony forming units (CFU) o f the bom p25
mutant at 48 hours post-infection (P<0.01, n = S). The macrophage killing assay
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examines the ability o f the bacteria to survive and replicate inside macrophages over 2
days. In murine macrophages strain 2308 and BA25 were killed at approximately the
same rate for the first 24 hours post-infection. In contrast, in bovine macrophages at
the same time point, the Aom p25 mutant showed a significant decrease in percent
survival when compared to strain 2308. The apparent difference between the ability
o f the B. abortus mutant to survive in murine and bovine macrophages at 24 hours
post-infection may reflect differences between macrophages.
The fact that B A25 was unable to replicate as quickly as the parental strain in
both murine and bovine macrophages may have important consequences in vivo.
Upon initial exposure o f an animal to brucellae, the pathogen is phagocytosed by
professional phagocytes which migrate via the lymphatics to the draining lymph node
(Enright, 1990; Thoen et al., 1993). By 2-3 weeks post-infection, the lymph node
becomes hemorrhagic due to the break down o f the vasculature within the node.
During this process some macrophages are lysed, and the brucellae enter the
bloodstream and a subsequent bacteremia develops (Enright, 1990; Thoen et al.,
1993). Since the Aomp25 mutant shows a decreased ability to survive and replicate
inside professional phagocytes in vitro, the mutant may be eliminated in the lymph
node preventing bacteremia and pathogen dissemination.
Four bovine dams inoculated with the B . abortus mutant developed no
antibodies to the O-polysaccharide side chain (O-side chain) o f the Iipopolysaccharide
(LPS) and were not colonized. In contrast every animal infected with the parental
strain developed anti-O-side chain antibodies and their tissues remained colonized
with the bacteria. The four sero-negative BA2S cows may have eliminated the
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pathogen from the draining lymph node shortly following exposure. As a result, the
bacteria were unable to colonize the host and anti-O-side chain antibodies were not
elicited.
A second important component of B rucella virulence is the propensity o f this
pathogen to colonize and replicate to high numbers inside the trophoblast cells o f the
placenta (Enright, 1990; Thoen et al., 1993). The resulting tissue necrosis causes
damage to the fetal membranes, allowing transmission o f the bacteria to the fetus.
Placental infection also induces significant alterations in the fetal/maternal relationship
that often result in abortion during the third trimester o f pregnancy (Enright, 1990;
Thoen et al., 1993). In a trophoblast cell line obtained from a late-gestational bovine
placenta, BA2S did not replicate inside these cells to the same level as the virulent
parental strain 2308. At 12 hours post-infection, both strains demonstrated a decrease
in survival. However by 24 hours post-infection, strain 2308 replicated to
approximately a log greater than the inoculation dose while BA23 increased to <10%
o f the inoculum. At 36 and 48 hours post-infection, strain 2308 increased to
approximately 2 logs higher than BA2S. Similar data was also obtained in early and
mid-gestational trophoblast cell lines.
The inability o f BA2S to adjust to the intracellular environment o f the
trophoblast as quickly as strain 2308 is similar to the data generated in both bovine
and murine macrophages. At 48 hours post-infection, BA2S was consistently unable
to replicate to the same extent as strain 2308 in either bovine or murine macrophages.
In bovine trophoblasts, while B A25 did replicate to almost 1 log greater than the
inoculum, it was still over 2 logs lower than virulent strain 2308. This reduced
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capacity to replicate inside the trophoblasts may play an im portant role in vivo. W hile
6/10 bovine dams exposed to BA25 developed antibodies to the O-side-chain and 5/10
were colonized, only three calves were colonized with only one abortion. As
previously discussed, fewer bacteria may have escaped the prim ary lymph node due to
increased killing by the macrophage. During the subsequent bacteremia, lower
numbers o f bacteria were present to infect the trophoblast cells, and once infection did
occur, replication was at a significantly decreased rate when com pared to the virulent
parental strain. The reduced numbers o f bacteria in the chorionic trophoblasts and the
inability o f the mutant to utilize these cells as efficiently as the virulent parental strain,
resulted in only one abortion out o f ten pregnant dams.
W hile the B. m elitensis Bomp2S mutant was not tested in caprine phagocytes
or trophoblasts, data from the in vivo goat study indicates that BM25 may also have a
decreased capacity to replicate in these cells. O f the nine caprine dams exposed to
BM25, only four were colonized, indicating that pathogen dissem ination may not have
occurred in five animals due to elimination o f the bacteria in the primary lymph node.
Although 4/9 goats were colonized by BM25, there were no abortions and only two
kids were infected at parturition. This again implies that insufficient bacteria reached
the placenta (infection o f only tw o kids) and failed to induce significant alterations o f
the fetal/matemal relationship to induce any abortions. In contrast, all o f the goats
exposed to the virulent parental strain aborted colonized kids.
The B . ovis Aamp25 mutant, B 025, was more attenuated than either BM25 or
BA25 in the mouse model. The B . m elitensis and B . abortus m utants did not show
statistically significant differences from the parental strains in mean CFU/spleen until
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6 and 18 weeks post-infection, respectively. W hile it did replicate to approxim ately 1
log higher than the inoculation dose at 1 week post-infection, B02S was still over a
log less than the parental strain (P<0.01, n = 5 per treatm ent group). From 2 to 8
weeks post-infection, B 025 was consistently more than 2 logs below the level o f the
parental strain and was cleared at 8 weeks post-infection.
The cell envelope o f B . ovis may be responsible for the increased attenuation in
mice o f B 025 w hen compared to the other two B rucella mutants. Unlike B . abortus
and B. m elitensis, naturally occurring strains o f B . o vis do not express the LPS O-side
chain (Blasco, 1990). Therefore, the loss o f an im portant structural Omp binding the
underlying peptidoglycan layer and outer cell m embrane may have profound effects
on the stability o f the B. ovis cell envelope. To determ ine if the B. ovis Aom p25
mutant is attenuated in ruminants, studies are currently underway in both rams and
ewes. Based on the attenuation o f smooth BA2S and BM25 in ruminants, we
hypothesize that the lack o f Omp25 will render B 0 2 5 highly attenuated in the ovine
host.
If attenuated in sheep, the B . ovis mutant will warrant further testing as a
vaccine candidate. In countries such as the U.S. where rams may be infected w ith B .
ovis but the use o f B . m elitensis strain Rev. 1 is prohibited, a new vaccine for ovine
brucellosis is necessary (Blasco, 1990; Jimenez de Bagues et al., 199S). Unlike strain
Rev. 1, B . ovis is devoid o f the LPS O-side chain; and exposed animals do not produce
anti-O-side chain antibodies (Blasco, 1990). This is im portant because all current
serologic tests for the diagnosis o f brucellosis identify infected animals by detecting
antibodies against the LPS O-side chain (Blasco, 1997; Garin-Bastuji et al., 1998).
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Vaccination o f sheep against B. ovis with strain Rev. 1 results in the generation o f
anti-O-side chain antibodies and makes the differentiation o f strain Rev. 1-vaccinated
and B . m elitensis-infected sheep difficult (Blasco, 1990). Also, B . ovis does not pose a
biological treat to humans while strain Rev. 1 can cause undulant fever (Blasco, 1990;
Blasco and Diaz, 1993).
Preliminary m urine vaccine studies with the B . o vis 6am p25 mutant indicate
that it may be efficacious against ovine brucellosis. M ice vaccinated with B 02S 8
weeks prior to challenge with virulent B . ovis were com pletely protected 2 weeks post
challenge. Compared to non-vaccinated controls, the bom p25 mutant provided S.6S
logs o f protection against virulent challenge (PO.OOl, n — 10 per treatment group).
The current vaccine, strain Rev. 1, provided 2.76 logs o f protection in mice following
challenge with virulent B . ovis. Based on these studies, B 02S is also currently being
evaluated in sheep as a vaccine candidate. These studies w ill determine if B02S is
safe and efficacious for ovine brucellosis.
The pathogenesis study o f the B. m elitensis Aom p25 mutant indicated that
BM25 does not cause abortions and encouraged vaccine trials o f this mutant in both
mice and goats. Vaccination o f B ALB/c mice with BM2S, 10 weeks prior to virulent
challenge, provided significant protection against all five m ajor Brucella spp. The
m elitensis &omp25 m utant provided 2.29 logs o f protection against virulent B.
m elitensis while strain Rev. 1 provided only slightly m ore protection at 2.45 logs. In
goats BM25 was found to provide levels o f protection equal to that o f B. m elitensis
strain Rev. 1. W hile 63% (5/8) o f the non-vaccinated, saline controls aborted
following virulent challenge, none o f the BM25 (n = 9) o r Rev. 1 vaccinates (n = 7)
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aborted (P<0.05, n = 7). BM25 also provided significant protection against
colonization o f both the kid and dam with the challenge strain (P>0.01, n = 9).
Vaccination o f pregnant goats or sheep with strain Rev. 1 may cause abortions
(Jones et al., 1964; Alton, 1966; Alton, 1990a; Blasco, 1997; Garin-Bastuji et al.,
1998). Blasco (1997) reported that during large field trials in Spain with over 200
animals, abortion rates >75% occurred when sheep were vaccinated subcutaneously
with 5 x 10s CFU o f strain Rev. 1 during the second and third months o f pregnancy.
Conjunctival vaccination o f adults with lower doses o f strain Rev. 1 has been
suggested as a possible alternative; however, 20% abortion rates have been reported in
well-controlled experimental trials (Zundel et al., 1992). D ue to the problems
associated with low dose vaccination, it is now recommend that the standard Rev. 1
dose be given to 3-8 month old small ruminants and that adults be vaccinated in the
conjunctival sac at least 1 month prior to breeding and/or after the completion o f
lactation (Alton, 1990a; Blasco, 1997; Garin-Bastuji et al., 1998). In the field,
vaccination o f adults one month prior to breeding and after completion o f lactation is
difficult and often unrealistic in remote or impoverished areas (Blasco, 1997; GarinBastuji et al., 1998). Besides vaccination, the only alternative for disease management
is herd depopulation and preventing the introduction o f infected animals. However, in
countries with extensively managed herds with a high rate o f brucellosis infection and
limited financial resources, depopulation o f infected animals and maintaining infection
free herds if very difficult to achieve (Blasco, 1997; Garin-Bastuji et al., 1998).
An efficacious vaccine such as BM25 that could be given to both sexually
immature small ruminants and pregnant adults without fear o f abortion would be an
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advantage in heavily infected areas. By vaccinating all the animals in the flock, the
infection can be controlled and eventually eradicated. In areas o f the world where
goats are pregnant o r iactating throughout much o f year, many o f the adults go
unvaccinated (Alton, 1990a). In these areas, BM25 would again be a prom ising
vaccine candidate to replace strain Rev. 1.
In contrast to the empirically derived B . m elitensis strain Rev. 1, the genetic
basis for the in vivo attenuation o f BM25 is known (Jones et al., 1964; Alton, 1990a).
Due to this genetic mutation, BM25 carries tw o readily detectable phenotypic markers,
kanamycin resistance and the lack o f Omp25. Since cattle are known to develop both
humoral and cell-m ediated immune responses to Omp25, a serological assay could be
developed to differentiated BM2S-vaccinated anim als from animals infected w ith
virulent field strains o iB . m elitensis (W inter and Rowe, 1988). In fact, Bowden et al.
(1997) have reported the development o f a latex coagglutination assay utilizing
monoclonal antibodies to Omp2S and LPS that is able to differentiate B . ovis isolates
from other rough B rucella spp. By ELISA or sim ilar technique, it may be possible to
identify vaccinated animals by the lack o f anti-Omp25 antibodies. Furthermore, to
prevent the introduction o f an antibiotic-resistant B rucella sp. into the environm ent, it
may be necessary to remove the kanamycin resistance cassette. It might be possible to
replace this gene w ith one coding for a surface protein typically not expressed in
B rucella spp. By looking for positive serological responses to this foreign protein and
negative responses to Omp25, vaccinated animals could be readily identified by
serological analysis.
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The persistence o f BM2S in the host should be approximately that o f strain
Rev. 1. In the caprine vaccine efficacy trial, o f nine dams vaccinated one month prior
to breeding, none had kanamycin resistant isolates upon bacteriological analysis
following parturition. Also, o f nine dams exposed to BM25 during late-gestation,
only four w ere colonized at parturition, approxim ately 1-2 months post-infection.
Infections o f m ice for up to 6 weeks and goats for up to 2 m onths has dem onstrated
that BM25 is stable in vivo. The omp25 gene o f BM25 lacks a 159 bp S ty l internal
fragment that is replaced with a 1.3 kb kanam ycin resistance cassette. To further lim it
the possibility o f reversion, more o f the om p25 gene could be removed from both the
5’ and 3’ends o f the gene.
In the future, several key aspects o f BM 25 need to be evaluated in small
ruminants. Safety and vaccine efficacy trials o f BM25 should be completed w ith
larger numbers o f both goats and sheep under experimental and field conditions. To
date, no studies have been performed on the safety or efficacy o f BM25 in pregnant
sheep. In areas where sheep and goats comm ingle and are infected with B . m elitensis,
BM25 could be given as a vaccine for both anim al species. To verify that the
attenuated phenotype o f BM25 is stable, serial in vivo passages o f this mutant in
pregnant goats need to be performed. Also the duration o f immunity provided by
BM25 in small rum inants is unknown. If future studies in larger numbers o f anim als
find BM25 to be safe, efficacious, and stable, then a new vaccine may be available for
caprine and ovine brucellosis. Based on the w ork presented in this dissertation, the
lack o f Omp25 rendered Brucella spp. attenuated in the rum inant host Furtherm ore, it
appears that the B. m elitensis and B . ovis £somp25 mutants are capable o f providing
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effective immunity in vaccinated mice and that BM25 is efficacious against caprine
brucellosis.
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APPENDIX 1
DESIGN OF THE SUICIDE PLASMIDS pAC2555 AND pAC2553
Dr. Axel Cloeckaert, Institut National de la Recherche Agronomique, Nouzilly,
France, provided the suicide plasmids pAC2555 and pAC2553 w hich were utilized to
produce B rucella &omp25 deletion mutants. The plasm ids pAC2S33 and pAC2535
containing the entire omp25 o f B . m elitensis strain 16M or B . avis strain 63/290
respectively, w ere created by inserting PCR-am plified om p25 into the unique X balSacl sites o f pUC19 (Cloeckaert et al., 1996b). The pUC19 plasmid functions as a
suicide plasmid in brucellae since pUC derivatives are incapable o f autonomous
replication in all B rucella spp. (Elzer et al., 1995). The unique 159 bp S tyl internal
fragment o f om p25 in plasmids pAC2533 and pAC2535 was then excised and
replaced with a 1.3 kb fragment containing the kanam ycin resistance gene from
pUC4K (Amersham Pharmacia Biotech, Piscataway, NJ). The resulting constructs,
pAC2553 and pAC2555, were subsequently used as suicide plasmids.
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APPENDIX 2
ADDITIONAL W ESTERN IM M UNOBLOTS O F BruceUa Som p25 MUTANTS
U TILIZIN G M ONOCLONAL ANTIBODIES S P E C IF IC FOR TH E OM P25
PROTEIN

**-

S / . W.’S w

43 5 kDa
3.9 kDa

1 7 4 kDa

Figure A2.1. W estern immunoblot analysis o f cell lysates from Somp25 mutants with
MAb A18/13D02/F05 specific for the Omp25 protein.
Lane 1: M olecular weight standards
Lane 2: B . abortus strain 2308
Lane 3: B. abortus strain B A25
Lane 4: B. abortus strain BA25p80
Lane 5: B . m elitensis strain 16M
Lane 6: B . m elitensis strain BM2S
Lane 7: B. m elitensis strain BM25p80
Lane 8: B . ovis strain LSU99
Lane 9: B . ovis strain B 025
Lane 10: B . ovis strain B025p81
Lane 11: Purified native Omp25
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Figure A2.2. W estern immunoblot analysis o f cell lysates from 6om p2S mutants with
MAb A76/15H07/E07 specific for the Omp25 protein.
Lane 1: M olecular weight standards
Lane 2: B . abortus strain 2308
Lane 3: B . abortus strain BA2S
Lane 4: B . abortus strain BA2Sp80
Lane S: B. m elitensis strain 16M
Lane 6: B. m elitensis strain BM2S
Lane 7: B. m elitensis strain BM25p80
Lane 8: B. ovis strain LSU99
Lane 9: B. ovis strain B02S
Lane 10: B. ovis strain B025p81
Lane 11: Purified native Omp25

181

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

F igure A2.3. Western im m unoblot analysis o f cell lysates from Aom p25 mutants with
MAb A76/12H09/A05 specific for the Omp25 protein.
Lane 1: Molecular weight standards
Lane 2: B. abortus strain 2308
Lane 3: B. abortus strain BA2S
Lane 4: B. abortus strain BA25p80
Lane S: B. m elitensis strain 16M
Lane 6: B. m elitensis strain BM25
Lane 7: B. m elitensis strain BM 25p80
Lane 8: B . ovis strain LSU99
Lane 9: B. ovis strain B02S
Lane 10: B . ovis strain B025p81
Lane 11: Purified native Omp25
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Figure A2.4. W estern immunoblot analysis o f cell lysates from tsom p25 mutants with
MAb A19/12B10/F04 specific for the Omp25 protein.
Lane 1: M olecular weight standards
Lane 2: B. abortus strain 2308
Lane 3: B. abortus strain BA2S
Lane 4: B . abortus strain BA25p80
Lane 5: B . m elitensis strain 16M
Lane 6: B . m elitensis strain BM2S
Lane 7: B. m elitensis strain BM25p80
Lane 8: B . ovis strain LSU99
Lane 9: B . ovis strain B 025
Lane 10: B . ovis strain B02Sp81
Lane 11: Purified native Omp25
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